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SDMMARY
Previous studies have suggested that gastric carcinogenesis 
is a multistage process involving first gastritis, then intestinal 
metaplasia, dysplasia of increasing severity and finally carcinoma. 
The exact role of intestinal metaplasia in the histogenesis of 
gastric carcinoma has been the subject of much debate. Recent 
work has identified an intestinal metaplasia variant (Type lib) 
which appears to be significantly associated with a particular 
histological type of gastric carcinoma.
The aim of the studies carried out in the preparation of this 
thesis was to investigate the histogenesis of gastric carcinoma 
with particular reference to the role of intestinal metaplasia in 
this process.
The material studied was a series of gastrectomy specimens 
resected for both benign and malignant disease. In addition fetal 
stomachs, endoscopic biopsy material from a group of patients who 
had undergone gastric surgery for peptic ulcer disease, and an 
animal experimental model of gastric carcinogensis were studied to 
examine specific aspects of the carcinogenetic sequence. The 
methods utilised in the studies involved histological assessment, 
mucin and immunocytochemical techniques and cell kinetic analysis.
The results of the histological investigation indicate that 
the presence and amount of intestinal metaplasia in the gastrectomy 
material is related to variables such as age and inflammatory 
change rather than the presence of a tumour. Ihe results also 
demonstrate that the presence of the type lib variant is related to
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age, inflammation and ulceration within the gastrectomy rather than 
the presence of any particular tumour sub-type.
The results of the mucin and immunocytochemical studies 
identified a series of phenotypic changes in the stages of gastric 
carcinogenesis which did not lend support to the role of intestinal 
metaplasia in the histogenesis of gastric carcinoma.
The cell kinetic study documented the changes in cellular 
proliferation that occur in the stages of gastric carcinogenesis. 
A series of cell kinetic abnormalities in the gastric mucosa of 
patients who had undergone gastric surgery for benign disease were 
identified. These abnormalities were shown to be related to 
alkaline reflux gastritis.
It is suggested that intestinal metaplasia and its variants 
do not represent a premalignant stage in the histogenesis of 
gastric carcinoma.
15
CHAPTER 1
nfEROOOCTICN AND lteeraiore review
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BTOttCOCTION
Intestinal metaplasia is defined as the appearance of 
intestinal epithelium in the stomach. The first description of
this phenomenon was by Kupffer in 1883. Earlier this century the 
presence of intestinal epithelium in the stomach was regarded as a 
congenital heterotopia (Taylor 1927), caused by sane "slight error 
of development" and plays "no part in the production of malignant 
disease". 'flie embryological theory of the origin of intestinal 
metaplasia was challenged by Magnus in 1937 with his observation 
"the presence of intestinal epithelium in the stomach is the result 
of the faulty regeneration of surface epithelium in a mucosa 
repeatedly damaged by gastritis and is an example of metaplasia 
resulting from chronic irritation". In his study of 110 
gastrectomy specimens, Magnus illustrated many of the features of 
intestinal metaplasia which have since been repeatedly demonstrated 
by successive studies:
1. Intestinal metaplasia involves the replacement of the
columnar gastric epithelial cells and specialised gastric 
cells by goblet cells interspersed with columnar cells with a 
well developed brush border and Paneth cells at the base of 
the glands, and numerous argentaffin cells.
2. Intestinal metaplasia occurs only in association with
gastritis.
3. Intestinal metaplasia is a common finding and occurs in two-
thirds of gastrectomy specimens removed for both benign and 
malignant disease.
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4. Emphasised the focal nature of the metaplastic process and 
the need to examine large amounts of the gastrectomy specimen 
to determine the true incidence of intestinal metaplasia.
The initial interpretation of intestinal metaplasia as an 
interesting congenital abnormality of the stomach thus shifted to a 
concept of an abnormal regenerative response in a mucosa damaged by 
chronic inflammation. By 1944 Warren and Meissner 
recognised intestinal metaplasia as the main epithelial feature of 
chronic gastritis and proposed the idea that chronic gastritis with 
the associated intestinal metaplasia might be a precursor of 
carcinoma of the stomach.
Three developments of major importance in defining the 
relationship of intestinal metaplasia to gastric carcinoma have 
emerged in the intervening 40 years since Warren and Meissner's 
work.
1. Jarvi and Lauren in 1951 recognised the histological 
heterogeneity of gastric carcinoma but identified a sub-set 
of carcinomas which displayed features characteristic of 
intestinal mucosa. On the basis of this finding they 
proposed a role for intestinal metaplasia in the histogenesis 
of this type of gastric car cinema.
2. The second significant development appeared in consecutive 
papers by Morson in 1955 in the British Journal of Cancer. 
In his first paper, Morson repeated the earlier work of 
Magnus and examined large areas of gastric mucosa from 119 
gastrectomy specimens from patients with duodenal ulcer,
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gastric ulcer and carcinoma. He identified a higher 
incidence and extent of intestinal metaplasia in the stanachs 
removed for malignant disease.
This higher incidence remained even when allowance was 
made for age. In his second paper he illustrated five 
examples of gastric carcinoma arising from areas of 
intestinal metaplasia. This paper by Morson is the most 
frequently quoted reference in the literature on intestinal 
metaplasia and warrants close scrutiny.
The first example described by Morson is of a carcinoma 
with early invasion of the submucosa in a stanach in which 
the gastric epithelium is completely replaced by intestinal 
metaplasia. The second and third examples show transition 
from the metaplastic mucosa to carcinoma involving a gradual 
loss of differentiation of the metaplastic mucosa. The 
fourth and fifth examples show carcinoma in situ change in 
areas of intestinal metaplasia in gastrectomy specimens at a 
distance from the main tumour.
Morson's work is frequently misquoted as evidence that 
intestinal metaplasia is a premalignant state. His 
histological description is not of carcinoma arising directly 
from intestinal metaplasia but of a metaplastic epithelium 
undergoing dysplastic change and transforming into carcinoma 
with intestinal features.
Following Morson's work, Lauren 1965, extended his 
original observations on the histological appearances of
19
gastric carcinoma. He identified two major histological 
types of tumour; an "intestinal type" with features of 
intestinal epithelium as opposed to a "diffuse type" with the 
histological appearance of gastric epithelium. The 
implication of his study was that the two types of tumour 
have different origins, the intestinal type from intestinal 
metaplasia and the diffuse type from gastric epithelium.
From the work of Lauren and Morson intestinal 
metaplasia appeared to have some place in the histogenesis of 
gastric carcinoma. The clinical problem which became more 
apparent with the advent of endoscopic biopsy material was 
that intestinal metaplasia was a common finding in both 
benign and malignant disease. Twenty five years after his 
initial work Morson et al., 1980, defined intestinal 
metaplasia as a premalignant condition. A premalignant 
condition is regarded as a clinical state associated with a 
significantly increased risk of cancer, a premalignant lesion 
is a histopathological abnormality in which cancer is more 
likely to occur than in its apparently normal counterpart. 
Intestinal metaplasia represents the premalignant condition, 
dysplasia the premalignant lesion which may occur in both 
gastric epithelium and intestinal metaplasia.
3. The third most recent work was by Jass in 1980 who identified 
a variant of intestinal metaplasia - type lib which was 
significantly associated with "intestinal type" cancers but 
not with "diffuse type" or benign lesions. Jass suggested
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that this variant might be a premalignant form of intestinal 
metaplasia.
The hypothetical histogenetic sequence outlined in 
Figure 1 is a summation of the work originated by Magnus and 
culminating in lass's description of the type lib variant. 
This thesis is concerned with the investigation of aspects of 
this hypothesis.
The sequence outlined in figure 1 represents a 
simplified hypothesis for the histogenesis of gastric 
carcinoma based on this brief introduction. Chapter 1 is a 
review of the literature which examines the evidence for the 
various stages of the sequence.
The epidemiology, aetiological factors and current 
concepts of therapy and prognosis of gastric carcinoma are 
examined in the first section. In the second part the 
classification systems for gastric carcinoma are detailed and 
discussed. The third part involves a review of the 
premalignant epithelial alterations that occur within the 
stomach and that are outlined in figure 1. The fourth area 
to be reviewed is the phenotypic changes in the gastric 
epithelium that can be identified by mucin histochemistry and 
immunocytochemistry at the various steps of the sequence. 
The fifth section examines the changes in cell kinetics that 
accompany gastric mucosal abnormalities and animal 
experimental models of gastric carcinogenesis. The sixth 
part reviews the relationship of the cell mediated immune
21
POSSIBLE HISTOGENESIS OF 
GASTRIC TUMOUR
Gastric Epithelium
gastritis 
Intestinal metaplasia
Type lib metaplasia
"Intestinal type" tumour "Diffuse type" tumour
Figure 1. Hypothetical sequence for the histogenesis of 
gastric carcinoma.
response in the lamina propria to the gastric epithelial 
changes in the sequence. The final section briefly reviews 
the current knowledge regarding the embryonic development of 
the stomach and the relevance of this to gastric 
carcinogenesis.
Following the literature review a more complex 
hypothetical sequence for gastric carcinogenesis can be 
drawn. The specific aims and areas of interest of this 
thesis are discussed in relation to this sequence at the end 
of Chapter 1.
22
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Gastric carcinoma accounts for 24.8 male and 16.6 female 
deaths per hundred thousand population in England and Wales per 
year (OCPS, 1982). This places stomach cancer as the fourth 
commonest cause of death from malignant disease. As with most 
other cancers the mortality rate rises almost exponentially with 
age.
A constant worldwide feature is the decline in the incidence 
of gastric carcinoma. In terms of mortality rates (world 
standardised) there has been a decline in incidence from 1950-1978 
(Waterhouse, et al.f 1983). Over this period the mortality rate 
in USA and England and Wales has shown an almost linear decline to 
approximately one-half of the initial rate. It has been suggested 
that this worldwide decline may be due to the refrigeration of food 
replacing spices, smoking and pickling in the preservation of 
foodstuffs (Waterhouse et al., 1983).
International comparisons
Crude mortality rates are not suitable parameters to make 
comparisons between different countries because of the differences 
in age structure that exist particularly between industrialised and 
Third World Countries. A comparison of age adjusted mortality 
rates from the Segi Institute of Cancer Epidemiology (1984) 
compares the rates between countries (see figure 2). There is a 
striking variation in the frequency throughout the world. Japan
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Age adjusted male death rates for cancer of the stomach per 100,000 population.
Country Rank Death rate
Japan 1 50.40
Chile 2 46.06
Portugal 6 30.88
Uruguay 12 24.04
Germany 15 22.58
Scotland 20 18.77
England/Wales 22 18.06
Norway 31 14.81
France 35 13.08
USA 42 6.4
Nicaragua 46 0.11
10 20 30 40 50
I  1-------    ‘ I    I ' I
Figure 2. Age adjusted male death rates for cancer of the 
stomach per 100,000 population in various 
countries. Data derived from Segi Institute 
of Cancer Epidemiology (1984).
and the United States, both highly industrialised countries, are at 
the top and near the bottom respectively; and the same disparity 
is true of less developed countries such as Chile and Nicaragua. 
The countries with a high risk of gastric carcinoma have been shown 
to have a high incidence of the "intestinal type" carcinoma (Munoz 
et al., 1968; Correa et al., 1973). Further epidemiological 
studies with age specific comparisons have shown no differences in 
the type, site or morphology of gastric carcinoma between high and 
low risk countries (Kubo, 1974). The controversy regarding this 
point will be further discussed in the classification of gastric 
carcinomas.
AETIOLOGY
Piet
The results of studies into the effect of diet on gastric 
carcinoma have been confusing with uncertain conclusions. Diet is 
difficult to study accurately. In gastric cancer dietary factors 
which may be most important are those of decades before. Eating 
habits are inextricably linked to culture and socio-economic 
status.
The factor in diet considered to be most related to gastric 
carcinoma is nitrate. The nitrate ion itself is relatively 
innocuous, however certain species of bacteria found in the mouth 
and sometimes the stomach can enzymatically reduce nitrate to 
nitrite (Reed et al., 1981). Nitrite represents a potential hazard 
as its participation in nitrosation reactions may give rise to N- 
nitroso compounds which are carcinogenic. Following this argument
24
there might be expected to be a relationship between the level of 
nitrate ingestion and gastric carcinoma. In the most well 
controlled and detailed study in the UK no direct relationship 
between environmental nitrate levels and gastric carcinoma risk has 
been demonstrated (Forman et al., 1985). This apparent lack of 
correlation between environmnental nitrate levels and gastric 
carcinoma may have several explanations. Firstly, nitrates are 
not related to gastric carcinoma or secondly, that exposure to 
nitrates per se does not increase the risk of gastric carcinoma but 
that enzymatic reduction of the nitrate to nitrite is required. 
The experimental evidence to support this second explanation comes 
from studies in the hypochlorhydric stomach . These studies show 
that in conditions of low acidity N-nitroso compounds are generated 
by the presence of nitrate reductase from gastric flora (Reed et 
al., 1981). This rise in gastric pH favouring the production of 
N-nitroso compounds fits well into the hypothesis of atrophic 
gastritis and intestinal metaplasia acting as precursor states 
which predispose to gastric carcinogenesis.
Polycyclic hydrocarbons are potential carcinogens widely 
distributed in food particularly if smoked or grilled. 
Experimental evidence has shown that they produce tumours in rats 
(Dungal, 1961) and may be responsible for the high incidence of 
gastric carcinomas in communities with a high proportion of smoked 
food in the diet.
Two other dietary factors which have been shown to be 
associated with hypochlorhydria and a degree of gastric atrophy are
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the ingestion of salt and protein malnutrition (Thomason et al., 
1980; Joossen and Geboers, 1983). Ihese factors are not thought 
to be carcinogenic but may result in damage to the gastric mucosa, 
cause achlorhydria and create the environment for the formation of 
N-nitroso compounds.
Genetic factors
Apart from sporadic reports in the literature of a "gastric 
cancer family syndrome" in which there is a high incidence of cases 
within a kindred family (Woolf and Isaacson, 1961), there are three 
lines of evidence for a role for genetic factors in the aetiology 
of gastric cancer? blood group associations, predisposing diseases, 
and risk of the disease in relatives of gastric cancer patients.
In 1953 Aird et al., noted that "the frequency of blood group 
A is greater and the frequency of blood group 0 is less in patients 
suffering from cancer of the stomach than in the general population
 ". These findings have been confirmed by other workers
(Roberts, 1959; Hoskins et al., 1965). The increased risk is 
modest, relative risk of gastric cancer in patients with blood 
group A compared to blood group 0 is 1.2. The blood group 
association is linked to the "diffuse" type of tumour, but not the 
"intestinal type" (Correa et al., 1973).
Pernicious anaemia and associated atrophic gastritis are 
thought to constitute a predisposing disease to gastric cancer. 
Pernicious anaemia is genetically determined and is itself 
associated with blood group A (Carter 1969; Callender et al., 
1971). There is debate in the literature concerning the reality
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of the risk associated with pernicious anaemia. The main point of 
dispute is the selection of a normal population to compare with 
pernicious anaemia sufferers. The risk of gastric cancer in 
pernicious anaemia patients has been estimated to be 3-6 times that 
of a "normal population" (Caygill et al., 1984; Svendsen et al., 
1986).
Relatives of patients with gastric carcinomas appear to be at 
risk of developing gastric cancer depending on the histopathology 
of the tumour. Lehtola (1978), in an extensive review showed that 
"intestinal" type carcinoma conferred no excess risk, but relatives 
of patients with the "diffuse type" had a sevenfold risk.
Iatrogenic causes of gastric carcinoma
The possibility that surgical treatment for peptic ulceration 
may be an iatrogenic risk factor in the development of gastric 
carcinoma is a controversial subject. There is a large body of 
published evidence which would appear to support the claim that 
previous gastric surgery for peptic ulceration leads to an 
increased incidence of gastric carcinoma.
The published data suggests that there is a latent period of 
15-20 years from gastric surgery after which the risk of (tying from 
gastric cancer is increased by three to six times in these patients 
(Stalsberg and Taksdal, 1971; Watt et al., 1984C; Caygill et al., 
1986; Viste et al., 1986). The risk appears to be greater in 
patients who have undergone surgery for the treatment of gastric 
rather than duodenal ulcer (Caygill et al., 1987) and a Billroth II 
resection confers greater risk than a Billroth I gastrectomy. The
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increased risk of gastric carcinoma is not restricted to patients 
who have had gastric resection but is also reported following 
truncal vagotomy and drainage procedures (Stalsberg and Taksdal, 
1971; Totten et al., 1983; Caygill et al., 1986). There is sane 
evidence that the latency period between surgery and the 
development of carcinoma is shorter in the vagotomy and drainage 
group than in the gastrectomy patients (Totten et al., 1983; Watt 
et al., 1984C).
The evidence from some studies relying solely on necropsy 
material must be interpreted carefully and not all studies have 
confirmed the increased incidence of gastric carcinoma (Ross et 
al., 1982), following surgery for benign disease.
If one accepts the observed increased risk of gastric 
carcinoma following surgery for benign disease then it is 
important to examine this finding in the context of other causes of 
death in these patients. Most studies demonstrate that the excess 
mortality from smoking related disease was greater by a factor of 
three or more than the total mortality from gastric carcinoma (Ross 
et al., 1982; Caygill et al., 1987). These findings have led 
some authorities to suggest that persuading patients to stop 
smoking after peptic ulcer surgery would be of greater benefit than 
any form of post-operative endoscopic screening programme (Logan 
and Langman, 1986).
The aetiology of this reported higher incidence of gastric 
carcinoma in the post-operative stomach requires to be fully 
answered. Achlorhydria or hypochorhydria resulting in bacterial
28
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Figure 3. TNM staging for gastric carcinoma UICC, AJC and 
JRSSC (1985)
From the monograph "Surgical Treatment and End Results of 
Gastric Cancer" by Dr K Maruyama.
SCHEMA OF T-CLASSIFICATION
GASTRIC CANCER
T 1 T2 T3 T4
- Mucosa 
Submucosa
--- Muscularis propria
... Subserosa 
Serosa
Contiguous structures
Figure 4. Diagrammatic representation of T staging (depth of 
penetration) for gastric cancer.
From the monograph "Surgical Treatment and End Results of 
Gastric Cancer" by Dr K Maruyama.
SCHEMA OF N-CLASSIFICATION
GASTRIC CANCER
N2
CH C LG S PG>3cm
t • V .
"'--■V.v p q < 3Cm
N1
N2 4
Perigastric < 3cm PG
Perigastric > 3cm PG
Left gastric LG
Common hepatic CH
Splenic S
Coeliac C
Figure 5. Diagranmatic representation of N staging (Nodal) 
for gastric cancer.
From the monograph "Surgical Treatment and End Results 
Gastric Cancer" by Dr K Maruyama.
growth and N-nitrosamine formation (Reed et al., 1981) and bile 
reflux (Domellof, 1979) are two of the factors which may be 
implicated in carcinogenesis. The exact mechanism and the 
importance of these post-operative changes require further study. 
HPGNDSIS AW SIEGING
The staging of gastric carcinoma is based on the T. tumour, 
N. Node, and M. Metastasis system. Hie most recent staging system 
was agreed by the UICC, Japanese Research Society for Gastric 
Cancer (JRSSC) and the American Joint Committee (AJC) in 1985 and 
takes into account that survival is most strongly related to both 
the depth of invasion and the lymph node metastasis. This system 
adheres to the basic principle of TNM staging that "each stage 
group is more or less homogenous in respect of survival and the 
survival rates in the four stage groups are distinctive". This 
new TNM classification was based on statistical analysis of 15,589 
cases from Japan and 4,785 cases from the USA of primary resectable 
gastric cancer (figure 3).
The depth of penetration of the tumour is shown clearly in 
figure 4 and is self-explanatory. Hie nodal status employed by 
the Japanese is based on the concept of defined rings of nodes 
(figure 5). nodes are perigastric nodes in the greater or
lesser omenta within 3 cm of the tumour. Spread then continues 
via the arterial supply, left gastric, right gastric and right and 
left gastro-epiploic arteries to involve the coelic, suprapyloric, 
infrapyloric and splenic nodes respectively and these constitute 
the second ring of N2 nodes. The M stage involves metastases to
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different organs ie. liver or nodes outwith the N2 ring. The 
third ring of nodes involves the nodes around the abdominal aorta - 
retrapancreaticoduodenal, middle colic, and hepato-duodenal 
arteries.
Table 1 outlines the major series in the American and 
European literature compared with the figures from the Japanese 
Research Society (1973) published by Maruyama in 1982.
The first (Oschner et al., 1958) and last (Dupont et al., 
1978) series originate from the same American centre. The 5 year 
survival has not increased (and shows a slight decrease) over the 
past 20 years. The Japanese figures show a stark contrast with 
the American and European experience. Although there are minor 
differences in the survival rates in the Western literature there 
is nothing to compare with the difference between the West and 
Japan. The Oriental and Occidental cultures are not only 
different but so is the philosopy to gastric carcinoma; the 
Japanese are reporting increasing resectability rates coupled with 
improving five year survival (whereas in the West an attitude 
approaching therapeutic nihilism prevails). Why is there such a 
difference? Many Western clinicians write off the Japanese 
success by claiming that the Orientals are dealing with a different 
disease, treating at an earlier stage and that the biological 
behaviour of the tumours are different.
What evidence is there for stating that the disease is 
different? Table 2 compares a European series classified 
according to the Japanese histological criteria.
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NO Qf Resectability 5 yr
% survival mortality
Series
Patients
Oschner et al. 1958 193
Remine et al. 1966 11,817 
Nadler et al. 1968 680
Hawley et al. 1970 205
Hoerr et al. 1973 478
Desmond et al. 1976 1,363
Costello et al.1977 226
Cady et al. 1977 
Buckholtz et al.1978 201
* Japanese 1973 12,535
Dupont et al. 1978 1,497
33 7.5% 9.3%
63 20.0% 8.9%
20 13.0%
19.4% 25.0%
63 15.0% 10.0%
53 8.0% 25.0%
66 8.5%
58 10.6% 11.0%
70 11.5%
80 53.25% 1.6%
48 7.4% 26.5%
♦Japanese Research Society for Gastric Cancer (Maruyama, K. 1982)
Table 1: Major published series of gastric cancer with
resectability rates, 5 year survival for 
surgical treatment and hospital mortality.
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Histological Type
Series Tabular Signet- ring cell j&pillary Mucinous Undifferentiated 
Paginini & 62% 10.5% 6.5% 10.5% 10.5%
Rugge 1982
Maruyama et 52% 25.0% 5.0% 4.0% 23.0%*
al., 1982
♦calculated
Table 2: Comparison between histological types of gastric cancer in
Europe (Paginini and Rugge, 1982) and Japan (Maruyama, 1982)
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Hie published standard photographs of the Japanese classification 
correspond to those of the WHO system* From the table (table 2) 
the broad proportions of the tumour types are similar, with 
difference in numbers between the Western and Eastern series it 
would not be appropriate to draw any more detailed comparison.
A more detailed comparison between the European and Japanese 
experience has been undertaken in the specific area of "early 
gastric cancer" (Evans et al., 197 8). Morphologically and 
histologically there appeared to be no difference between the two 
groups and importantly, this study involved discussion between 
Western and Japanese pathologists.
Hie Japanese have the highest incidence of gastric carcinoma 
in the world. Hie combination of screening programmes and high 
public awareness results in 14% of tumours (Miwa, 1979) being 
identified at the T-^ stage, compared with 1-2% in most Western 
series (Kennedy, 1970) . The Japanese have rigid protocols for 
pathological staging and therapy but unfortunately this is not so 
in the West. Large multicentre reports from European centres have 
a complete absence of TNM staging (Lundh, 1974). A higher 
incidence of early lesions in Japanese series does undoubtedly 
improve survival overall. Comparison of stage and survival 
between East and West is difficult because of the aforementioned 
lack of standardisation of criteria. Hoerr's (1973) personal 
series of 498 is the only Western study with adequate pathological 
data that can be compared with the Japanese. Hie overall 5 year 
survival is 15%: comparable to most Western series. However the
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5 year survival rate for patients undergoing a "curative" resection 
was 42%. Hie staging used by Hoerr involved stage Al which was 
defined as superficial cancers with negative nodes and was 
equivalent to Stage I, tumours extending on to the serosa or 
spreading to regional nodes are Stage All, BI and BII in Hoerr's 
classification and Stage II and III in the Japanese classification.
A comparison of the five year survival rates between the 
series published by Hoerr (1973) and the Japanese data from 
Maruyama (1982) is shown in table 3.
This data suggests that the progress in surgically treated 
early lesions is not greatly different between East and West but 
that the Japanese are better at treating more advanced lesions. 
To support this the Japanese have noted that the prognosis of early 
lesions has not changed significantly over the past 20 years, the 
improvement in survival has come from the treatment of advanced 
lesions (Nagata et al., 1983).
Is there a difference in the biological nature of factors 
affecting prognosis between the West and Japan? Hie two factors 
identified by the Japanese which most affect prognosis are the 
depth of penetration of the primary tumour and the nodal status. 
These two factors have also been shown to be the main prognostic 
determinants in several series from the West (Monafo et al., 1962; 
Hawley et al., 1970).
In summary, the Japanese gastric cancers appear 
histologically similar to those in the West. Although the 
Japanese see a greater proportion of early lesions their survival
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Stage X
Japan (Maruyama) 96% (34)
USA (Hoerr) 91% (12)
Stage II + III
53 (21.2)
38 (57)
Stage I = Stage Al (Hoerr) = Superficial tumours,
node negative
Stage II + III = Stage All, BI, BII (Hoerr) = Extension to serosa
± node positive 
(Figures in parentheses % of total number of cases)
Curative Gastrectomy = Resection extends to a greater degree of
Table 3: Comparison of five year survival of "curative" 
gastrectomy between USA (Hoerr, 1973) and Japan 
Maruyama, 1982).
node clearance than the tumour
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figures are better for more advanced lesions and the prognostic 
variables appear similar to those in the West.
TREATMENT
The mainstay of current therapy for gastric carcinoma is 
surgical excision. Surgical treatment may be broadly divided into 
curative and palliative. As the depth of penetration and spread 
to nodes are the two most important prognostic variables, a 
curative resection must be directed towards these factors.
To treat effectively and compare methods of treatment an 
exact definition of therapy is required. The Japanese have 
introduced this concept.
In addition to the TNM staging of gastric carcinoma, the 
Japanese have also introduced the concept of standardisation in the 
type of resections performed for carcinoma of the stomach and by 
such standardisation the type of surgical treatment can be assessed 
ie "curative" or non-curative. Four types of gastrectomy are 
described:
Rq Gastric resection including the incomplete removal of 
lymph nodes of Group 1.
R-^ Gastric resection including the complete removal of 
Group 1 lymph nodes (N^ ).
R2 Gastric resection including the complete removal of 
Group 1 and Group 2 lymph nodes.
R3 Gastric resection including the complete removal of 
Group 1, 2, 3 lymph nodes.
In practical terms the R^ resection involves clearance of the
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No of cases Survival %
Curative resection
Absolute 2,706 78
Relative 823 39
Non-curative resection
Relative 281 16
Absolute 923 1.4
Table 4: Cumulative 5 year survival based on radicality of surgical
resection as determined by histology (Maruyama et al., 1982)
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group of nodes in the lesser and greater omenta. The R2 
resection involves clearance of the N2 and involves splenectomy and 
hemi pancreatectomy. An resection may require partial 
colectomy, hepatectomy, sub total pancreatectomy or pancreatico­
duodenectomy.
For each case the resections are classified into:
(a) Curative resection
A. Absolute curative resection
B. Relative curative resection
(b) Non-curative resection
A. Relative non-curative resection
B. Absolute non-curative resection
An absolute curative resection is defined as R >N ie. the 
resection has extended to a greater degree of lymph node clearance 
than the tumour, a relative curative resection R = N. In both 
these categories M = 0 and resection margins (proximal and distal) 
are greater than 5 cm. In a relative non-curative resection M = 
0, R = N, but resection margins are not clear. In an absolute 
non-curative resection there is clear residual cancer.
This system has the advantage of standardisation and combines 
surgical and pathological data. The prognostic implications of 
the types of resections are shown in table 4.
The Japanese are at a considerable advantage over those in 
the West, being able to perform a large number of curative 
resections. Unfortunately there is no comparable data from 
Western sources as the definition of curative is usually based
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solely on operative staging without pathological input (Lundh et 
al., 1974).
IVo-thirds of patients in the West will have such advanced 
disease (Hoerr, 1973) that palliation is all that can be offered. 
Hhe type of palliation required depends on the clinical context and 
the predominant symptoms. The common distressing symptoms are 
obstruction, pain or haemorrhage.
Failure of therapy
Table 4 shows that approximately 40% of patients who had a 
curative resection failed to survive five years. Ihe pattern of 
recurrence in patients who have had a gastric resection is 
predominantly local and/or regional to the area of the gastric bed, 
or to the regional lymph nodes (Maruyama, 1982).
ftfljwvant -theratg:
To try to overcome the local and regional node recurrence 
attention has been directed to the use of chemotherapy and 
radiotherapy as an adjunct to resection. No randomised controlled 
trial has shown any benefit from adjuvant therapy. However trials 
with multi-agent cytotoxics in combination with radiotherapy are 
being undertaken but no results are yet available.
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EBKE-2
PATHOLOGY AND HISTOLOGICAL CLASSIFICftTIOW
Twmnmmr
Neoplasms of the stomach are predominantly adenocarcinomas. 
In the largest unselected series reported with histological data 
the Third National Cancer Survey 1969-1971 (Cutler and Young, 1975) 
from the USA reviewed 5041 gastric neoplasms, of which 7.2% were 
not adenocarcinoma and comprised lymphomas, squamous carcinomas and 
soft tissue tumours. This thesis deals with adenocarcinomas, any 
reference to gastric cancer or carcinoma may be taken to be 
adenocarcinoma unless otherwise specified.
HISTOLOGICAL CLASSIFICATION SYSTEMS
"All tumours are different. Some tumours 
are more different than others".
The histological classification of gastric carcinoma is a 
complex problem. Any classification system is a compromise; 
artificially grouping tumours into loosely defined categories. 
The biological nature of gastric carcinoma with widely varying 
structure within a single tumour makes attempts at classification 
especially difficult.
There are four main classifications for gastric carcinoma in 
the recent literature: WHO 1977, Mulligan and Rember (1972),
Lauren (1965), Ming (1977). The simplest method of classification 
is on purely descriptive histological grounds and this is the basis 
of the WHO system. The three remaining systems have examined
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gastric carcinoma on a more conceptual level. Mulligan (1972) 
identifies three morphological types of gastric carcinoma and 
relates this to the origin of the tumour from different gastric 
cell types in a histogenetic classification.
Lauren (1965) divides gastric carcinomas into two main types 
on the basis of a combination of morphological variables. Hie two 
types have differing epidemiological and clinical behaviour and 
Lauren himself describes this classification as "histo-clinical".
Ming (1977) divides gastric cancer into two types, 
infiltrative and expanding using the mode of growth of the tumour 
as his main criteria. Like Lauren (1965) this patho-biological 
classification results in two groups of tumours with differing 
clinical and epidemiological features.
These attempts at classification almost reach a complexity 
which mirrors that of gastric carcinoma itself. The fact that so 
many classifications exist serves to illustrate the problem which 
confronts the histopathologist in categorising gastric tumours.
None of the systems are free from criticism. Each attempt 
at defining sub-groups has illustrated seme facet of the histology 
of gastric carcinoma which was previously not appreciated. The 
classifications, which are now discussed in detail, should not be 
regarded as such, but as contributions to the understanding of the 
histological diversity of gastric carcinoma.
The initial classification proposed by Mulligan and Rember 
(197 2) was updated by Mulligan (1975) and is based on a
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histological analysis of 297 gastric carcinomas. Mulligan (1975) 
argues that the gastric mucosa contains a variety of cell types; 
the mucous cells of the crypt surface, the mucous neck cells, the 
pyloric and cardiac gland cells deep in the mucosa of the antrum 
and cardia, parietal and chief cells, metaplastic intestinal 
epithelial cells and Paneth cells. All of these cell types 
theoretically may be progenitors of gastric carcinoma. Using this 
histogenetic concept Mulligan (1975) classifies the tumours into 
three main groups, (1) mucous cell, (2) pyloro-cardiac, (3) 
intestinal cell.
Mucous cell
The hallmark of this type is the signet ring cell. These 
cells are arranged in cords, widely invading and eliciting a stomal 
response in the form of a dense fibrosis with a marked lymphocytic 
infiltrate. Microscopic satellite foci often appear in the mucosa 
adjacent to the main carcinoma. The cell of origin is presumed to 
be from the mucous cells and the mucous neck cells.
Pyloro-cardiac
These tumours tend to be located in the antrum or the cardia 
and are presumed to arise from the pyloric and cardiac gland 
epithelial cells deep in the gastric mucosa. Macroscopically the 
tumours are well demarcated and tend to fungate into the lumen. 
Microscopically the tumours form glands of varying size lined by 
cells which have stratified or in a single layer. The cells vary 
from low to tall but have central to basal nuclei, clear cytoplasm 
and distinct cell borders. The cells are strongly PAS positive.
42
These tumours tend to spread both into the lumen and into the 
deeper layers of the stomach. Deep invasion is not associated 
with inflammatory or fibrotic response unless there is marked 
ulceration of the tumour.
Intestinal Cell
This is subdivided into two types:
Intestinal Cell 1: The tumour is composed of glands formed
from stratification of cells with 
indistinct cell borders and irregular 
nuclei. Polymorphonuclear leucocytes are 
often present in the centre of the glands 
and lymphoid tissue is associated.
Intestinal Cell 2: The tumour is formed by loose sheets of
tumour cells with a few small glandular 
areas with intermingled lymphoid tissue.
Ming Classification
Ming (1977) bases his classification on a study of 171 
gastric carcinomas. Ming argues that the classification systems
previously described are based on purely descriptive histological 
features and do not represent the biological behaviour of the
tumour. His classification divides gastric carcinomas into two
groups, expanding and infiltrative, using the mode of growth of the
tumour. This system incorporates the biological behaviour and the
resultant appearance of the tumour.
Expanding type: The characteristic features of this type is the
presence of aggregates of cells maintaining a
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coherent relationship. The periphery of the 
cell aggregates is sharply delineated and the 
surrounding tissue compressed. The aggregates 
of cells in well differentiated tumours 
contained well formed glands.
Infiltrative, type; In contrast to the first type the tumour cells
are isolated individual cells. Occasional 
aggregates of cells are present. Ihe tumours 
were composed of cells of differing degrees of 
differentiation, the well differentiated cells 
appearing as signet ring cells.
Tanrpn Classification
Lauren drew attention to the intestinal features displayed by many 
gastric carcinomas before Mulligan's publication of his classification 
(Jarvi and Lauren, 1951). Lauren (1965) subsequently reviewed 1344 
cases of gastric carcinoma in an effort to establish whether a distinct 
group of carcinomas with intestinal features could be identified, and if 
by approaching the classification of gastric carcinomas in this manner 
other groups of gastric carcinomas with specific histological properties 
could be determined. On the basis of four structural characteristics 
Lauren divided the tumours into two main groups, intestinal and diffuse.
(1) General structure: Intestinal type carcinoma are composed of
distinct glandular lumina. Diffuse carcinoma 
exhibited single or small clusters of cells with 
little cohesion.
(2) Cell structure: Intestinal type carcinoma are composed of large
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cells of variable shape with irregular 
hyperchromatic nuclei.
The cells lining the glandular lumina possessed a well developed brush 
border. The diffuse tumour cells tend to be smaller and more regular 
in shape with more uniform nuclei. Enterochromaffin cells stained by 
the argyophil and argentaffin technique are more frequent in diffuse 
type car cinema.
(3) Secretion: Mucous secretion products are present in
scattered cells in 80% of the intestinal type 
tumours. In diffuse type carcinomas all
tumours display secreting cells in almost all of 
the tumour cells. In intestinal type tumours 
the secretion forms a distinct theca in the 
cytoplasm: in diffuse carcinomas it is evenly
distributed in the cytoplasm.
(4) Mode of Growth: Intestinal type carcinoma spread in a clearly
defined area, but with variation in structure 
between the centre of the tumour and the 
periphery. Large glandular lumina are present 
in the central area whilst at the margin of 
spread small solid cords of cells.
Diffuse carcinoma forms poorly defined tumours 
and this pattern of growth was consistent 
throughout the tumour.
The mode of growth differ in three other 
aspects:
mucosal infiltration, connective tissue 
proliferation and inflammatory response. 
Intestinal tumours infiltrate the mucosa 
directly above the tumour resulting in 
ulceration. Diffuse tumours spread widely 
within the mucosa and do not result in 
ulceration as the surface mucosa remains intact. 
Diffuse tumours provoke a marked stromal 
proliferation compared with the intestinal type. 
Intestinal type tumours provoked a largely 
polymorphonuclear response whilst diffuse 
tumours provoked a scanty mononuclear 
infiltrate.
COMPARISON OF EgSKXOGIC&L FEATURES
The histological criteria which determines these three 
classifications contain common features. The Lauren (1965) and Ming 
(1977) classification recognise two main categories of tumour. 
Lauren's (1965) description of the mode of growth of the intestinal and 
diffuse type carcinoma is comparable to Ming's (1977) expanding and 
infiltrative type respectively. The mucous cell and intestinal cell 
group of Mulligan coincide with the diffuse and intestinal type of 
Lauren. The Lauren (1965) and Mulligan (1975) classifications differ 
in the recognition by Mulligan (1975)of the pyloro-cardiac gland 
carcinoma as a separate entity, whereas Lauren (1965) includes the 
intestinal cell and the pyloro-cardiac gland cell carcinoma in his 
intestinal type.
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The three classifications have independently divided gastric 
carcinoma into two broad types as shown below (assuming intestinal cell 
and pylorocardiac are grouped together). Figure 6 illustrates 
graphically the sub-division of gastric cancer by Lauren, Mulligan and 
Ming.
The morphological criteria embodied in any classification must be 
easy to apply and be reproducible in order to permit comparisons between 
different research groups. Paginini and Rugge (1982) examined the 
diagnostic agreement between two pathologists in 75 cases of gastric 
carcinoma using the WHO, Lauren, Ming and Mulligan classifications, the 
results of this study are shown in table 5.
The authors ascribe the high figure for the WHO classification as 
being due to the pathologists familiarity with the architectural 
features which form the basis of this classification. The diagnostic 
disagreement in Lauren 's classification was in cases with a high 
content of mucus which the authors found obscured the morphological 
features.
The diagnostic disagreement in the Ming classification occurred in 
cases where the main mass of the tumour exhibited an expanding pattern 
with peripheral areas showing infiltrative features. It is important 
to note that Lauren (1965) draws attention to this pattern in his 
description of the mode of growth of intestinal type tumours. The Ming 
(1977) classification although superficially simpler by concentrating 
solely on the mode of growth according to Paginini & Rugge (1982) 
interpretation has resulted in a greater diagnostic confusion than 
Lauren (1965).
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Comparison of Classification Systems
Classification Number of Histological types
system cases % total
0 10 20 30 40 50 60 70 80 90 100
 1-- 1-----1----1----- 1------ 1- -- 1--- 1----1--- 1
Lauren 1,344 Intestinal 53
Diffuse 33 
Unclassified 14
Ming 171 Expanding 67
Infiltrative 33
Mulligan 297 Intestinal cell 24
Pylorocardiac 28
Mucous cell 45 
Unclassified 3
Figure 6. Comparison of sub-divisions of Lauren (1965), 
Ming (1977) and Mulligan (1972) Classification 
Systems.
HSQ. Lauren Ming. Mulligan
Diagnostic 96% 92% 88% 82.7%
agreement
(Paginini and Rugge, 1982)
Table 5: Diagnostic agreement of classification systems based on study 
with two observers (Paginini and Rugge, 1982).
The poor reproducibility of the Mulligan (1977) classification has 
been noted by other authors (Day and Morson, 1978). The area of 
diagnostic confusion is in the recognition of the pyloro-caridiac cell 
carcinoma as distinct from the intestinal cell type unless obvious clear 
cells are present.
The heterogenous appearance of gastric carcinoma has been 
described previously. There is not only variation between cases but 
marked differences in histological appearance within the same tumour. 
The larger the area of tumour sampled the greater the variation (Day & 
Morson 1978). Extensive sampling of tumour frequently results in more 
than one histological type (in all classification systems) being 
identified (Paginini and Rugge 1982). The application of a 
classification system is then based on the histological appearance of 
the largest area within the tumour (Paginini and Rugge 1982). Therefore 
the observer in classifying the tumours is using the subjective 
impression of the most frequent feature.
CT.TNTCAT, mRRETATTDW OF CLASSIFICATION SYSTEMS
The three classifications also examined the clinical features of 
the sub-types. Lauren (1965) discovered marked differences between the 
intestinal and diffuse types. The intestinal group showed a 2:1 
male:female ratio with a mean age of 55.4 years. The diffuse group had 
a male:female ratio of approximately one and a lower mean age of 47.7 
years. Ming (1977) describes a similar sex ratio; expanding carcinoma 
being twice as common in the male than the female and infiltrative 
carcinoma being equally distributed between the sexes. The age 
distribution also corresponded to that found by Lauren (1965).
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Mulligan's (1975) analysis of the variables of age and sex show 
approximately comparable data if the intestinal cell and pyloro-cardiac 
cell carcinomas are considered together. A striking feature is a 4.13 
male to female ratio for the pyloro-cardiac group alone compared with 
2.81 for all types.
Lauren (1965) assessed the prognosis in 153 cases in which 
curative treatment had been given. Intestinal type had a more 
favourable prognosis with 43% survival at three years compared with 35% 
for diffuse carcinoma. In an age and stage adjusted comparison 
(Stemmerman and Brown 1974) this prognostic difference between Lauren's 
sub-types was confirmed with a 27.4% five year survival for intestinal 
type and a 9.9% five year survival for diffuse type. No difference in 
5 year survival between the intestinal and diffuse types was seen in one 
series (Hawley et al., 1970), however, in this series the age and stage 
of tumour were not taken into account.
Mulligan (1975) in evaluating the prognostic significance of his 
classification describes the stage of the sub-types of tumour in terms 
of extension outwith the stomach: 92.4% of mucous cell carcinomas,
77.8% of pyloro-cardiac gland tumours and 58.7% of intestinal cell 
tumours extended outwith the stomach. These differences in stage are 
reflected in corresponding differences in prognosis. No data is 
available for stage adjusted data using the Mulligan system so 
differences in biological behaviour between the sub-types is impossible 
to assess.
Ming (1977) although claiming that there is a survival difference 
between his two types of tumour, produces no data to support this and
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merely quotes the survival data for intestinal and diffuse type.
The largest series of survival data based on the WHO 
classification is from a Japanese series (Maruyama 1982) which gives 
five year survival rates of 74% for well differentiated tubular 
adenocarcinoma, 61% for moderately differentiated tubular 
adenocarcinoma, 54% for signet ring cell, 46% for poorly differentiated 
carcinoma, 46% for papillary carcinoma and 39% for mucous carcinoma. 
EPIDEMIOLOGICAL APPLICATION OF CLASSIFICATION SYSCEMS
Extensive epidemiological data is available on the Lauren 
classification. Hie marked worldwide variation in the incidence of 
gastric carcinoma has been previously described. The incidence of 
diffuse carcinoma is similar between high risk and low risk areas, the 
excess of stomach cancer in high risk areas is predominantly of 
intestinal type (Munoz et al., 1968). This data is supported by migrant 
studies (Correa et al., 1973). Migration of Japanese from high risk 
Japan to low risk Hawaii results in a decrease in intestinal tumour 
incidence whilst the diffuse type incidence is not significantly 
altered. Hie two studies quoted (Correa et al., 1973; Munoz et al., 
1968) which support the concept of two distinct types of tumour with 
differing epidemiology are both by protagonists of the Lauren 
classification. The differing incidence of intestinal and diffuse type 
tumours has not been supported by other studies (Kubo 1974) and in this 
study the age distribution of the populations was taken into account. 
IMPLICATIONS FOR HISTOGHESIS
Lauren (1965) describes four structural characteristics of the 
tumour as the basis for his classification system. It is important to
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note that his original description does not include any allusion to 
metaplasia in the mucosa adjacent to the tumour as a criteria used in 
the classification. What Lauren (1965) does describe is that once 
classified on structural characteristics the intestinal type tumours are 
surrounded by mucosa with a higher incidence and severity of intestinal 
metaplasia than the diffuse type. Although this may seem a subtle 
point it is important. The Lauren (1965) classification has been 
"modified" by several authors (Jass 1980) so that the presence of 
intestinal metaplasia adjacent to a tumour is used as one criteria for 
classifying that tumour into the intestinal group.
On the basis of the histological features, the differing age and 
sex characteristics, prognosis and intestinal metaplasia in the adjacent 
mucosa Lauren put forward the hypothesis that there are two biologically 
different types of gastric carcinoma with differing aetiology and 
pathogenesis. Although there is some conflict in the epidemiological 
data, the majority of work supports this hypothesis. Although the 
Lauren classification identifies and the epidemiological data appears to 
confirm two biologically distinct tyepes of gastric carcinoma, the 
histogenesis of the two types remains hypothetical. The inference is 
often made that the intestinal type arises from intestinal metaplasia 
and the diffuse type from "true" gastric epithelium. The evidence for 
this histogenetic sequence is discussed in the next chapter.
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EBKE.3
EBSESMCERQPS SIMES OF THE GASTRIC MUCOSA
The term precancerous states in the chapter title is used in 
the broadest sense and includes both precancerous conditions and 
precancerous lesions as defined by Morson et al., 1980. The 
precancerous states generally recognised in the stomach are 
gastritis, intestinal metaplasia, gastric ulcer, gastric polyps and 
Menetrier's disease.
GftSmTIS
Histological appearance
The term "gastritis" means "many things to many men" (Warren 
and Meissner 1944). To the clinician it means a change in colour 
of the gastric mucosa visible endoscopically, to the pathologist it 
means a wide range of histological appearances. Generally the 
term gastritis implies inflammation of the gastric mucosa. 
Histologically gastritis is characterised by two distinct changes; 
an inflammatory component and alteration in the epithelial 
structure. These two components display a broad range of 
severity. At the extremes of severity different histological 
features are clearly seen but as the various stages probably 
represent different steps in one dynamic process, the distinction 
between successive grades are not so clear cut.
The inflammatory component in mild forms consists 
predominantly of polymorphs in the superficial layer of the 
epithelium. More severe inflammation is typified by the presence 
of chronic inflammatory cells with plasma cells in the upper layers
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and lymphocytes in the lower layers of the mucosa often forming 
follicular lymphoid aggregates.
The epithelial component ranges from loss of one or two 
tubules to almost complete loss of all tubules. This atrophy is 
normally associated with severe inflammation in the deeper layers. 
The atrophy of gastric tubules coincides with the development of 
metaplastic glands and an end stage is recognisable with severe 
atrophy of gastric tubules, widespread intestinal metaplasia with 
lymphoid aggregates and a negligible inflammatory infiltrate. 
Histological classification
A variety of classifications of chronic gastritis have been 
proposed (Motteram 1951; Whitehead et al., 1972). Two major sub­
divisions are advocated; superficial and atrophic gastritis. 
Superficial gastritis involves only the superficial epithelium 
above the level of the gastric pit. Atrophic gastritis is defined 
as deep extension of the inflammatory infiltrate around the tubules 
associated with atrophy of the tubules which may be classified as 
mild, moderate or severe. The end stage lesion is often termed 
"gastric mucosal atrophy" or "gastric atrophy" to emphasise the 
severe loss of gastric epithelium and quiescent inflammatory 
component.
A scoring system has been devised to grade chronic gastritis 
(Watt et al., 1983). Two separate scores ranging from 0 - 6  are
given depending on the severity of the inflammatory component and 
the degree of atrophy. This numerical scoring system allows for 
statistical comparisons between different groups to be made but has
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simply replaced a descriptive histological term with a nunber. 
Aetiology o f G a s tr itis
Gastric Mucosa —  > Chronic Gastritist
? STIMULUS
The stimulus which induces the inflammatory change leading to 
chronic gastritis is of vital importance.
The first step in unravelling the aetiology of chronic 
gastritis was the recognition that chronic gastritis may result 
from differing stimuli. Strickland and McKay (1973) recognised 
two distinct types of atrophic gastritis, type A and type B on the 
basis of gastric morphology, function and pathogenesis. Type A 
gastritis involves a diffuse atrophy predominantly in the fundus 
and is associated with parietal cell and intrinsic factor 
antibodies and decreased acid secretion. Type B gastritis which 
was the most prevalent type was focal in distribution predominantly 
in the antrum and was associated with an absence of antibodies to 
parietal cells and only slightly impaired acid secretion. The 
aetiology of type A gastritis on the basis of this evidence is 
related to pernicious anaemia. The aetiology of the numerically 
larger group type B remained speculative with ingestion of alcohol, 
salt and salycylates or the reflux of bile being promoted as 
possible factors.
The commonest cause of acute inflammation is bacterial 
infection in any body system. The secretion of acid by the stomach 
constitutes a major non-specific defence mechanism. Until
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recently the normal stomach has been regarded as virtually sterile 
with bacterial counts less than 105 organisms/ml. Reduction in 
acid secretion predisposes to infection with a variety of organisms 
- tubercle, salmonellae, brucella and dysentery bacilli. 
Infection with these organisms are rare clinically. The 
description of campylobacter-like organisms (CLO) in a high 
percentage of gastric mucosal biopsies by Warren and Marshall in 
1984 identified a possible infective agent responsible for 
gastritis, and aetiological factor for peptic ulceration.
Hie campylobacter-like organisms have been identified as gram 
negative, flagellate and micro-aerophillic and have recently been 
named as Helicobacter pylori. Hie organism appears to lie close 
to the mucosal surface deep to the mucus layer (Steer 1985). 
Numerous studies have shown a significant association between the 
presence of the Helicobacter pylori and histological gastritis 
(Rollason et al., 1984; Jones et al., 1984). Hie relationship 
between the organism and peptic ulcer disease is still disputed 
with some authors finding no significant association (Forrest et 
al., 1984; Langenberg et al., 1984) whilst others have 
demonstrated a significant association (Warren and Marshall 1984).
The exact role of Helicobacter pylori in gastric pathology 
requires further clarification and the current hypotheses advanced 
regarding the organism and peptic ulceration are outwith the scope 
of this thesis. The original observation of Magnus 1937, that 
gastritis results from a mucosa repeatedly damaged by chronic 
irritation suggests that Helicobacter pylori may at least in some
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cases represent the cause of the chronic irritation. Correa
(1984) in his hypothetical aetiological model of gastric 
carcinogenesis present chronic superficial gastritis as the initial 
step in the carcinogenetic process. The cause for the chronic 
superficial gastritis has been presumed to be ingested dietary 
contents such as alcohol, salt and salicylates. What evidence is 
there to suggest that Helicobacter pylori may play a role in this 
process and how is this related to the development of intestinal 
metaplasia and carcinoma?
There is now considerable evidence that the presence of 
Helicobacter pylori in the gastric mucosa is significantly 
associated with chronic active gastritis. Does the organism cause 
the gastritis or is it simply an opportunist capable of colonising 
an altered environment caused by the gastritis? Marshall himself 
answered this question by ingesting a culture of Helicobacter 
pyloridis and proving Koch's third postulate that the organism 
reproduces the gastritis when inoculated into a susceptible host 
(Marshall et al., 1985). Serological studies have also shown a 
strong correlation between the presence of the organism, detectable 
circulating antibody and gastritis implying a host response to the 
organism (Jones et al., 1984). Immunoperoxidase studies on 
gastric biopsies demonstrate IgA, IgM, and IgG coating of 
Helicobacter pylori again implying a host response to the organism 
(Wyatt et al., 1986).
Gastritis in the post-operative st-rmach
In addition to the genetic cause and possible infective cause for 
gastritis attention has been directed to iatrogenic causes - namely
57
gastric surgery for benign disease.
The development of gastritis has been reported after both 
Billroth I and Billroth II gastrectomy and after proximal gastric 
vagotomy alone and in combination with gastro-enterostcmy (Pulimood 
et al., 1976; Roland et al., 1975; Watt et al., 1983). Gastric 
mucosal abnormalities have been reported to occur more frequently 
in patients after gastric surgery than in age and sex-matched 
controls (Savage and Jones 1979; Watt et al., 1983).
A significant increase in dysplasia, the frequency and 
severity of gastritis and intestinal metaplasia have been described 
in the post surgical group compared with medically treated peptic 
ulcer patients (Watt et al., 1983). Post-operative gastritis 
occurs even when there has been no surgical manoeuvre to physically 
alter drainage of the stomach ie. highly selective vagotomy (Dewar 
et al., 1983).
The two factors which may cause gastritis post-operatively 
are reflux of alkaline small bowel contents (often termed bile 
reflux) and an increase in the gastric pH with subsequent N-nitroso 
compound formation.
The exact role that the reduction in gastric pH or of bile 
reflux (that occurs after most forms of gastric surgery) play in 
the aetiology of the gastric mucosal abnormalities is difficult to 
differentiate. Ihe changes in peak acid output following proximal 
gastric vagotomy alone are not sufficient to explain the subsequent 
gastritis. Highly selective vagotomy has been shown to result
in less severe post-operative gastritis and bile reflux than other 
types of surgery (Dewar et al., 1983) but unfortunately the effect
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of changes in pH were not determined in this study.
A significant correlation between high pH and the incidence 
of gastric mucosal abnormalities has been demonstrated in patients 
after vagotomy and gastroenterostomy. However the high pH 
correlated with nitrite concentration but not with total N-nitroso- 
compound concentration (Watt et al., 1984B).
Reflux Gastritis
The concept of gastritis caused by the reflux of alkaline 
bile containing duodenal or small bowel contents has been gaining 
acceptance (Dewar et al., 1983; Ritchie 1984). The term "bile 
reflux" has now been changed for the more accurate and descriptive 
terminology - alkaline reflux gastritis (Ritchie 1984). Alkaline 
reflux gastritis is a common clinical problem causing considerable 
morbidity in patients after gastric surgery. Alkaline reflux 
gastritis has recently been shown to have distinct histological 
features compared with other types of gastritis (Dixon et al., 
1986). The main and most distinctive mucosal abnormality is an 
elongation, tortuosity and hypercellularity of the gastric pits 
leading to foveolar hyperplasia. This gives the mucosa a
villous appearance (Dixon et al., 1986; Niemela et al., 1987). In 
addition to this foveolar hyperplasia there is vasodilatation and 
congestion of capillaries in the superficial lamina propria; 
oedema and increased numbers of smooth muscle fibres in the lamina 
propria. Although this may appear to be a contradiction in terms 
in the description of a gastritis there is a striking paucity of 
neutrophil polymorphs and chronic inflammatory cells in the lamina
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propria (Dixon et al., 1986).
Dixon et al., 1986, combined these histological features to 
give a composite reflux score. The variables were graded from 0-3. 
The inflammatory cell infiltrate was graded in an inverse manner 
with 0 representing a severe increase to 3 representing normal or 
reduced numbers. The reflux score was shown to be correlated to 
the bile acid concentration and hypochlorhydria in the stomachs of 
post-operative patients who had undergone their surgery for peptic 
ulcer disease. The histological scoring system for the reflux 
score is shown in table 6.
The importance of Dixon's work is that it has drawn attention 
to changes in the mucosal architecture which appear to result from 
alkaline reflux gastritis. The foveolar hyperplasia has been 
noted by other authors (Niemela et al., 1987) but the radical 
concept that reflux gastritis is characterised by a decrease in 
inflammatory cell infiltrate has not yet gained acceptance. The 
foveolar hyperplasia found with alkaline reflux gastritis may be 
misinterpreted as dysplasia and this may account for the finding of 
this mucosal abnormality in endoscopic surveys of post-operative 
patients (Watt et al., 1983; Watt et al., 1984B).
The mechanism by which reflux of the alkaline bile containing 
small bowel contents cause gastric mucosal injury is not entirely 
explained. Bile acids act to remove membrane-associated material 
from cells and act as co-carcinogens in experimental models of 
gastric carcinogenesis (Domelloff 1979) . Small bowel contents 
appear to have a trophic action on the progenitor cells in the
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RHFLDX GASmrnS SCORING SXSTEM
Histological variahlps Score
Foveolar hyperplasia
Oedema and smooth muscle fibres 0-3 for each
Vasodilatation and congestion variable
Polymorphonuclear infiltrate 
Chronic inflammatory infiltrate
Total score possible 15
NB. Polymorphonuclear and chronic inflammatory 
infiltrate were graded in an inverse manner 
ie 0 = severe increase in cells,
3 = normal number of cells 
after Dixon et al., 1986.
Table 6s Reflux gastritis scoring system described by 
Dixon et al., 1986.
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gastrointestinal tract and increased cell proliferation (Weser et 
al., 1977). This may be the mechanism for the development of the 
foveolar hyperplasia.
Relationship of chronic gastritis to gastric cancer
The reported increased incidence of gastric carcinoma in 
patients with pernicious anaemia and type A gastritis has been 
discussed in Part 1. There have been several reports of a high 
incidence of gastric carcinoma in patients with type B gastritis. 
There appears to be an approximately 10% incidence of gastric 
carcinoma developing in patients with chronic gastritis after 15-23 
years follow-up (Walker et al., 1971; Siurala et al., 1974). 
Epidemiological surveys indicate that chronic gastritis is more 
prevalent in high risk than low risk populations for gastric 
carcinoma, and that it occurs at a younger age group (Correa et 
al., 1976).
The increased incidence of gastric carcinoma in post­
operative reflux gastritis has been discussed in Chapter 1, Part 1. 
INTESTINAL METAPLASIA
Metaplasia is defined as the transformation of one type of 
differentiated tissue into another (Muir's Textbook of Pathology 
(1978)). Intestinal metaplasia has been regarded as the 
histological hallmark of chronic gastritis and intestinal 
metaplasia is thought to represent an adaptive change of the lining 
epithelium to a type likely to be more resistant to injury.
The classical description of intestinal metaplasia in the 
stomach is of an epithelium identical to that of the small
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intestine. The metaplastic glands are formed by two main types of 
cell - the goblet cell and columnar absorptive cells with a well 
developed brush border. At the base of the glands Paneth cells 
are frequent and neuro-endocrine cells are present.
Hpchanism of metaplastic transformation
The gastric crypts are formed by division of stem cells in 
the neck of the glands (Winawer and Lipkin 1969). Division of stem 
cells produces columnar mucus cells which migrate upwards and the 
specialised parietal and peptic cells which migrate downwards 
(Stevens and Leblond, 1953; Creamer et al., 1961; Winawer and 
Lipkin 1969) . The transformation to metaplastic epithelium 
involves the proliferation of the stem cells into goblet and 
columnar absorptive cells (Mukawa et al., 1987). This process 
results in the gradual development of metaplastic glands. The 
stimulus for this change in differentiation of the stem cells has 
classically been thought to be chronic inflammation ie. chronic 
gastritis (Warren and Meissner, 1944). Recent histological studies 
have identified that minute foci of intestinal metaplasia are 
associated with areas of regenerative epithelium formed during 
healing of erosions. The aetiology of the erosions was not 
determined and chronic gastritic changes were apparent in the 
mucosa examined in this study (Mukawa et al., 1987).
The origin of intestinal metaplasia in the neck zone of 
gastric crypts affected by inflammation explains the focal 
distribution of metaplasia often seen in gastrectomy specimens 
(Stemmerman and Hayashi 1968). Sane authors have questioned the
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association of intestinal metaplasia with chronic gastritis because 
of the absence of lymphoid aggregates or lymphocytic infiltration 
in areas completely replaced by metaplasia. This absence of an 
inflammatory component may be explained by the concept of 
metaplasia and consequent gastric atrophy representing the end 
stage of the inflammatory process.
Inherent in the transformation involved in metaplasia is that 
some biological advantage is accrued. Histologically there is a 
reduction in inflammation in areas with metaplasia. The recent 
identification of Helicobacter pylori as a common cause for type B 
gastritis may explain the biological advantage (Warren and 
Marshall, 1984).
A consistent feature in the reports concerning Helicobacter 
pylori is the absence of the organism in foci of intestinal 
metaplasia (Rollason et al., 1984; Steer 1985) in stomachs in which 
the organism was present. This finding leads to the hypothesis 
that intestinal metaplasia may represent a host response which 
results in eradication of the organism. Isaacson (1982) in a 
study performed prior to the recognition of Helicobacter pylori 
illustrated the adaptation of gastric epithelial cells to 
inflammation by synthesising secretory component and transporting 
IgA. This ability of the gastric epithelium is strikingly 
enhanced in areas of metaplastic epithelium (Valnes et al., 1984). 
Does the enhanced secretory immunity demonstrated in intestinal 
metaplasia result in eradication of the organism and the resolution 
of the associated gastritis?
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Relationship Of intestinal metaplasia i-n gastric carcinrraa
The finding of extensive intestinal metaplasia in gastrectomy 
specimens removed for gastric carcinoma was the initial stimulus 
for interest in intestinal metaplasia as a possible precancerous 
state (Morson 1955A) . The incidence and the severity of 
intestinal metaplasia has consistently been shown to be higher in 
stomachs removed for malignant disease rather than for benign 
disease (Morson 1955A; Stemmerman and Hayashi 1968). Furthermore 
the distribution of intestinal metaplasia in the pyloric antrum 
corresponds to the commonest site for gastric carcinoma (Morson 
1955A). These findings are not consistent, however, and some 
authors have described individual gastrectomy specimens removed for 
carcinoma with little or no evidence of metaplasia (Stemmerman and 
Hayashi, 1968).
The description of two types of gastric carcinoma, a diffuse 
type and intestinal type by Lauren (1965) may explain this absence 
of metaplasia adjacent to some tumours. The intestinal type of 
tumour appears to be associated with marked metaplasia whereas the 
diffuse is not (Lauren 1965; Ming 1967; Stemmerman et al., 1977). 
This histological evidence is supported by epideniological studies 
in which the incidence of metaplasia runs parallel to that of the 
intestinal type tumour (Munoz and Matko 1972).
The evidence presented above supports an association with 
intestinal metaplasia and intestinal type cancer but the causal 
sequence is not defined. There are three possible explanations of 
the association.
1. Intestinal metaplasia transforms into intestinal type of
cancer.
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2. Intestinal metaplasia and gastric carcinoma arise from a 
common stimulus to the undifferentiated stem cells of the 
gastric mucosa.
3. Intestinal metaplasia within the stomach results in an 
environment ie. rise in pH, nitrate formation that increases 
the exposure of the gastric mucosa to carcinogens.
The first explanation has attracted the greatest interest. 
There are two arguments proposed to counter this. Firstly that 
small intestinal tumours are rare lesions and that malignant 
transformation of mature small intestinal epithelium in the stomach 
would seem unlikely.
Second that intestinal metaplasia is a common abnormality, 
occurring in 20- 37% endoscopic biopsies (Rothery and Day 1985; 
Filipe et al., 1985). This problem has vexed the histopathologist 
as the presence or absence of intestinal metaplasia has no easily 
definable prognostic value when detected in endoscopic biopsies.
The realisation that intestinal metaplasia was not a 
homogenous entity brought renewed interest in the structure of 
intestinal metaplasia. Several variants and classifications of 
intestinal metaplasia have been described in an attempt to identify 
a sub-group of intestinal metaplasia that might represent a 
possible "marker" for gastric cancer in biopsy material. Three 
main classifications of intestinal metaplasia have been proposed. 
The literature is confusing as different authors have used 
differing criteria for their systems. The three classifications 
and relationship to gastric carcinoma are discussed below.
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Classification of Intestinal Metaplasia
Complete and incomplete metaplasia
Ming et al., (1967) in an ultrustructural study first 
identified columnar cells in the gastric mucosa affected by 
intestinal metaplasia that had characteristics of both intestinal 
and gastric foveolar epithelia. These cells contained small 
amounts of mucus granules and rudimentary microvilli and were 
thought to represent intermediate forms in the transition from 
gastric to metaplastic epithelium. Further studies identified 
complete glands of intestinal metaplasia containing these abnormal 
columnar cells, and these were regarded as being an intermediate 
type of metaplasia which eventually would develop into complete 
metaplasia and the term incomplete coined (Iida et al., 1978). The 
enzyme and mucin histochemistry of this variant have been 
characterised by other authors and the results summarised in the 
table 7 (Matsukara et al., 1980A).
Studies on gastrectomy specimens have identified an 
association between the incomplete variant and the intestinal type 
of gastric carcinoma. The hypothesis that incomplete metaplasia 
is an immature type and that the intestinal type of gastric 
carcinoma originates from this variant is proposed on the basis of 
these findings (Matsukara et al., 1980B).
"Small Intestinal Type" and "Colonic Type"
Histochemical methods identified different type of intestinal 
metaplasia with differences analagous to those existing between 
normal colonic and small intestinal mucosa (Abe et al.., 1974;
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Goblet cells 
Columnar cells
Paneth cells 
Enzymes
Complete
Present, mainly 
sialomucins
Well developed 
brush border
Present
Sucrase, leucine 
aminopeptidase 
trehalase, alkaline 
phosphatase
Incomplete
Present mainly 
sulphomucins
Absent brush border 
mucingranules with 
neutral or sulpho- 
mucins
Absent or reduced
Sucrase, leucine 
aminopeptidase
Table 7: Characteristics of "complete" and "incomplete" intestinal 
metaplasia in terms of mucin and enzyme histochemistry 
and cell types.
Teglebjaerg and Nielsen 1978). On the basis of the type of mucus 
detected in the goblet cells a "small intestinal type" was found to 
be the predominant type with neutral mucins and sialomucins 
predominating in the goblet cells whereas the "colonic type" 
contained 0-acetytl and sulphomucins (Teglebjaerg and Nielsen 
1978). Unfortunately the mucus profile of the columnar cells was 
not discussed. The "colonic type" of tumour was found 
significantly more frequently in association with tumours of 
presumed intestinal histogenesis than in those with tumours of 
prescribed non-intestinal histogenesis. Hie incidence of the two 
sub types was not determined in non-malignant stomachs.
The classification into "small intestinal" and colonic type 
has certain drawbacks. Firstly the classification ignores the 
columnar cells and any mucus contained within than. Secondly the 
term "colonic" is a misnomer as the crypts do not resemble colonic 
epithelium and the presence of sulphomucin is not solely restricted 
to the colon (Filipe 1979).
The Jass Classification of Intestinal Metaplasia
Prior to the description of the incomplete sulphomucin 
positive type by Matsukara et al.f (198QA), Jass and Filipe (1979) 
reported a similar variant with similar histological features. 
Jass (1980) followed this in the following year with a paper 
outlining a simple classification for intestinal metaplasia and the 
relationship of the sub types to gastric neoplasia. Hie crucial 
aspect of this classification was that it combined the mucin 
histochemistry of the goblet and columnar cells with the
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morphological features of the metaplastic epithelium.
The intestinal metaplasia is divided into two types, I and II 
on the basis of the nature of the columnar cells. In type I 
metaplasia the columnar cells possessed a brush border, this type I 
with goblet cells and columnar absorptive cells is equivalent to 
the complete type of Ming (1967). The type II metaplasia is 
characterised by the loss of the brush border and the presence of 
mucus in the cells. The type II is further subdivided into type 
Ila in which the columnar cells secrete neutral mucins, in type lib 
the columnar cells were distended with mucus and stained strongly 
for sulphomucin. In addition to the presence of mucin in the 
columnar cells the goblet cells showed differences in the nature of 
their mucin; in type I the goblet cells contained a mixture of 0 
and N-acetyl sialomucin, in type II N-acetyl mucins predominated 
and 0-acetytl mucin was absent. The crypts of type Ila and b also 
varied in structure. The type lib crypts were elongated and with 
an increase in cell height and branched cryps (see figure 7).
In his series of 48 gastric carcinomas and 25 benign 
specimens, Jass found that type lib was significantly associated 
with gastric carcinomas of the "intestinal type". The advantages 
of the Jass classification are its simplicity and combination of 
easily recognisable morphological and histocbemical variables. 
The histochemical techniques can be easily applied to formalin 
fixed paraffin embedded material which allows for greater 
application than the more sophisticated enzyme histochemical 
techniques. One of the main criticisms of Jass's work is the
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DIAGRAM OF JASS CLASSIFICATION 
Jass J.R., JCIinPath.,1980
Type I
Type n a
0/ o
Type II b
o Neutral mucins 
o Sialomucins 
© O-acetyl Sialomucins 
•  Sulphomucins
Figure 7. Diagrammatic representation of Jass Classification 
of intestinal metaplasia based on cell type and 
mucin histochemistry (after Jass, JR., 1980).
classification of tumours which did not adhere strictly to Lauren's 
(1965) definition. The use of a scoring system in which 
"extensive intestinal metaplasia round the tumour" is likely to 
result in an "intestinal" classification. This will inevitably 
result in tumours with extensive metaplasia and a higher chance of 
the type lib sub type being classified as intestinal type and thus 
forming a circular argument.
Studying gastrectomy specimens is somewhat like shutting the 
gate after the horse has bolted. If type IIB metaplasia 
represents a variant of intestinal metaplasia associated with 
carcinoma then its detection in endoscopic biopsy specimens may be 
of value in the clinical situation.
A review of 1,465 endoscopic biopsies reviewed from a four 
year period showed that type lib metaplasia was significantly 
associated with gastric carcinoma (Rothery and Day, 1985) . In 
addition to this the frequency of type I, Ila and lib was assessed 
(see table 8).
This study shows that type IIB metaplasia is not solely 
restricted to carcinoma, occurring in dysplasia and benign 
conditions. The presence of type IIB variant in benign conditions 
does not negate the association of this variant with gastric 
carcinoma as careful follow-up of these individuals would be 
required to determine if they subsequently develop car cinema.
A retrospective study has been reported in which the question 
of the role of type lib metaplasia as a marker of premalignant 
change has been partially answered (Ectors and Dixon 1986). After
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Diagnosis Types, of Intestinal Metaplasia
I Ila Ilk
Chronic gastritis 92% 31% 4%
Benign gastric ulcer 89% 42% 5%
Gastric dysplasia 100% 41% 7%
Gastric carcinoma 90% 19% 11%
Table 8: Frequency of Intestinal Metaplasia subtypes in 
Endoscopic Biopsies (Rothery and Day, 1985)
an eight year follow-up of 230 patients with chronic atrophic 
gastritis none of 28 patients with type lib metaplasia identified 
developed gastric carcinoma. This indicates that the finding of 
type lib on endoscopic biopsy material does not appear to confer a 
short term risk for the development of gastric carcinoma. This 
fact though of great clinical value does not fully answer the 
question of whether type lib does have the potential to undergo 
malignant transformation.
A prospective multicentre study of gastric biopsies is 
currently under way (Filipe et al., 1985) but to date only the 
preliminary results are available that have shown an incidence and 
distribution of sub-types similar to those of Rothery and Day
(1985). The results of this study should hopefully establish the 
clinical value of detecting the variants of intestinal metaplasia 
in gastric biopsies.
The Jass (1980) classification is simple, can be applied in 
paraffin embedded material using techniques available in most 
routine diagnostic laboratories, and allows comparison of results 
from different centres. Type lib metaplasia and its relationship 
to intestinal type carcinoma as originally described by Jass (1980) 
appears superficially to be a strong candidate for a premalignant 
variant of intestinal metaplasia. However its finding in benign 
stomachs by subsequent studies (Rothery and Day 1985; Ectors and 
Dixon 1986; Filipe et al., 1985) and its lack of prognostic 
significant raises doubts. The finding that type lib was present 
in a significantly older age group (Rothery and Day 1985; Ectors
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and Dixon 1986) may indicate that the production of variant is 
simply a reflection of the duration and severity of gastric mucosal 
injury in older patients. As gastric carcinoma arises in this 
older age group the co-existence of type lib with carcinoma may 
result by chance rather than being a premalignant change. 
Alternatively type lib may represent a reactive phenomenon to 
malignant transformation.
Quantification of intestinal metaplasia
Intestinal metaplasia is a focal condition and the degree of 
intest inali sat ion of the gastric mucosa ranges from one or two 
crypts to almost complete replacement (Magnus 1937; Morson 1955A). 
The majority of published work has used semi-quantitative 
subjective assessments of the amount of intestinal metaplasia. 
Morson (1955) used a three part grading system; Grade I - 
scattered islands of intestinal epithelium, Grade II approximately 
half the mucosa affected by metaplasia, Grade III more than half 
the mucosa affected. Jass (1980) employed a similar semi- 
quantitative system but with different values for the grades viz:
Little or none +/0 (<5%)
Moderate ++ (5-20%)
Extensive +++ (20-100%)
These grading systems are extremely subjective and give only 
a broad indication as to the extent of intestinal metaplasia. 
They are, however, better than simply defining the presence or 
absence of metaplasia as is performed by some authors (Teglebjaerg 
and Nielson 1978).
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An attempt at a more objective means of quantification has 
been produced (Rubio et al., 1985). An Intestinal Metaplasia 
Index was established by calculating the ratio between the length 
of mucosa affected by metaplasia and the length of gastric mucosa 
examined. The advantage of such a system is that statistical 
comparisons between benign and malignant specimens and intestinal 
and diffuse tumours can be made. Unfortunately the report using 
the quantitative data did not mention the statistical tests used. 
Although the report appeared to confirm the semi-quantitative 
findings of a higher degree of metaplasia in malignant stomachs 
than benign and in intestinal type rather than diffuse type, the 
lack of adequate statistical methods renders this finding 
valueless.
DYSPLASIA
Histological features
Epithelial dysplasia is recognised as the precancerous lesion 
in the stomach which may occur in gastric epithelium or in 
intestinal metaplasia (Morson et al., 1980). Dysplasia has been 
defined as having three histological features: (1) cellular atypia
(2) abnormal differentiation (3) disorganised mucosal architecture. 
According to the severity of the changes dysplasia is classified 
into three grades, mild, moderate and severe. Although 
deceptively simple this classification has three major drawbacks
(1) histological intrepretation (2) reproducibility and (3) 
prognostic significance.
Histological interpretation:
Where does dysplasia begin and end? The cytological 
abnormalities which accompany the disordered architecture of an 
inflamed or regenerative epithelium may be extremely difficult to 
separate frcm mild dysplasia. At the other extreme, severe 
dysplasia is difficult to differentiate from carcinoma in situ as 
it is difficult to be certain that the neoplastic cells have not 
breached the basement membrane of the crypts into the lamina 
propria.
Reproducibility
The use of highly subjective criteria in the interpretation 
of a rare lesion, often in epithelium with a significant 
inflammatory component, is bound to lead to sane degree of observer 
error. An assessment of observer variation in the grading of 
dysplasia in the colon showed agreement between observers as low as 
34% (Brown et al., 1985). No such study has been performed on 
gastric material but similar figures might be expected.
Prognostic significance.;.
The degree of risk conferred by epithelial dysplasia is not 
yet known. The finding of severe dysplasia is generally
considered to indicate an inevitable progression to carcinoma but 
there is no firm evidence for this in the gastric epithelium. 
Several workers have examined the incidence and natural history of 
dysplasia in the post-operative stomach (Watt et al., 1983; 
Offerhaus et al., 1984) and shown patients with severe dysplasia in 
one biopsy subsequently having carcinona identified in a subsequent 
biopsy. This, however, is not direct evidence that severe
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dysplasia progressed to carcinoma. The interpretation of 
dysplasia in the post-operative stomach is also likely to be more 
liable to error in view of the characteristic foveolar hyperplasia 
identified in these patients (Dixon et al., 1986). In a study of 
389 patients (Oehlert et al., 1979) severe dysplasia appeared to 
regress after 2-3 years in 23% of patients. Although the authors 
of such studies claim to have biopsied the same area the focal 
nature of the dysplastic change makes the interpretation of any 
study based on endoscopic biopsy material suspect because of the 
sampling error.
The prognostic significance of mild and moderate dysplasia is 
even less clear, and the reversibility of these lesions equally 
unknown.
Classification of Dysplasia
The classification of gastric dysplasia has been discussed by 
several authors (Cuello et al., 1979; Morson et al., 1980; Jass 
1983; Ming et al., 1984). The majority of classification systems 
have concentrated on two aspects; the histological criteria to 
differentiate regenerative changes from true dysplasia and the 
grading of the severity of the dysplasia.
The classification systems all recognise an initial category 
of regenerative changes occurring in inflammation or ulceration 
where the cells are not proliferating in response to injury. 
There appears to be a general consensus in the middle ground that 
dysplasia has less severe ie. mild or moderate forms. At the 
furthest extreme there is some confusion of terminology - 
borderline lession, possible carcinoma, severe dysplasia etc. This
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problem stems from the difficulty particularly in biopsy material 
of determining the presence of invasion of the lamina propria 
(Morson et al., 1980).
Two authors (Cuello et al., 1979; Jass 1983) have noted 
heterogeneity within gastric dysplasia. Both authors describe two 
histological patterns with the cellular features of dysplasia. 
Jass (1983) in a detailed study of 53 carcinomas and eight adenomas 
classified dysplasia into two types I and II. Type I resembled 
dysplasia described in colonic adenomas with columnar cells, 
secreting sulphomucin, pseudostratified nuclei and occasional 
Paneth cells. Type II comprised of irregular glands with pseudo 
villi composed of both columnar cells and goblet cells. The 
columnar cells secreted acid or neutral mucins and had large ovoid 
nuclei with vesiculation and a prominent nucleus. Cuello et al., 
1979, described essentially similar types but concentrated more on 
the glandular architecture naming his types adenomatoid and 
hyperplastic which correspond to type I and type II respectively. 
Jass also includes a category of "grade 0" dysplasia applied to 
incomplete intestinal metaplasia with architectural alteration but 
no cellular atypia which is synonymous with type lib metaplasia.
Jass (1983) describes a statistically significant difference 
between type II dysplasia and poorly differentiated intestinal type 
of tumour, and an association between type I and well 
differentiated intestinal type. Jass (1983) advances the 
hypothesis that type I dysplasia represents maturation arrest at 
the stage of an undifferentiated cell whereas type II dysplasia 
(which consists of two populations of cells - goblet and columnar)
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represents arrest at the level of an intermediate cell. His 
theory is that type I dysplasia may evolve gradually into well 
differentiated adenocarcinomas, type II dysplasia represents a more 
aggressive form which may transform into poorly differentiated 
intestinal tumours (see figure 8).
GASTRIC POLYPS
Polyps are considered uncommon in the stomach although no 
data exists as to their true incidence. Polyps derived from the
mucosa are divided into three main groups (Morson and Dawson 1979) 
(1) Hamartomatous polyps - such as juvenile polyps, polyps
occurring in the Peutz-Jeghers syndrome and heterotopias 
commonly formed from aberrant pancreatic tissue. Such 
polyps are regarded as having no malignant potential and are 
not further discussed.
(2) Regenerative (hyperplastic) polyps.
(3) Neoplastic (adenomas) polyps.
The last two groups have premalignant potential but of 
different grade. The regenerative polyps are composed of 
mature hyperplastic foveolar cells and varying numbers of 
pyloric type glands. The neoplastic polyps are adenomas 
consisting basically of immature glands with 
pseudostratification and numerous mitoses and usually show 
areas of intestinal metaplasia.
Malignant transformation has been rarely reported in 
hyperplastic polyps, separate co-existing carcinomas are 
present in 22% of cases (Ming 1977B). Malignant change in 
neoplastic polyps is frequent and is in the area of 40% (Ming 
1977B).
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Jass hypothesis of the histogenesis of 
gastric carcinoma (Jass, 1983).
HENEmERS DISEASE
In 1888 Menetrier described a diffuse mucosal hyperplasia 
(polyadenomes en nappe). He considered the lesion benign in 
itself but to have an affinity with a more malignant state and 
these lesions may be transformed into epitheliomas and gastric 
cancers. In the intervening 100 years there have been over 30 
case reports of gastric carcinoma associated with Menetriers 
disease (Wood et al., 1983). However many of the case reports do 
not contain a clear histological diagnosis of Menetriers disease. 
There are only three reports in the literature of gastric 
carcinoma developing subsequent to a diagnosis of Menetriers 
disease (Von Loewenthal et al., 1960? Chusid et al., 1964; Wood et 
al., 1983). Menetriers disease although featuring prominently in 
most textbooks as a premalignant condition, numerically would 
appear to be of little importance.
GASTRIC DDCER
The role of chronic gastric ulcer as a precancerous state has 
been a controversial subject for several years. The controversy 
is due to the difficulty in distinguishing between a chronic 
gastric ulcer which has undergone malignant change and a cancer 
which has ulcerated. Histologically a chronic gastric ulcer will 
show complete interruption of the muscular coat. Although cases 
of ulcer - cancer do exist the incidence of gastric cancer in pre­
existing ulcer has been estimated less than 1% (Mason 1974).
SCMMAKY OF IRBCAHCEROOS TJSTfiHS OF TOE GASTRIC MPCQSA
"Chronic gastritis" results from several factors - genetic,
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"infective" or chemical (alkaline reflux). Alkaline reflux
gastritis has specific histological features. The inflammatory
damage to the gastric mucosa is associated with transformation into 
metaplastic glands. This may represent an adaptive change to 
eliminate Helicobacter pylori. The transformation from gastric 
mucosa to classical intestinal metaplasia is associated with a 
variety of hybrid forms of intestinal metaplasia - these variants 
are associated with intestinal type cancer and may represent 
premalignant lesions. The role and assessment of dysplasia is 
unclear.
81
PftKT 4
M SM Sm JCBM L. M CM  AM) DtCN0C™CHEMIC3VL STOPIES
There is considerable debate regarding the role of the 
precancerous states discussed in chapter in gastric carcinogenesis. 
This debate has led to much scientific endeavour being directed 
towards identifying changes in the phenotypic expression that 
accompany these histological abnormalities. Much of the published 
work is based on the premise that if factor X is identified in 
intestinal metaplasia and in the intestinal type of tumour then 
this is evidence of a histogenetic link. The logic of such 
arguments is discussed in the conclusion to this chapter.
The three areas which have received most attention are the 
ultrastructure, mucin histochemistry and immunocytochemistry of the 
precancerous states and of gastric carcinoma itself.
DLTOAgERPCTORAL STUDIES
The ultrastructure of normal gastric mucosa, intestinal 
metaplasia and gastric carcinoma have been examined in two major 
studies (Ming, 1967; Nevalainen and Jarvi, 1977). Foveolar and 
surface cells in normal gastric mucosa are morphologically similar 
with closely packed apical mucus granules and a few poorly 
developed microvilli. rflie microvilli on these cells possess no 
central core.
Metaplastic epithelium consists of two main cell types, the 
goblet cells and intervening columnar cells. Ultrastructurally 
these cells are indistinguishable from those of the small 
intestine. rIhe most striking feature of the columnar cells is a 
well developed brush border on the apical surface formed by
82
microvilli. In contrast to the scarce rudimentary structures seen 
on the foveolar cells the microvilli on the metaplastic epithelium 
consist of an evenly distributed pattern with a central 
microfilament core. The mucus granules in the goblet cells were 
abundant throughout the cell with a pale staining granular inner 
texture compared with the small round homogenous darkly staining 
granules of the surface and foveolar cells of the gastric 
epithelium.
There is disagreement between the studies as to the presence 
of mucus granules in the columnar cells of intestinal metaplasia. 
No evidence of such granules was demonstrated by the first study, 
(Ming, 1967) whereas a variable number of granules in the apical 
zone of the columnar cells was seen by the second author 
(Nevalainen and Jarvi, 1977).
The cells of gastric carcinoma display a variety of features. 
Microvilli were seen particularly in cells lining tumour acini and 
the structure varied from well formed structures similar to those 
seen on the metaplastic columnar cells to the rudimentary 
structures of the foveolar cells. The mucus granules within the 
cells ranged from small dark oval bodies to pale structures often 
filling the entire cytoplasm to produce signet ring cells (Ming 
1967; Nevalainen and Jarvi, 1977).
The two authors studied separate aspects of classification of 
gastric carcinomas. In the first study seven gastric carcinomas 
were examined (Ming 1967) and classified into undifferentiated and 
differentiated. Ihe poorly differentiated tumour cells showed a 
variable number of microvilli and mucus granules. In the second
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second study (Nevalainen and Jarvi, 1977) 47 gastric carcinomas
were divided into diffuse and intestinal type using the Lauren 
1965) classification. The intestinal tumour cells contained 
homogenous granules and well organised microvillar brush border. 
The diffuse type tumours contained cells with pale mucus granules 
and also areas of cuboidal cells with relatively well developed 
microvilli.
The interpretation of such ultrastructural studies is 
complex. As both intestinal and diffuse tumours possess cells 
with microvilli and such structures, however rudimentary, are 
present on gastric epithelial cells it is difficult to argue that 
the intestinal features of intestinal tumours result from an origin 
in intestinal metaplasia.
The disagreement between the two authors on the presence of 
mucus granules in the columnar cells of intestinal metaplasia may 
be explained by our present knowledge on the heterogeneity of 
intestinal metaplasia. The incomplete variants (see previous 
chapter) do possess columnar cells with mucus secretion detectable 
at the light microscopic level.
MPCIN HISTOCHBGSEKY 
Introduction
Carbohydrate histochemistry has been extensively used in 
diagnosis and research in the gastrointestinal tract. The mucins 
(mucus glycoproteins) are the main carbohydrate-protein component 
of the secretory mucus and cell membranes that characterise the 
epithelial cells of the gut.
Three main categories of mucins are recognisable by
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histochemical techniques: (a) Neutral mucins, (b) Sialomucins,
(c) Sulphomucins. Histochemical studies have established the 
distribution and composition of mucins in the gastrointestinal 
tract and the alterations that occur in certain disease states. 
However the significance and physiological role that alterations in 
mucin histochemistry play remain to be fully elucidated. 
Experimental evidence suggests that mucins are of importance in 
immunological recognition (Deman et al., 1974), adhesion (Rios and 
Simmons, 1973) and the regulation of cell division (Weiss, 1973); 
processes fundamental to the development of metaplasia and 
neoplasia.
Current knowledge 
Normal mucosa:
The mucous neck cells and the mucous cells of the surface 
epithelium in both the fundus, the antrum and the cardia, contain 
predominantly neutral mucins (Lev, 1965; Jass and Filipe, 1979). 
Traces of sulpho and sialomucins can be detected in the mucous neck 
cells and sialomucin in deeper foveolar cells in the body. In the 
antrum sialo and sulphomucins are found in small amounts in the 
lower part of the gland (Lev, 1965; Jass and Filipe, 1979). Near 
the oesophago-gastric junction marked staining for sulpho and 
sialomucin can be seen (Jass and Filipe, 1979).
Inflamed gastric mucosae
There are few systematic studies on the histochemical 
appearances of gastritis and atrophy. Sialomucins and 
sulphomucins have been reported in mucous cells in stomachs 
affected by chronic gastritis (Gad, 1969; Jass and Filipe, 1979)
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and a consistent feature is the reduction in mucus secretion. 
Intestinal metaplasia
The mucin content of intestinal metaplasia and its relation 
to the various classification systems have been discussed in the 
previous chapter. The two important variants identified which 
appear to be linked to gastric carcinoma are the "colonic" type 
with 0-acetyl and sulphomucins within the goblet cells (Abe et al., 
1974; Teglebjaerg and Nielsen, 1978) and type lib (Jass and 
Filipe, 1979) with sulphomucins in the apical mucus granules of the 
columnar cells. The relevance of this pattern of mucin secretion 
to that seen in gastric carcinoma is discussed below.
Gastric Carginoma
Most authorities agree that gastric carcinomas contain a 
mixture of neutral, sialomucin and sulphomucin (Lev, 1965; Jass 
and Filipe, 1979; Lev, 1965; Filipe, 1979; Montero and Segura, 
1980; Paginini and Rugge, 1983).
If Lauren's (1965) concept of two types of gastric carcinoma, 
intestinal and diffuse with a histogenesis from IM and gastric 
epithelium respectively is accepted, then differences in mucin 
histochemistry between the two types might be expected. Lauren 
himself (Lauren and Sorvar, 1969) identified a "higher proportion" 
of neutral mucin in diffuse carcinomas and sialo and sulphomucins 
in intestinal type tumours supporting the origin of diffuse tumours 
from the gastric epithelium. This fact has been used as a 
diagnostic aid in identifying secondary deposits of gastric 
carcinoma (Cook, 1982).
The difficulty with using this expression of mucin by tumours
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as evidence of histogenesis is that most tumours produce all three 
major classes of mucin (Filipe 1979). The expression of mucin like 
the histological appearances vary throughout the tumour. Studies 
which cite "higher proportion" or "predominantly" one type of mucin 
associated with one type of tumour must be viewed cautiously 
(Lauren and Sorvar, 1969; Paginini and Rugge, 1983). No simple 
relationship such as, diffuse tumours secreting only neutral mucin 
and intestinal tumours secreting 0-acetyl or sulphomucin in a 
similar pattern to intestinal metaplasia has ever been 
demonstrated.
of h*bcm*ceroos states and gastric carcinoma
General p rin c ip les
Immunocytochemistry is the study of tissue sections with 
labelled antibodies.
The basis of immunocytochemistry is the union between 
antibody and its corresponding antigen. The crucial part of the 
antigen is the epitope normally a small fraction of the whole 
antigenic macromolecule which binds with the antigen binding site 
of the antibody. A single epitope can combine with several 
antibodies with different antigen binding sites.
Injection of a foreign antigen into animals results in 
stimulation of plasma cells and the formation of plasma cell 
clones, each producing antibodies with differing antigen binding 
sites to one or more epitopes of the injected foreign antigen - 
polyclonal response. The antibodies may cross-react with other 
antigens which share the same epitopes as the original foreign 
antigen. This cross reaction may reduce the value of the anti
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serum for identifying the original antigen.
The production of monoclonal antibodies (ie identical 
antibody with identical antigen binding sites) by Kohler and 
Milstein in 1975 was a major achievement. The fusion of antibody - 
producing ceils from the spleen of appropriately immunised animals with 
myeloma cells to produce "hybridoma" producing a perpetual supply 
of specific antibody was a brilliant conceptual and technological 
advance.
Application of imrajnohistoloqy
Immunocytochemical techniques have been used to study three 
main aspects of gastric pathology.
(1) Antibodies to specialised cells.
(2) Alterations of cell function.
(3) Acquisition of oncofetal antigens.
1. Antibodies to specialised cell types
Two antibodies, intrinsic factor and pepsinogen, directed 
against the specialised epithelial cells of the stomach, the 
parietal and peptic cells have been studied. The theoretical value 
of such antibodies is that the specialised cells which they 
identify are predominantly located in the body of the stonach, and 
therefore such antibodies might be expected to identify tumours of 
"true" gastric origin (ie diffuse type) rather than those with 
possible histogenesis from intestinal metaplasia. In addition to 
specialised epithelial cells, immunohistology has been used to 
identify the specialised cell types of the neuroendocrine system. 
Pepsinogen
Two immunologically distinct types of pepsinogen exist within
the human gastric mucosa, pepsinogen I (PGI) and pepsinogen II 
(FGII). PGI is restricted to the mucus neck cells and chief cells 
of the fundus, whereas PGII is produced by these cells and also by 
the antral and cardiac glands (Samloff and Townes, 1970; Samloff 
and Liebman, 1973) • Neither of the pepsinogens are present in
intestinal metaplasia. Pepsinogen I and II would appear to be a
marker for gastric epithelium - however irnnunocytochenical studies 
of gastric tumours shows a mixed picture with a third of intestinal 
type tumours staining positively for PGII and 5-15% of diffuse and 
intestinal type tumours staining positively for PGI (Reid et al., 
1983? Stemmerman et al., 1985). Adenocarcinomas from other organs 
showed no evidence of pepsinogen (Reid et al., 1983). It is 
extremely difficult from this type of data to comment on any theory 
of histogenesis of gastric carcinomas.
Intrinsic factor
In the adult the parietal cell produces both hydrochloric 
acid and the glycoprotein intrinsic factor (Levine et al., 1980). 
Like the chief cells, the parietal cells are classically regarded 
as being located exclusively in the body of the stomach. Recent 
work has shown that parietal cells though fewer in number are also 
distributed in the antrum (Tominaga, 1975). The parietal cell 
represents the first differentiated cell to appear in the fetal 
stomach and intrinsic factor antibodies specifically identify 
parietal cells (Aitchison and Brown, 1988). Preliminary work in a 
small number of gastric carcinomas identified positive staining for 
intrinsic factor within diffuse type tumours but not intestinal 
type tumours (Brown, 1982).
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Neuroendocrine system
The recognition by Feyrter in 1938 of a gastrointestinal 
system of clear cells (Helle Zellen) with an endocrine or paracrine 
function has led to the current concept of a diffuse endocrine and 
neuro-endocrine system (Pearse and Takor, 1979). The origin of 
the cells of the diffuse endocrine systen were originally thought 
to be from neural crest {Pearse, 1969). This narrow origin, 
however, has been extended to embryonic epiblast with special 
neuro-endocrine programming (Pearse and Polak, 1971). This 
concept has also been challenged (Sidhu, 1979) and the possibility 
of endodermal derived epithelium itself giving rise to endocrine 
cells, along with mucous cells and the other specialised cell 
types, ie. parietal, has been proposed.
The antral region of the stomach contains neuro-endocrine 
cells which secrete the neuropeptides gastrin and somatostatin, the 
endocrine cells in the body secrete vaso-active intestinal 
polypeptide, glucagon and 5-hydroxytryptamine (Dawson, 1984). The 
duodenum and jejunum contain endocrine cells that secrete gastrin, 
somatostatin, vasoactive intestinal polypeptide (VIP) , 
enteroglucagon, gastrin inhibitory polypeptide (GIP) , motilin and 
bombesin (Bryant and Bloom, 1979).
The occurrence of endocrine cells within metaplastic 
intestinal epithelia in the stomach has been clearly demonstrated 
(Bordi and Ravazzola, 1979; Ho et al., 1984). Irmrunocytochenical 
studies have identified somatostatin, gastrin, cholecytokinin, 
secretin, GIP and enteroglucagon cells in foci of intestinal 
metaplasia (Bordi and Ravazzola, 1979; Ho et al. 1984).
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Tsutsumi et al. 1983, identified several interesting features 
in the gastric mucosa endocrine cell population. The gastric 
mucosa affected by atrophic gastritis shows a relative increase in 
G cells (gastrin), areas of intestinal metaplasia show a decrease 
in the number of somatostatin and gastrin containing cells 
paralleled by an increase in enteroglucogan containing cells. 
These authors also noted that in the "incomplete type" of 
metaplasia the numbers of endocrine cells appeared greater than in 
the complete type. Mingazzini et al., 1984, compared sulphated 
versus sialomucin containing intestinal metaplasia and found no 
difference in the number of endocrine cells between the two types 
but only small foci were examined.
A variety of polypeptide hormones have been identified in 
gastric carcinoma (Ho et al., 1984), namely gastrin, somatostatin 
and enteroglucagon. Some authors have identified a higher number 
of endocrine cells in poorly differentiated tumours (Azzopardi and 
Pollock 1963) while others describe a higher number in well 
differentiated tumours (Ho et al., 1984).
2. Alterations in normal function
Secretory immunity in normal, inflamed, metaplastic and 
neoplastic gastric mucosa is the main aspect of normal function 
that has been examined by immunocytochemical techniques. 
Secretory component and IgA are well demonstrated in tissue 
sections by immunocytochemistry. The function of the secretory 
immunoglobulin (Ig) system is to transport dimeric IgA secreted by 
mucosal plasma cells through the epithelial cells to the mucosa 
surface (Braendtzaeg, 1981). The epithelial transport of IgA is
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mediated by secretory component synthesised by the mucosal 
epithelial cells (Braendtzaeg, 1981). Secretory component is an 
epithelial glycoprotein of approximately 83,000 daltons 
(Brandtzaeg, 1974). Hie incorporation of J chain into IgA induces 
a configurational fit with secretory component in the baso-lateral 
surface of the epithelial cell. The SC-IgA complexes are then 
transported into the gland lumen in cytoplasmic vesicles 
(Braendtzaeg, 1981).
Secretory component is normally expressed on the plasma 
membrane of columnar epithelial cells of the small and large 
intestine (Braendtzaeg 1974). Normal gastric body mucosa shows no 
evidence of secretory component, and only scattered lamina propria 
plasma cells stain for IgA (Isaacson 1982). As material for 
studies is obtained from gastrectomy specimens Isaacson in 1982 
drew attention to the fact that "normal" antral mucosa is never 
seen in such material as there is always a slight degree of 
superficial gastritis. With this degree of inflammation the 
foveolar mucous cells stain negatively for secretory component but 
became faintly positive in the isthmus or mucous neck region. The 
presence of secretory component was accompanied by an increasing 
number of IgA positive plasma cells (Isaacson, 1982).
In gastritis the mucus neck cells of the body stain 
positively for secretory component and the distribution of staining 
was similar to that of the antrum, with the foveolar mucous cells 
show no staining. Intestinal metaplasia demonstrates strong 
staining with secretory component similar to that of the crypts of 
intestinal villi (Isaacson, 1982).
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Dysplasia diagnosed on the basis of Morson's criteria (Morson
et al., 1980) was also examined by Isaacson (1982). Dysplasia
showed intense staining for both secretory component and IgA.
The expression of secretory component and IgA by the cells of 
gastric carcinoma appears to be related to the differentiation of 
the tumour. Well differentiated tumours have an approximately 80- 
90% incidence of SC immunoreactivity on tumour cells regardless of 
the stage of the tumour (Sumiyoshi et al.f 1984). Poorly
differentiated tumours show considerably less expression of SC, in 
the region of 40% (Isaacson, 1982; Sumiyoshi et al., 1984).
Ultrastructural studies demonstrate that the SC is expressed over 
the entire surface of the neoplastic cells rather than on the 
basolateral surface as occurs in the normal glandular epithelial 
cells (Nagura et al., 1983).
The pattern of IgA staining paralleled that for SC. IgA 
positive plasma cells were present in large numbers in well 
differentiated tumours and the tumour cells themselves showed IgA 
immunoreactivity. In poorly differentiated and anaplastic 
carcinomas the IgA immunoreactivity was markedly reduced or 
completely absent (Nagura et al., 1983; Sumiyoshi et al., 1984).
Isaacson , 1982, divided his series of gastric carcinomas 
into diffuse and intestinal type according to Lauren's 
classification. Intestinal type and diffuse type showed positive 
staining for both secretory component and IgA only in well 
differentiated tumours of both types.
3. Acquisition of oncofetal antigens
The appearance of embryonal antigens in extracts of tumour
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tissues has been described in a variety of epithelial tumours. 
Several embryonal antigens have been detected in gastric carcinoma. 
Carcino-embryonic antigen 
The major oncofetal antigen of the human gut, carcino embryonic 
antigen (CEA) was extracted from human fetal intestine and adult 
colon cancer tissue by Gold and Freeman, 1965A; 1965B. CEA is a
single glycosylated peptide with the antigenic determinants 
apparently residing in the peptide portion of the molecule 
(Turberville et al., 1973A; Westwood et al., 1978). Antisera to 
CEA however are known to cross-react with other glycoproteins. 
CEA antisera cross-react with non-specific cross- reacting antigen 
(Von Kleist et al., 1972) biliary glycoprotein antigens of the ABO 
- blood group system and non-specific cross-reacting antigen 2 
(NCA2) (Burtin et al., 1973A; 1973B; Holbourn et al., 1974). The 
latter antigen is present in gastric juice . Hiese cross-reactions 
have led to considerable confusion in the literature. The source 
and specificity of antisera used in various studies is poorly 
defined and has led to the term "CEA-like material" being coined to 
describe positive staining with CEA antisera and the cross-reacting 
antigens.
CEA-like material has been reported to be present in normal 
stomach by some authors (Ejeckman et al., 1979) and to be absent by 
others (Burtin et al., 1973; Nagura et al., 1983). The CEA-like 
material is found in the mucous neck cells in gastric mucosa 
affected by intestinal metaplasia or with a marked infiltrate of 
IgA labelled plasma cells. It would appear that mucosa affected 
by gastritis expresses CEA-like material whereas normal mucosa
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expresses little or none (Borch et al., 1987).
CEA-like material is expressed by intestinal metaplasia 
(Burtin et al., 1973; Ejeckman et al., 1979; Nagura et al., 1983). 
ultrastructural immunoperoxidase studies (Nagura et al., 1983) 
have shown that the CEA-like material is expressed on the apical 
surfaces and intracellularly in columnar cells of intestinal 
metaplasia but not within the goblet cells. The intensity of the
immunocytochemical reaction for CEA-like material is strong 
(Ejeckman et al., 1979; Nagura et al., 1983) and appears to be 
related to the severity of the metaplasia (Nagura et al., 1983).
CEA-like material can be demonstrated in the majority of 
gastric carcinomas (Burtin et al., 1973; Ejeckman et al., 1979; 
Nagura et al., 1983; Borch et al., 1987). The antigen is seen
clearly on the surface lining of tumour acini and ultrastructurally 
the microvillous, basolateral and intracytoplasmic structures show 
positive staining for the CEA-like material (Nagura et al., 1983). 
The relationship between the histological type of tumour and CEA 
expression has not been extensively studied but CEA expression has 
been demonstrated in both the intestinal and diffuse type of Lauren 
(Borch et al., 1987), "signet ring cell carcinoma", and anaplastic 
carcinoma (Ejeckman et al., 1979).
A recent study examining in detail the cross-reactivity of 
commercially available anti CEA sera has demonstrated that CEA 
expression in the normal stomach is due to cross-reaction with the 
NCA2 antigen. To what extent the CEA expression determined in 
intestinal metaplasia, dysplasia and carcinoma outlined in the 
studies above is due to the presence of NCA2 rather than true CEA
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is impossible to determine.
Duodenal and colonic high molecular weight antigens
Bara et al., 1981 demonstrated a high molecular weight 
antigen associated with intestinal metaplasia and the intestinal 
type of gastric carcinoma. In further studies they identified 
three antigens, M3 Small Intestine, M3 Duodenum, M3 Colon, derived 
from the injection of high molecular components of duodenal or 
colonic mucosa into rabbits (Nardelli et al., 1983) .
Immunocytochemical studies of normal adult and fetal 
gastrointestinal tissues demonstrated that M3D reacted primarily 
with the goblet cells of the duodenum, M3SI with the goblet cells 
in the small intestine and proximal colon and M3C with the goblet 
cells of the colon. M3D and M3SI was associated with goblet cells 
in the duodenal fetal mucosa at all gestational ages, whereas the 
M3C antigen was detected only after three months1 gestation.
In intestinal metaplasia from stomachs resected for benign 
disease only the M3D and MSI antigens were observed. This 
finding was interpreted by the authors as indicating the small 
intestinal origin of such metaplasia. Metaplasia adjacent to 
carcinomas contained the M3C antigen in addition to the M3D and 
M3SI antigens. This pattern of expression was repeated in the 
intestinal type of tumours and the common differentiation features 
displayed by the metaplasia and adjacent intestinal type carcinoma 
was regarded as supporting the role of intestinal metaplasia in the 
histogenesis of the intestinal type of carcinoma.
Second trimester fetal antigen
Extracts of second trimester fetal lung, liver, kidney and
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large bowel were injected into rabbits and the resulting anti 
serum isolated and absorbed with adult lung, liver, kidney and 
colon, and colonic carcinoma cell lines. The absorbed antibody 
designated anti STF a/b was found to be unreactive with normal 
adult gastrointestinal tissue but to react with gastric, 
oesophageal and rectal carcinomas. Immunohistochemical studies 
performed on normal, inflamed and metaplastic and dysplastic 
gastric epithelium showed increasing reactivity on the epithelial 
cells with anti STF a/b with the aforementioned sequence of gastric 
epithelial alterations. Differing types of gastric carcinoma and 
fetal tissue were not studied (Higgins et al., 1984).
Human chorionic gonadotrophin (HCG)
Human chorionic gonadotrophin is a glycoprotein secreted by 
the placental syncytiotrophoblast. Ito et al., (1983) studied 164 
gastric carcinomas using immunoperoxidase techniques and 
demonstrated a 10% incidence of immunoreactivity for HOG. There 
was no difference in the incidence of HOG positive cells between 
well and poorly differentiated carcinomas.
SOMCVRY
Despite the advances in technology that electron microscopy 
mucin histochemistry and immunocytochemistry represent, these 
techniques have done little to advance our understanding of the 
histogenesis of gastric carcinoma. The majority of studies have 
tried to identify a single factor ie. sulphomucin positivity, CEA 
positivity which will act as a marker for pre-malignancy. The 
studies have often used complex classification systems for 
intestinal metaplasia and gastric carcinoma in an attempt to prove
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the authors conceived hypothesis. Added to this is the lack of 
standardisation of antibodies and their specificities and the 
development of antibodies ie. duodenal antigens, fetal antigens 
which are available only to the workers concerned.
EftKT 5
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Cells pass through a series of distinguishable phases between 
one mitosis and the next. The period of DNA synthesis is 
designated the S phase. The interval between the previous mitosis 
and the S phase is called the phase, and the interval following 
S and leading to the next mitosis is called the G2 phase. During 
G^ the cell may manifest its characteristic function and enter a 
resting phase - Gq.
TOCSNIODES TO STODY CRT.T. KTNEHCS IN HOMAN GASTRIC MPCDSA
Tritiated thymidine has been shown to be electively 
incorporated into DNA during the premitotic S phase (Taylor et al., 
1957). The tritiated thymidine incorporated into DNA synthesising 
cells can be visualised using autoradiography. The Labelling Index 
(LI) can be derived by counting the number of labelled cells and 
the total cell number in the cell population under consideration. 
The Labelling Index is expressed normally as a percentage viz:
LI = &  x 100
Nj = number of labelled cells
Nfc = total cell number of the given cell population
The Labelling Index provides only a static picture of the 
cell cycle, and does not provide any indication of the duration of 
the S phase.
The techniques of pulse labelling with tritiated thymidine or
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in vivo double labelling with 3H and 14C thymidine allows for 
calculation of the length of the S and G phases of the cell cycle. 
These in vivo techniques are ideally suited for experimental 
animals but ethical considerations preclude their general adoption 
in humans. The double labelling technique is difficult to 
interpret on histological sections (Hansen et al., 1975).
The Labelling Index may be assumed to be proportional to the 
rate of cell proliferation if the DNA-synthetic phase (S phase) is 
constant. The S phase has been measured by continuous in vitro 
labelling and the results indicate that the S phase has a constant 
duration in normal gastric mucosa and in patients with different 
degrees of gastritis (Hansen et al., 1979). Alterations in the 
Labelling Index in gastric mucosa are interpreted in the majority 
of published work in this field as reflecting changes in the rate 
of cell turnover.
Techniques for the in vitro labelling of gastric biopsy 
material have been developed by incubating the specimens in tissue 
culture medium with labelled DNA precursors and good agreement has 
been demonstrated between the in vivo and in vitro estimates of 
kinetic parameters in experimental animals (Willems et al., 1970). 
The majority of published work in humans has used the in vitro 
thymidine incubation technique. Biopsies obtained using fibreoptic 
instruments are ideal for the study of cell proliferation in the 
human gastric mucosa using the in vitro thymidine incubation 
technique.
The small biopsies are difficult to orientate and
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longitudinal sections of the foveolae are difficult to obtain in 
sufficient numbers for satisfactory estimation of the labelling 
indices, although some authors appear to be able to achieve this 
(Assad et al., 1980). Hansen et al., 1975, describe a technique 
in which labelled cells in cross sections of foveolae are counted. 
Serial sections are counted and the labelling indices are thus 
based on cell counts throughout the whole of the proliferative 
zone. This technique has been shown to be highly reproducible 
with a small observer error. This technique of counting cross 
sections of foveolae generates an estimated labelling index which 
may be corrected using the equation (l-p)n = 1-p/LI (see appendix). 
This technique is easier to perform as it requires no orientation 
of material. However, the disadvantage with this technique is 
that as cross sections are used changes in the site of the 
proliferative zone within the crypts cannot be easily detected.
w m &  sngm o n
The gastric mucosa as with the remainder of the 
gastrointestinal tract is a steady state cell population, the 
equilibrium maintained by a regular cell loss from the mucosal 
surfaces and a sustained cellular production (Stevens & Leblond, 
1953; Creamer et al., 1961;
The site of cell synthesis in the gastric mucosa of the body 
lies at the level of the mucous neck and lower part of the foveolae 
ie the isthmus of the gland. Undifferentiated cells in the 
isthmus area incorporate tritiated thymidine, and pulse labelling 
studies demonstrate that the cells produced by the undifferentiated
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stem cells migrate upwards and reach the surface epithelium in 48- 
54 hours (Winawer and Lipkin, 1969). The undifferentiated cells 
also act as stem cells for the parietal cells which differ only by 
the route of migration in a downwards direction (Willems and Lehy, 
1975) . Peptic cells have also been shown to originate from the 
undifferentiated cells in experiments using gastric explants 
(Matsuyama and Suzuki, 1970). The origin of the peptic cells is 
disputed by some authorities and radio-autographic studies in 
normal mucosa in experimental animals have claimed to show that 
peptic cell renewal depends on slow mitotic activity of existing 
peptic cells (Willems and Lehy, 1975).
A similar kinetic situation is present in the antrum; the 
undifferentiated stem cells lie at the isthmus of the glands and by 
continual cell proliferation give rise to newly formed cells which 
migrate upwards to the gastric surface (Creamer et al., 1961) and 
downwards to form the glandular cells (Hattori and Fujita, 1979). 
PRjauXFERATICN KINETICS OF G M C  MUCOSA IN  DISEASE 
G a s tritis .
■3
Using an in vitro incubation technique with JH-thymidine 
Hansen et al., (1975) studied gastric biopsies from patients with 
atrophic gastritis. A significantly higher labelling index was 
demonstrated in both the antral and body mucosa in patients with 
endoscopic evidence of atrophic gastritis. In a further study 
(Hansen et al., 1977) a significant correlation between the 
severity of the gastritis and the labelling index was demonstrated.
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Intestinal metaplasia
Winawer and Lipkin, 1969, reported on an vivo human 
experiment on a patient with marked intestinal metaplasia of the 
gastric mucosa. The labelling index in the intestinalised mucosa 
was higher than normal gastric mucosa and the abnormal mucosa 
showed incorporation of thymidine into cells at or near the luminal 
surface.
The increased labelling index in intestinal metaplasia has 
been confirmed by other authors (Hattori and Fujita, 1979). An 
elegant morpholgical study demonstrated that the generative cell 
zone in intestinal metaplasia shifts from the isthmus to the base 
of the gland resulting in a situation identical to that of the 
small intestine. The incorporation of thymidine into cells in the 
surface epithelium was not found by these authors. This 
discrepancy may be explained by the different thymidine labelling 
patterns that have been shown when the sub-types of intestinal 
metaplasia are examined. The variant of intestinal metaplasia 
defined as the incomplete type (absence of alkaline phosphatase 
activity) (Matsukara et al.r 198QA) shows an extended generative 
zone from the base to the middle of the glands compared with the 
complete type (alkaline phosphatase activity) which possesses a 
generative zone localised to the base of the glands (Hashimoto et 
al., 1983). This extension of the labelled zone did not involve 
the surface epithelium and so the incorporation of thymidine into 
this area described by Winawer and Lipkin, 1969, remains 
unconfirmed by other workers.
W 3
Gastric carcinoma
The in vitro thymidine index labelling of biopsy specimens 
from gastric carcinomas show a wide variation from 1.4 to 40.8% 
(Sasaki et al., 1984). The labelling index has not been shown to 
be related to the stage of the tumour, the histological type or 
degree of differentiation.
The labelled cells appear to be distributed haphazardly 
amongst the tumour cells. Signet ring cells do not label with 
thymidine and nests of tumour cells within the lymphatic channels 
have a higher labelling index than surrounding tumour (Sasaki et 
al., 1984).
In vivo studies on human gastric carcinoma are technically 
difficult to perform. Such a study using the metaphase arrest 
technique (vide infra) reported a widely varying cell production 
rate between carcinomas ranging from 3-24 cells/1000 cells/hour in 
keeping with the variation in labelling index detected in the 
thymidine labelling studies (Wright et al., 1977).
Effect of surgery on gastric cell kinetics
There are at least three factors which may theoretically 
influence cell kinetics in the post-operative stomach; the changes 
in gastrin levels, the effect of vagotomy and the development of 
gastritis.
Hie surgical excision of the antrum combined with vagotomy 
results in a decrease in available gastrin (McGuigan et al., 1972). 
Gastrin has been shown to be trophic to body epithelium (Pearl et 
al., 1966), and the post-operative reduction in gastrin might be
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predicted to decrease epithelial proliferation.
The effect of vagal sectioning on cellular proliferation in 
the gastric mucosa is unclear. In experimental animals both a 
negative and a positive trophic effect after vagotomy have been 
described (Ley et al., 1973). Proximal gastric vagotomy results 
in an increase in circulatory levels of gastrin. Gastrin is 
trophic to body epithelium but appears to have an inhibitory effect 
on cell proliferation in the antral mucosa (Pearl et al., 1966).
An increase in the frequency and severity of gastritis has 
been described after antrectomy and vagotomy and vagotomy alone 
(Roland et al., 1975; Pulimood et al., 1976; Watt et al., 1983). 
The increased rate of epithelial cell renewal associated with 
gastritis suggests that this change is likely to result in an 
increased Labelling Index in the mucosa of post-surgical patients.
Hansen et al., (1978), examined the Labelling Index in 
patients prior to partial gastrectomy or vagotomy and within the 
first post-operative year. The Labelling Index increased in the 
body mucosa after antrectomy and in both body and antral mucosa 
after vagotomy alone. Patients who had undergone vagotany and 
antrectomy for duodenal ulcer disease between 4 months and 14 years 
previously were also shown to have increased labelling indices in 
the body mucosa (Assad and Eastwood, 1980) and the proliferative 
zone expanded to occupy a greater fraction of the gastric crypts. 
Both these studies (Hansen et al., 1978; Assad and Eastwood, 1980) 
attributed the increase in Labelling Index in the post-operative 
stomach to the gastritis found in these stomachs.
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The gastritis following gastric resection may be due to 
reflux of bile and pancreatic secretions. These secretions in 
addition to causing the gastritis may also have a direct effect on 
the progenitor cells and increase cell proliferation (Weser et al., 
1977). The aetiology of the gastritis following proximal gastric 
vagotomy alone is unclear.
In summary, the situation in the post-operative stomach is 
complex. Theoretical effects of changes in gastrin levels or 
vagal sectioning on cell proliferation seen of secondary importance 
compared with the post-operative development of post-surgical 
gastritis. Not only does the labelling index increase but the 
proliferative zone itself appears to expand. The role of the 
foveolar hyperplasia and relative absence of inflammatory changes 
described by Dixon et al., 1986 in reflux gastritis has not been 
considered in the published material on post-operative kinetic 
changes.
E ffec t. q£  drug therapy
The effect of H2 receptor antagonist cimetidine on gastric 
mucosal cell proliferation has been extensively studied in 
experimental animals. Chronic ingestion of this drug has been 
shown to have no effect on cell proliferation in either the antral 
or the body region in rats (Eastwood and Forrest, 1983). Studies 
in humans, however, have shown an increase in labelling index in 
both antral and body mucosa after cimetidine therapy when the 
degree of gastritis remained the same (Fich et al., 1985; 
Svendson et al., 1986).
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EXPERmaravL gbsiric crrchpgqesis
The induction of tumours in experimental animals has 
theoretically many advantages for the investigation of pre- 
malignant stages in carcinogenesis. There are considerable 
constraints in extrapolating data free animal models to the human 
situation. Animal experiments do allow for the investigation of 
the critical step from pre-cancerous lesion to a frankly malignant 
state; a sequence which is extremely difficult to examine in the 
human.
Early models for induction of gastric cancer in rodents 
involved the direct intramural injection of a polycyclic 
hydrocarbon, 20-methyl cholanthrene (Stewart et al., 1958). This 
results in neoplastic transformation of glands within four days and 
the development of adenocarcinomatous and sarcomatous lesions. 
Sugimura and Fujimira (1967), developed an animal model involving 
administration of a carcinogen, N-methyl-N'-nitro-N- 
nitrosoguanidine (MNNG) in the drinking water. Administration of 
MNNG for 12 months led to the development of adenocarcinoma in 70% 
of the animals. The concentration of carcinogen used in these 
early experiments (83 ug/1) led to erosion, regenerative 
hyperplasia and adenomatous hyperplasia (Saito et al., 1970) and 
finally adenocarcinoma, a situation not thought analogous to human 
carcinogenesis. Such a sequence of events would appear to 
indicate that the carcinogen has a direct toxic effect on the 
gastric mucosa. To avoid this direct injury experiments have been 
performed using a lower concentration of the carcinogen for a
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shorter duration (Matsukara et al., 1980B; Tatematsu et al., 
1983). In rats treated for a shorter duration with (83 ug/ml) MNNG 
for two to four months although erosions and regenerative 
epithelium were still present it was noted that intestinal 
metaplasia also developed (Matsukara et al., 1980B). By reducing 
the concentration of carcinogen (MNNG) in drinking water to 50 
ug/ml and exposure to four months this resulted in the induction of 
intestinal metaplasia and gastric carcinoma without ulcerative or 
regenerative changes (Tatematsu et al., 1983). In a similar 
manner, the administration of N-propyl-N-nitro-N-nitrosoquanidine 
(PNNG) the propyl derivative of MNNG, and weaker carcinogen 
resulted in the induction of intestinal metaplasia after one month 
of treatment with PNNG and adeno-carcinomas after 12 months 
treatment, without ulcerative or regenerative changes (Sasajima et 
al., 1979). Thus a model exists for the induction of intestinal 
metaplasia and carcinoma without causing ulceration and 
regenerative change by administration of a low concentration of 
MNNG (50 ug/ml) or its weaker propyl derivative INNG.
The advantage of such an experimental model is that more 
sophisticated kinetic parameters can be measured than in the 
constraints of a human situation. Autoradiography can be used to 
measure the Labelling Index. The measurement of this kinetic 
parameter is time consuming and laborious and although the 
Labelling Index allows the proportion of cells in a given 
population proliferating to be established, it does not allow for 
changes in phase durations ie. the mitotic duration and the
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duration of DNA synthesis.
The metaphase arrest or stathmokinetic technique establishes 
the kinetic parameter, the rate of entry of cells into mitosis 
(also known as the cell birth rate or mitotic rate). The basis 
for the technique is the addition of stathmokinetic agents which 
cause cells to accumulate in the metaphase stage of mitosis by 
interference with the formation of the metaphase spindle. With 
the addition of a stathmokinetic agent and fixation of samples of 
the cell population over a period, the progressively rising 
metaphase index can be determined and the rate of entry of cells 
into mitosis can be found.
For tissue in a kinetic steady state -
rm = In/tm rm = rate of entry into mitosis
Ijn = mitotic index
= duration of mitosis 
The stathmokinetic equation is derived from this -
rm = ^met/^
where IIliet. is the metaphase index at the end of the arrest period 
tA. As during mitosis one cell generates two progeny, rm gives 
the birth rate Kg. In a steady state situation experimental 
results are plotted as shown in figure 9. rm is represented by 
the slope of the graph, the cell cycle time (tea) is given by the 
reciprocal of the slope ie. I/rm.
Bowel crypts act as closed kinetic systems from which 
arrested metaphases are unable to escape. The estimation of
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Metaphase
Index
S1°pe = rm
reciprocal of 
slope = tca
time
t
Addition of stathmokinetic agent
Figure 9. Accumulation of metaphases after addition of
stathmokinetic agent. Slope of graph represents 
rate of entry into mitosis (Cell birth rate).
arrested metaphases within crypts allows for the metaphase data to 
be expressed in the form of crypt cell production rates (CCFR).
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The inflammatory response in the gastric mucosa is manifest 
histologically by the appearance of gastritis. Gastritis is 
regarded by some authorities as the initial and fundamental step in 
the histogenesis of gastric carcinoma (Correa, 1984). The 
immunological responses that occur in the gastric mucosa during the 
development of gastritis, metaplasia and neoplasia are important in 
the understanding of gastric carcinogenesis.
The human immune system is complex. This section provides a 
brief summary of the salient points of relevance to the work of 
this thesis.
OTRRFWr roanwLEDGB 
Gastric Mimsa
The histological classification of gastritis (Whitehead et 
al., 1972) is based on a combination of the density of the 
inflammatory cell infiltrate in combination with degree of mucosal 
atrophy. The humoral component of the inflammatory response has 
been extensively investigated (Crabbe and Heremans, 1966; Kreunig 
et al., 1978; Valnes et al., 1986). The gastric mucosa contains a 
preponderance of IgA producing plasma cells which increase in 
number with increasing severity of gastritis (Valnes et al., 1986). 
IgM, IgG, IgD and IgE producing plasma cells are also present but 
in small numbers. The IgG isotype shows a greater relative
increase in numbers with gastritis compared to IgA (Valnes et al., 
1986).
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In areas of intestinal metaplasia the number of inflammatory 
cells is seen to be reduced on conventional histology and this has 
been reported to be due to a decrease in IgG labelled plasma cells 
predominantly (Tsutsumi et al., 1984), compared with the others.
The humoral immune response in the stomach has been 
investigated as described above but until recently there has been 
relatively little knowledge of the cell mediated immune response 
within the human gut. Experimental animal work has shown that the 
gut associated lymphoid tissues differ from the systemic immune 
system with respect to cellular constituents, effector functions 
and the modulation of these functions. The gut provides the major 
barrier between the internal environment and the antigens of the 
external environment many of which are non-pathogenic. Thus there 
is a need for inhibition of most immune responses in the gut in 
contrast to the amplification of the response to parenterally 
encountered antigens in the systemic immune system.
The majority of published work in the field of gastro­
intestinal immunology relates to the small intestine and disease 
states such as inflammatory bowel disease and coeliac disease. 
The intestinal mucosa appears to contain two distinct populations 
of T lymphocytes; those in the lamina propria and lymphocytes 
lying in the epithelial lining itself - intraepithelial lymphocytes 
(IEL). The majority of the lymphocytes in the lamina propria 
express the phenotype associated with helper/inducer T cells whilst 
the IEL express the phenotype associated with cytotoxic suppressor 
T cells (Selby et al., 1981; Cerf-Beunissan et al., 1983).
112
The intra-epithelial lymphocytes appear to be a highly 
specialised population of activated lymphocytes which possess 
natural killer activity (Mowat et al., 1983). The exact biological 
role and function of the intra-epithelial lymphocytes remains to be 
fully elucidated.
In the human stomach the pattern of distribution of 
lymphocytes appears to be similar to that of the intestine with a 
predominance of T helper/suppressor lymphocytes in lamina propria 
and T cytotoxic/suppressor cells in the intra-epithelial location. 
Natural killer cell phenotype is seen in a few lymphocytes in both 
locations. In areas of intestinal metaplasia there is a diminution 
in numbers of lymphocytes but the distribution of the T cell 
subsets appears to be the same to that of the gastric mucosa 
(Tsutsumi et al., 1984).
Class II histocompatibility antigens (HIA Dr) are genetically 
encoded molecules that restrict the immune reponse. The presence 
of such antigens is well known on B lymphocytes, macrophages and 
activated T cells. Recently the presence of such antigens has 
been detected on epithelial cells lining the gastrointestinal, 
urinary and respiratory tracts (Daar et al., 1984).
The Class 11 MHC antigens detected by anitbodies to HIA Dr 
have an interesting pattern of distribution. In gastric mucosa 
without inflammation there is virtually no expression but with 
increasing degrees of gastritis HIA Dr expression is seen on the 
epithelial cells particularly those in the area adjacent to 
lymphoid aggregates (Spencer et al., 1986). This has led to the
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suggestion that the epithelial cells expressing HIA Dr antigens may 
play a role in presenting antigens from the gut lumen to 
lymphocytes in the adjacent lymphoid follicles (Spencer et al., 
1986).
Carcinoma
The relationship between the immune response and neoplasm has 
provoked speculation for over 100 years (Underwood, 1974), yet 
despite the recent advances in immunology this field remains to be 
completely elucidated. Lauren (1965) in his initial description 
of intestinal and diffuse type of tumour noted differences in the 
inflammatory response between the two types. There have been 
sporadic reports in the literature (Monafo et al., 1962) that 
suggest that the degree of lymphocyte response to human gastric 
carcinomas is associated with the prognosis. Such studies have 
involved only conventional assessment of the lymphocytic infiltrate 
on light microscopy.
Modern immunocytochemical techniques have shown that the 
infiltrate surrounding tumours are heterogenous and consist of 
mononuclear phagocytes, various subsets of lymphocytes and other 
cell types - plasma cells and mast cells. The role of individual 
elements of the immune system in immune surveillance and the 
response to malignant change is complex and not fully explained. 
The diagram illustrates a summary of the interactions in the immune 
system which are currently thought to be involved in tumour 
immunity (figure 10).
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activated lymphocytes
lymphokines
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complement
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Figure 10. Simplified summary of interactions of the immune 
system involved in tumour imnunity.
BftKT 7 
HCHftN FETftL STOMftCH
Several features of the embryonic development of the gastric 
epithelium are of direct relevance to gastric carcinogenesis. The 
first feature is the original interpretation of intestinal 
metaplasia as a congenital heterotopia by Taylor in 1927. Taylor 
recognised that intestinal epithelium might arise from regenerative 
changes around gastric ulcers but regarded areas of mature small 
intestinal epithelium in the absence of inflammation as placing the 
"congenital nature beyond doubt". Magnus in 1937 examined 12 
fetal stomachs from 6-9 months gestation and failed to find any 
intestinal epithelium and discarded the concept of congenital 
heterotopia. A more recent study (Salenius 1962) identified 
goblet cells in the pyloric canal at 11 weeks gestation. Goblet 
cells and cells with a striated border were seen in both the 
pyloric canal and the cardia from 20 weeks until term. A single 
neonatal stomach was examined and goblet cells and intestinal 
striated border cells identified in both cardia and pylorus.
Salenius's (1962) work raises the possibility that the 
presence of intestinal epithelium in the stomach may to seme degree 
be due to a congenital rather than acquired phenomenon.
The second feature of interest is the presence of antigens 
common to the embryonic gut and gastro-intestinal tumours. Gold 
and Freedman in their original description of carcino-embryonic 
antigen in 1965 identified the antigen in fetal gut, liver and 
pancreas between 2-8 months gestation. The immunocytochanical
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localisation of CEA has not been determined in the embryonic 
stomach.
The third aspect of interest in the embryonic stomach is the 
expression of mucin by the developing gastric epithelium and the 
relationship to the abnormal mucin histochemistry in disease states 
in the adult stomach. Two studies have been reported (Stenmerman 
1967; Lev 1968) in the literature which have identified 
sialomucins in the fetal stomach although only small numbers of 
cases were studied.
TWKmPMENT QF THE FETAL STOMflffl
The stomach appears initially as a fusiform dilatation in the 
foregut in the neck, by the seventh week of gestation it descends 
into the abdomen. Circular smooth muscle appears in the eighth to 
ninth week at which time the epithelium forms as a single 
pseudostratified layer. The glandular pits form in rudimentary 
fashion at ten to eleven weeks gestation.
Succinic dehydrogenase activity can be detected in gastric 
homogenates at eight to nine weeks indicating the presence of 
developing parietal cells (Salenius, 1962) . At the same time 
endocrine cells are present and by ten weeks all the currently 
identifiable endocrine cell types are present (Facer et al., 1989). 
Chief cells can be identified by 12 weeks by their high RNA content 
and granules staining black with iron haematoxylin. PAS-positive 
mucus neck cells appear at 13-14 weeks (Salenius 1962).
The antral body glands gradually increase in size from the 12th 
week of gestation and have an adult pattern by the 24th week of 
gestation. The circular muscle of the fetal stomach increases in 
thickness during the 12th to the 24th week of gestation.
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BffiX 8
A simplified diagrammatic representation of the possible 
histogenesis of gastric carcinoma is displayed in figure 11. A 
question mark can be placed beside each arrow and step in this 
sequence. The aim of this thesis is to attempt to investigate 
some of these questions. To obtain material for this study a 
prospective series of gastrectomy specimens from both benign and 
malignant cases was collected.
The first question to be addressed is the division of tumours 
into intestinal and diffuse types. The histological criteria of 
the Lauren system are investigated and a comparison with other 
classification systems undertaken.
The second question examined in the gastrectomy material is 
the relationship of intestinal metaplasia and its variants to the 
sub-types of gastric carcinoma. Several aspects of this 
relationship are examined. The amount of metaplasia in benign and 
malignant stomachs and the effect of other variables such as age, 
inflammation, ulceration and the presence of Helicobacter pylori 
are determined. The aim of this section of the thesis is to 
investigate if the relationship between intestinal metaplasia (and 
in particular Type lib metaplasia) and carcinoma rather than 
representing a premalignant association might be explained by other 
factors.
The third aspect of the histogenetic sequence to be evaluated 
is dysplasia. The interpretation of dysplastic change is 
difficult and highly subjective. The investigation of dysplasia
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t
Adult gastric mucosa
Surgery
H. pylori
Alkaline reflux
Gastritis
Intestinal metaplasia
DysplasiaType lib
Intestinal type tumour Diffuse type
Figure 11- Hypothetical steps in the histogenesis of gastric 
carcinoma which are studied in this thesis-
is limited to documenting the incidence of dysplasia, the 
histological appearance and the relationship to benign and 
malignant changes in the gastrectomy material.
In conjunction with the collection of the histological 
material the clinicopathological data of the patients undergoing 
gastrectomy was collated. The aim of this section of the thesis 
was to document the methods of treatment, prognostic parameters and 
survival of patients with gastric carcinoma.
The histological assessment of the gastrectomy material 
outlined above results in the subtypes of metaplasia, types of 
tumour, dysplasia etc. being identified and classified. This 
material was then used to examine changes in the phenotypic 
expression of the epithelium at the various stages throughout the 
histogenetic sequence. Mucin histochemistry and 
immunocytochemistry were used to identify such changes. The aim 
of this part of the thesis was to determine if epithelial 
alteration in phenotype yielded any information to support or 
refute the possible steps in histogenesis. The phenotypic 
expression of the gastric tumours was also examined and the 
patterns of phenotypic expression that occurred in the different 
histological classification systems determined.
The next element to be examined was the cell kinetic changes 
that take place at different stages of the sequence. Material 
from the gastrectomy study was used in this part of the thesis and 
in addition epithelium from a selected group of patients who had 
undergone gastric surgery for benign disease was studied. Ihe aim 
of this part of the thesis was to document the alterations in cell
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kinetics that occur at various stages of the histogenetic sequence.
An animal experimental model of gastric carcinogenesis was 
used to study the cell kinetics of metaplasia and neoplasia using 
the stathmokinetic technique. The aim of this section of the 
thesis was to examine the more sophisticated parameters of the cell 
cycle and extend the human experimental observations.
The studies listed above are primarily concerned with 
epithelial changes. The cell mediated immune response within the 
lamina propria of the gastric mucosa was examined in the next part 
of the thesis. The aim of this was to determine the interaction 
between the immune response and the epithelial alterations.
The final section of the thesis involves a study of the fetal 
stomach. The aim of this section was to determine the 
histological development and phenotypic expression of the embryonic 
stomach and compare this with the changes that take place in the 
adult.
CHAPTER 2
SUBJECTS, MATERIALS AND METHODS
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SUBJECTS* MATERIALS AMD METHODS 
SDBJBCTS
Human to s tre c to o y  StLK^y
A prospective collection of gastrectomy specimens submitted 
to the Department of Pathology, Western Infirmary, Glasgow, was 
initiated in December 1984 and continued to December 1987. The 
Pathology Department serves both the Western Infirmary and 
Gartnavel General Hospital. The two hospitals function as a 
single unit. There are ten Consultant General Surgeons.
A consecutive series of 94 gastrectomy specimens surgically 
resected for adenocarcinoma of the stomach and benign disease were 
collected, see table 9.
Mucin Histonhemi st-ry Study
The subjects studied included all the 94 patients who had a 
gastrectomy performed as described in the Human Gastrectomy Study. 
XTiyainocytoctoaical Study
The subjects studied included all the 94 patients who had a 
gastrectomy performed as described in the Human Gastrectomy Study. 
Cell Kinetic Study
Three groups of patients were studied.
Medical Treatment Group
Patients undergoing routine upper gastro-intestinal endoscopy 
for diagnostic or treatment purposes. This group was designated - 
MEDICAL TREATMENT GROUP.
The patients for this part of the study were drawn from the 
endoscopy clinic of a Consultant General Surgeon (WRM). The
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Human Ga.strectony fitufly
DiagnQsis
Benign
Malignant
Table 9s
lumber Pathology
22 9 gastric ulcer
13 duodenal ulcer
72 Adenocarcinoma
Gastrectomy specimens collected between 
December 1984 and December 1987. 
Pathological condition resulting in 
gastrectomy detailed.
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endoscopy clinic provides a diagnostic and therapeutic service for 
medical and surgical patients. The indications for endoscopy fall 
into two main categories; investigation for upper gastro­
intestinal tract symptoms and follow-up of patients with both 
gastric and duodenal ulceration. The biopsy material was 
collected from 48 patients over an 18 month period, see table 10. 
Surgical Treatment Group
Sixteen patients who had undergone gastric surgery for benign 
peptic ulceration between 4-25 years previously, see table 11. 
Biopsies were taken 1 cm, 3 cm and 5 cm from the gastro-enterostomy 
stoma when present. This group was designated SURGICAL TREATMENT 
GROUP.
Gastrectony Group
Thirty seven patients who underwent gastrectomy, 30 for 
malignant disease and seven for benign disease from the Human 
Gastrectomy Study described previously. The gastrectomy specimens 
were sampled at three sites; A: the tumour, B: the gastric
mucosa immediately adjacent to the tumour/ulcer within 1cm, C: the
gastric mucosa at a distance of at least 5 cm from the 
tumour/ulcer.
Animal Experimental Model
Ninety five male Wistar rats aged between 4-6 weeks were studied. 
Iimmnl ngical StlKfr
Twenty patients from the Human Gastrectomy Study were 
examined in this study. Twelve patients had a gastrectomy 
performed for malignant disease and eight for benign disease. The
Medical Treatment Group
Mean Age 52.5
(range) (19 - 80)
Diagnosis 11 gastric ulcer
23 non-ulcer dyspepsia
14 duodenal ulcer
Sex 26 female
22 male
Table 10: Age, diagnosis and sex of patients undergoing routine 
upper gastro-intestinal endoscopy and biopsy for 
diagnostic and treatment purposes - Medical Treatment 
Group
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Age Sex
Suraical Treatmpni-
Operation
71
62
53
45
63
47
59
32
50
61
65
58
63
41
39
74
M Truncal vagotomy and drainage
M " " " n
p n n n h
jkj n n n n
p n n n n
1 4 "  n n n
h n n n
^  n n n  h
p n n u n
J4 " ” n n
p n n n it
jyj n n n r
M  " n n R
M Billroth 11
F Billroth 11
M Billroth 11
Time since 
operation 
(years) 
12 
11 
25 
9 
8 
24 
17 
4 
12 
8 
9
13
7
12
4
10
Table 11: Age, sex, nature of operation and time since
operation in sixteen patients who had undergone 
gastric surgery for benign disease - Surgical 
Treatment Group.
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gastrectomy specimens were sampled at three sites. A: 
tumour/ulcer, B: the gastric mucosa imnediately adjacent to the 
tumour/ulcer within 1 cm, C: the gastric mucosa at a distance of
at least 5 cm from the tumour/ulcer.
FfH-al Shm arh
Forty fetal stomachs, obtained from legal and spontaneous 
abortions, and four neonatal stomachs were studied.
MATERIALS AND METHODS 
Human, Gastrectomy Study
The gastrectomy specimens were collected from theatre immediately
after resection, opened along the greater curvature and a
macroscopic examination of the stomach and a description of any
mucosal lesion made. The stomachs were then pinned on a cork
board, inverted and fixed in 10% formol saline for 24-48 hours.
Blocks were then taken in a standard fashion from the tumour and
the length of the greater and lesser curves (see figure 12). A
minimum of five blocks were taken from the tumour and adjacent
mucosa. The length of the sections taken ranged from 2-3 cm.
The tissue was processed to paraffin blocks and serial 4 urn
sections were cut. The sections were stained with haematoxylin
and eosin, the Cresyl Violet technique and the mucin histochemical 
procedures outlined below.
Mucin Histochemical Techniques
Neutral N-acetyl 0-acetyl Sulpha 
Diastase-periodic acid Schiff (D-PAS) Red Red
Perodate-borohydride (PB KOH PAS) — — Blue “
Alcian Blue AB pH 2.5/PAS (AB/PAS) Red Blue Blue Blue
High iron diamine/AB pH 2.5 (HID/AB) - Blue Blue Brown/
Black
126
Sampling of Gastrectomy
Areas sampled 
Tumour
Lesser curve 
Greater curve
Figure 12. Technique of fixation and sampling of gastrectomy 
specimens.
Hie following flow chart illusrates the technique used to 
identify the mucins.
H & E identify tissue
D-PAS identify typical goblet cells and mucous cells
AB/PAS identify neutral mucins (red) or mixture acidic
plus neutral purple 
HID/AB identify sulphomucins (black) and sialomucins
(0-A and NA) blue
PB/KOH/PAS identify type of sialomucin (O-Acetyl-blue).
The material from the Human Gastrectomy Study was examined in 
four main topics; clinico-pathological features, classification of 
tumours, intestinal metaplasia and dysplasia.
Clinico-pathological
Hie following clinico-pathological variables were noted for 
each patient.
Age
Sex
Presenting symptoms 
Duration of symptoms 
Drug history
Type of surgical resection 
Length of post-operative survival 
Size of tumour
Distance to nearest resection margins 
Number and pathology of lymph nodes identified 
Depth of penetration of tumour (T stage)
Presence of distant metastasis
127
Classification of tumours 
Classification procedure
On the basis of the histological appearance the malignant 
gastrectomy specimens were classified into the various sub-groups 
outlined in the five classification systems in Chapter 1. The 
classification into the Lauren system was performed by two 
observers, the author and a Consultant Pathologist. The remaining 
classification systems were interpreted by the author alone.
(1) WHO
(2) Lauren
(3) Mulligan and Rember
(4) Ming
(5) The Jass modification of the Lauren system.
Evaluation of Lauren System
In order to examine the heterogeneity of gastric tumours and 
the implications on the Lauren system, a detailed analysis of the 
histological features of the gastric tumours using a scoring system 
was employed. Each tumour was examined in detail and all areas of 
the sections surveyed. The four main histological features of the 
Lauren classification were then assessed and a score assigned. (A 
score of +1 was assigned for each intestinal type histological 
feature, conversely a score of -1 was assigned for each diffuse 
type feature. A tumour displaying all four histological features 
of the intestinal type derived a score of +4. If however there 
were areas of single cells with poor cohesion in addition to well 
defined glandular lumina and all the other features of an 
intestinal type tumour then a score of 4+ -1 = 3) (see table 12).
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Scoring Jgystfm for Lauren aassificatiQQ
Variable
General structure
Histological Features
glandular lumina, cell cohesion
single cells, clusters of cells 
with poor cohesion
Score
+1
-l
Cell structure
large, variable morphology, 
mitotic figures +1
uniform, poorly defined, regular nuclei -1
Secretory cells {
few, extracellular mucin 
plentiful, intracellular mucin
+1
-1
Mode of growth
well defined, peripheral edge, poly- +1 
morphonucler response in invaded tissue
poorly defined, peripheral edge, lympho— 1 
cyte response and connective tissue 
proliferation in invaded tissue.
Table 12. Scoring system for Lauren Classification. On the 
basis of the four histological variables described 
by Lauren, tumours are assigned positive mark for 
intestinal feature, negative for diffuse.
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Intestinal Metaplasia
Quantification and classification of intestinal metaplasia
All sections from each gastrectomy specimen were examined. 
The number of sections ranged from 12-23 with a median of 17. The 
number of gastric crypts and crypts of intestinal metaplasia were 
counted. The total number of crypts in each specimen examined was 
thus determined and the percentage of the total which were of 
gastric type or metaplastic types was calculated for the 
intestinal, diffuse and benign gastrectomy specimens. The sub- 
types of intestinal metaplasia as defined by the morphological and 
histochemical criteria of Jass were identified using the serial 
sections stained for mucins. The percentage of each sub-type as a 
total of all crypts in each specimen (ie. gastric and metaplastic) 
and the percentage of each sub-type as a total of the metaplastic 
crypts only were calculated. Using the results of the 
quantitative analysis the amount of the gastric mucosa replaced by 
metaplastic epithelium was graded: little or none <5%, moderate 5-
20%, extensive 20-100%.
The crypt counting technique was performed by one observer. 
Ten gastrectomy specimens were selected at randan and recounted. 
Analysis of Variance between the two counts was performed to 
determine the validity of using the results from the counting 
technique in a statistical analysis.
Relationship of variables within the gastrectomy specimens to 
intestinal metaplasia
Six variables were assessed in relation to intestinal 
metaplasia.
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(i) Diagnostic group - using the data from the previous section 
the gastrectomies were subdivided into intestinal, diffuse 
and benign groups according to Lauren and intestinal, 
"gastric" and benign, according to Jass. In determining the 
relationship between type lib and the histological type of 
tumour as defined by Lauren (1965) all the gastrectomy 
specimens were analysed. However in the analysis of type 
lib and the histological types of tumour defined by Jass 
(1980) only those stomachs which showed extensive IM were 
used as this was the selected group in which Jass (1980) 
described a significant relationship between type lib and 
intestinal type of tumour.
(ii) Presence of ulceration - ulceration was defined as the breach 
of the mucosal layer to the level of the sub-mucosa at least,
(iii) Inflammation - the severity of the inflammation present 
within the gastric mucosa was graded on a scale of 0 - 6 
using standard photographs after the method described by 
Watt et al., 1983. The method was modified to include 
gastritis and atrophy on a single scale rather than examining 
these features independently. The score depended on the 
quantity of inflammatory cells in the lamina propria and 
degree of atrophy. Standard photographs illustrating scores 
of 1, 3 and 5 were used. Score 1 showed a minimal 
infiltrate of cells in the superficial layer of the lamina 
propria; 3 indicated a heavy infiltrate of chronic 
inflammatory cells throughout the mucosa Specimens with 
score 3 and score 5 showed some degree of atrophy and were
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roughly equivalent to chronic atrophic gastritis and active 
chronic atrophic gastritis. The severity of gastritis 
varied in different areas sampled.
Hie area with the most severe inflammatory changes was used 
to determine the grade for each stomach.
(iv) The presence of Helicobacter pylori in the Cresyl Violet 
stained sections was determined.
(v) The age of the patients undergoing gastrectomy was also 
determined.
(vi) The sex of the patient undergoing gastrectomy was determined. 
Hie data were analysed using Chi square analysis with Yates 
correction to test the association between intestinal metaplasia 
and the subtype lib and the diagnostic group.
Hie question of whether the presence of intestinal metaplasia 
or the subtype lib is associated with any of the factors, 
ulceration, inflammation, diagnostic group, age, or any combination 
of these was investigated using the statistical package GLIM 
(Generalised Linear Interactive Modelling). In determining 
significant combinations of factors this technique investigates the 
probability of the presence of intestinal metaplasia on the factors 
and then, for any combination of factors found to be significant, 
provides estimates of the probability for any specific case. 
Dysplasia
The sections taken from the area of the tumour/ulcer were 
examined by one observer. A subjective description of the 
variants of dysplasia was made. The criteria used to assess 
dysplasia were those outlined by Morson et al., 1980.
The frequency of the variants of dysplasia occurring in the 
diagnostic groups of the Lauren (1965) classification and benign
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disease was determined. The tumours were classified into well and 
poorly differentiated categories on subjective histological grounds 
by one observer and the occurrence of dysplastic variants 
determined for these two groups.
Minin Histochemistry Stanfr
Using the flow chart outlined in the mucin histochemical 
techniques the serial sections from the human gastrectomy study 
were examined.
The mucin histochemistry of the gastrectomy material was 
examined in four ways.
(1) The mucin expression in normal and inflamed gastric mucosa in 
both the benign and malignant groups was determined. The presence 
or absence of mucins was solely determined; no attempt was made to 
grade the amount.
(2) The mucin profile of intestinal metaplastic crypts of 
subtypes I, Ila and lib from gastrectomy specimens containing 
benign, intestinal type and diffuse type tumours of the Lauren 
(1965) classification. Ten gastrectomy cases from each group were 
selected randomly and 100 crypts of each subtype which were axially 
sectioned were studied. Hie mucin content of the goblet cells in 
type I and the goblet cells and columnar cells in type Ila and type 
II recorded. Hie presence or absence of a particular mucin within 
the goblet or columnar cells of the individual crypts was noted; 
no attempt was made to quantify the number of cells expressing a 
specific mucin within a crypt.
(3) The presence or absence of the mucin subtypes within the
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tumours was determined by examining all the sections taken from 
each tumour. The mucin content was related to the classification 
systems and the degree of differentiation.
(4) The sulphomucin content of the tumours was related to the 
presence or absence of type lib metaplasia in the mucosa of the 
gastrectomy specimen.
Tiiminocytnchgnical Sfakfr
Epithelial ceLL_and oncofetal antibodies
Blocks were selected from each case from the human 
gastrectomy study to include representative portions of 
tumour/ulcer, adjacent mucosa and areas of intestinal metaplasia. 
Axially sectioned crypts of intestinal metaplasia were examined in 
order to determine the distribution of the immunoperoxidase 
staining throughout the crypts. Specimens which showed less than 
perfect fixation were excluded. The antibodies used were against 
carcino-embryonic antigen (CEA), secretory component (SC), IgA and 
intrinsic factor (IF). The source and dilution of the antibodies 
is shown in table 13.
Production of Intrinsic Factor Antibody
Antibodies to hog intrinsic factor were produced by 
immunisation of New Zealand white female rabbits with 75 ug 
purified hog intrinsic factor in aqueous solution in a 2 ml 
emulsion with Freund's adjuvant and boosted at 14 day intervals 
with Freund's complete adjuvant. Antibody to intrinsic factor was 
detected in the rabbit serum by its ability to block the binding of 
Vitamin B12 by intrinsic factor in vitro. Ihe titre of antibody
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varied but typically 1 ml of rabbit serum blocked the binding of 
approximately 200 ng of cyanocobalamin by intrinsic factor. In 
Ouchterlony plates a single precipitin line was detected between 
the rabbit anti-intrinsic factor and purified intrinsic factor. 
When the antibody was run against an intrinsic factor - vitamin B12 
complex a faint accompanying line was detected, indicating the 
presence of antibody to intrinsic factor - vitamin B12 complex. 
Non-intrinsic factor vitamin B12 binding proteins did not cross- 
react with the antibody.
Absorption techniques with CEA antibody
NCA2 was obtained from normal stomachs of cancer free 
patients. The stomach mucosa was stripped off and freeze dried
and 50 mg of tissue powder used for absorption. Human spleen was 
prepared in a similar manner.
Absorption was performed by mixing the stomach and spleen 
powder with antiCEA serum, incubated at 4°C overnight. The mixture 
was centrifuged at 100,000 revs for one hour and the supernatant 
extracted (Nap et al., 1983).
Neuro-endocrine cells
Selected blocks from formalin fixed paraffin wax material 
from benign and malignant gastrectomy specimens which included 
representative areas of normal, inflamed and sub-types of 
metaplasia, were stained using antibodies raised against. 
Chromogranin 
Glucagon 
Gastrin
Vasoactive intestinal polypeptide (VIP)
Cholyecystokinin (CCK)
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Glucose dependent insulinotropic peptide (GIP)
Calcitonin gene related peptide (OGRP)
Bombesin
Somatostatin
The source and dilution of the antibodies is shown in table
13.
Immunoperoxidase methods
4-5 um sections thick mounted on freshly polished slides, 
degreased in 99% alcohol for a minimum of 24 hours. Sections
dried overnight at 37°C followed by 15 minutes at 60°C. 
Peroxidase-antiperoxidase method
This technique was used for the anti CEA, IF, SC and Neuro­
endocrine antibodies.
1. Dewax and hydrate sections
2. Removal of endogenous peroxidase with 0.5% Hydrogen Peroxide 
in methanol half an hour.
3. Ten minute exposure to normal inactivated swine serum, 
diluted 1:5 with Tris buffered saline. Excess drained off.
4. Treat with primary antibody.
5. Wash Tris buffered saline x 3
6. Swine anti-rabbit IgG for 30 minutes at roan temperature
7. Wash Tris buffered saline x 3
8. Rabit antiperoxidase-peroxidase complex.
9. Wash Tris buffered saline x 3.
10. Visualisation using Diamino Benzidine Tetra Hydrochloride
136
Antibosfe Dilution Source Incubation
CEA 1/5 DAKO 12 hrs 4°C
Secretory component 1/600 DAKO 1 hr roan temp.
IgA 1/600 DAKO 1 hr room temp.
Intrinsic factor 1/500 S.A.P.U. 1 hr room temp.
Chromogranin (Human) 1/200 RPMS 12 hr 4°C
Glucagon 1/2000 RPMS It N
Gastrin 1/5000 RPMS n n
CCK (9-20) 1/200 RPMS it it
GIP 1/5000 RPMS n n
OGRP 1/2000 RPMS n n
Bombesin 1/2000 RPMS it ii
Somatostatin 1/5000 RPMS it it
SAPU = Scottish Antibody Production Unit
RPMS = Royal Postgraduate Medical School, Hammersmith
Table 13: Source, dilution and incubation period of antibodies
used in immmocytochemical study.
Controls
(1) Pooled heat inactivated normal rabbit serum diluted at the 
same strength as the test serum.
(2) Section treated for endogenous peroxidase and DAB only.
(3) Known positive control sections.
Avidin-Biotin Technique
This technique was used for the anti IgA antibody using the 
ABC kit.
Interpretation of, Xmmunocytochemical Preparations
The interpretation of immunoperoxidase staining is highly 
subjective. The simplest analysis involves the determination of 
presence or absence of staining within the particular tissue under 
study. The pattern and morphological distribution of the staining 
is of prime importance. In the neoplastic epithelium the 
following features of peroxidase staining were noted:
1) Cellular distribution ie cytoplasmic, apical, brush border.
2) Types of cells stained ie Signet ring cells.
3) Distribution of labelled cells within tumour - ie. focal or
diffuse and the areas within the tumour stained.
4) Number of cells within tumour stained - objective assessment 
graded 0 - 4 . 0 = no cells, 1 = >20%, 2 = 20-50%, 3 = 50-
80%
4 = 80-100% cells stained.
The peroxidase staining of the gastric and metaplastic mucosa 
was assessed in a similar fashion but with some modification.
1) Cellular distribution.
2) Types of cells ie goblet cells, columnar cells, parietal
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cells.
3) Distribution of cells within the crypt and type of crypt, 
antral/gastric, type of metaplasia, and dysplasia.
4) Level of inflammation in the surrounding lamina propria 
according to the 0 - 6  scale outlined previously.
Quantification
The staining of the antibodies against SC, IgA and CEA was 
quantified in the subtypes of metaplasia. 1,323 crypts axially 
sectioned to include the base and luminal surface were examined. 
The number of crypts of each subtype which showed positive staining 
with the antibodies against CEA, SC and IgA were determined. The 
figure was expressed a percentage of the number of crypts examined 
of the three subtypes.
The staining pattern of the antibodies against the 
neuropeptides in normal, inflamed and metaplastic epithelium was 
also quantified. The quantification of neuroendocrine cells has 
been investigated by Pietroletti et al., 1986. These authors 
describe a technique of counting positively stained cells in a 
given morphological unit. This technique of counting was used 
with a morphological unit of six crypts. Using the 
antichromogranin antibody the number of endocrine cells positively 
stained per morphological unit was determined. The antibodies 
raised against specific neuropeptides did not stain cells in 
sufficient frequency to allow for a meaningful count to be made; 
often only one or two cells stained positively with the antibody 
against a specific neuropeptide in 30-40 crypts. The positive 
staining of cells with antibodies against specific neuropeptides is
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presented as a list in descending order of frequency.
Cell Kinetic Studies
Tissue preparation
The material from the three groups of patients was handled in 
an identical manner. The tissue was diced into small fragments, 
incubated in medium containing tritiated thymidine, fixed, 
processed into paraffin blocks and 20 serial 4 urn sections cut. 
Every third section was developed to visualise the incorporated 
thymidine. The intervening sections were stained with 
haematoxylin and eosin and High Iron Diamine/Alcian Blue to 
identify the subtypes of intestinal metaplasia. A Cresyl Violet 
stain was also performed to identify any Helicobacter pylori 
present. The tritiated thymidine technique is detailed below.
The tissue was diced into small pieces and placed in 5 ml of 
RPMI 1640 medium containing, foetal calf serum 10%, insulin 20 
units, glutamine 1 ml (29.3 mgs), penicillin/streptomycin 2 mis 
cone 5,000 units/5,000 ug/ml) per 100 ml volume.
Fifty ul of tritiated thymidine was added to medium, 
concentration of thymidine 1 mCi/ml, giving concentration of 10 
uCi/ml in medium. 95% 02/5% CO2 bubbled into medium for 20 
seconds. Specimen tubes were placed in 37°C shaking ^0 bath for 
two hours.
Samples were then immersed in 10% buffered formalin and 
processed to paraffin wax. Serial 4 urn sections were cut and 
placed on slides coated with gelatine, chrom. alum. Slides were 
dewaxed and rehydrated.
Slides were coated with Ilford K2 liquid emulsion, placed in
light-tight box containing silica and crushed solid 002. The box 
was closed and placed in a cool place for two weeks. The slides 
were developed using D19 developer for 5 minutes, 30 second wash in 
deionised H20, Kodafix for 5 minutes and then washed in running tap 
water for 15 minutes. The sections were then stained with 
haematoxylin and eosin.
Histological variables
The mucosa was classified as antral or body type on the basis 
of histological examination. The severity of the inflammation was 
graded 0 - 6 as previously described. The reflux gastritis score 
was determined using the criteria outlined by Dixon et al., 1986. 
The subtypes of intestinal metaplasia were identified using Jass's 
criteria (Jass 1980). The presence of Helicobacter pylori was 
determined using the Cresyl Violet technique. The tumour material 
examined was not classified using the small tissue samples obtained 
for the thymidine incubation technique but by reference to the 
histological material taken for the Human Gastrectomy Study. 
Counting tgchrugaea 
Gastric mucosa
Cells were considered labelled if they had five or more 
grains over the nucleus. In the majority of the cases the crypts 
had been sectioned perpendicular to their axis resulting in cross- 
sectioning.
In the gastric mucosa labelled cells in all cross-sections of 
foveolae containing one or more labelled cells were counted. The 
total number of cells in all cross-sections and the number of 
foveolae were also counted. In each sample a minimum of 2,000
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cells were counted and the percentage of labelled cells (Labelling 
Index (LI)) estimated* This counting technique tends to 
overestimate the LI as cross-sections through the progenitor region 
which do not have labelled cells will not be included in the 
estimation of the LI. This error was reduced by means of an 
equation for correction described by Hansen et al., 1975 described 
in the previous text. The LI quoted in the results are the 
corrected values.
In addition to the examination of cross-sections of gastric 
crypts, the biopsies were re-orientated and axial sections of the 
antral crypts cut. The axial sections were examined to determine 
the distribution of the labelled cells within the crypts and the 
relative lengths of the crypts in cell numbers counted and 
expressed as column length. To determine the column length the 
number of cells from the luminal surface to the base of the crypt 
were counted. It proved technically difficult to achieve axial 
sections which included the complete length of a crypt. In the 
gastric crypts the column length and the geographical position of 
the labelled proliferative zone was determined. The position of 
the labelled cells in the crypts were counted in defined positions. 
The cell at the luminal surface of the crypts was designated cell 1 
and the cells numbered in increasing order towards the base (see 
figure 13). The number of labelled cells were counted in defined 
positions of the crypt; above the luminal surface, cell postion 1- 
5, cell position 6-10, etc. One hundred crypts were examined from 
selected biopsies from the Medical Treatment Group at gastritis 
scores 1, 3 and 5 and the cell counts pooled and expressed as 
number labelled cells at a defined cell position as a percentage of
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DIAGRAM OF GASTRIC PIT
Figure 13.
Cells numbered from cell at luminal surface. 
Cell position 10 shown labelled.
Lumen
Labelled cell• •
12
13
14
Base
Diagrammatic representation of axially sectioned 
crypt and cell numbering technique. Cell at 
luminal surface of crypt is numbered cell 1 and 
adjacent cell 2 and so forth, towards the base 
of the crypt. Cell in position 10 is shown as 
labelled with thymidine.
the total number of labelled cells. Twenty five crypts from the 
Surgical Treatment Group were examined in a similar fashion. This 
allows for the position and distribution of the generative zone to 
be assessed in both the Medical and Surgical Treatment Groups. 
Intestinal metaplasia
The labelling index of the intestinal metaplastic crypts was 
determined using a modified technique. It was not possible to 
determine the type of metaplasia in cross-sections so axial 
sections were examined. In these axial sections the labelling 
index was defined as the percentage of the labelled cells and 
counted in a total number of 2000 nuclei in the generative zone; 
the generative zone was defined as the region between the level of 
the uppermost labelled cells to that of the lowermost labelled 
cells.
Gastrectonty_G£oup
The Labelling Index of the mucosal samples from areas B and C 
were determined by counting labelled cells in cross-sections of 
crypts as previously described.
Ihe Labelling Index of the tumours was determined by counting 
the number of labelled cells and unlabelled cells in high power 
fields (x 400). A minimum of 2,000 cells were counted for each 
case and the LI expressed as a percentage of labelled/unlabelled 
cells. The type and distribution of the labelled tumour cells was 
assessed histologically.
Validation of Counting Technique in Thymidine Labelled, Material
The objective of this study was to determine to what extent 
'observer error', either in the form of a person being able to 
reproduce stable relative counts of labelled to unlabelled cells or
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in the form of variability across different selected areas of 
tissue, would affect the results of the study.
Three pairs of counts (L,U) of labelled and unlabelled cells 
were obtained on ten cases from the endoscopic biopsy material 
(five from the Medical Treatment Group and five from the Surgical 
Treatment Group) and ten cases of gastric carcinoma from the 
gastrectomy material. The first pair of counts was on area 1, the 
second and third counts were on the same area 2. This provided 
information on the reproducibility of the count ratio L/U between 
two different areas of the same case and also on the ability of the 
investigator to reproduce relative counts in the same area. Using 
this data a statistical analysis was performed to determine if the 
observer error was small and insignificant to allow valid 
statistical comparisons to be made, or alternatively if the 
observer error was of such a magnitude to make statistical 
comparisons invalid.
For the purposes of discussion of the statistical analysis it 
is convenient to imagine that there are three 'observers' j = 1, 2, 
3, with observer 1 being regarded as the investigator determining 
the counts on the first area, observer 2 the investigator at his 
first attempt on the second area and observer 3 the investigator on 
his second attempt on the second area.
For data of this compositional type a standard recommendation 
is that instead of the ratio L/U of labelled to unlabelled cells 
the logarithm of L/U (shortened to logratio) should be studied. 
Let x^ j denote the value of this logratio recorded for the ith case 
by observer j. For the given data set the maximum possible
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explanation of the variability of the logratios is provided by a 
model M involving both case and observer effects as follows: 
xij = u + i + ■ + error e^
where u is the general mean, i is specific to the ith case and j 
is specific to the jth observer. Hypotheses of interest can then 
be posed within this model and set out in a lattice. The different 
levels of the lattic correspond to different degrees of complexity 
of explanation of the variability observed in the logratios log 
(L/U), with hypotheses at lower levels providing simpler 
explanations than those at higher levels. Level 0 corresponds to 
the simplest hypothesis HQ that the logratios do not depend on 
either case or observer. At level 1 there are two hypotheses, Hj 
that the variability depends on case only and H2 that the 
variability depends on observer only. At level 2 there are again 
two hypotheses, H3 that there is no difference between replicate 
count determinations within a given area and H4 that there is no 
difference between replicate count determinations between different 
areas. Level 3 corresponds to the model M.
For the statistical testing of the various hypotheses within 
this lattice the statistical package GLIM (Generalized Linear 
Interactive Models) was used. For this particular problem the 
'response variable', log (L/U), is 'continuous' and the hypotheses 
can be defined in terms of the two factors, 'case' at 10 levels and 
'observer' at 3 levels. For the model and each hypothesis GLIM 
provides a fit to the data. For the model M and each hypothesis H 
a measure of the lack of fit is reported as a 'deviance' or Dy, 
together with a number of 'degrees of freedom' d^  and dH. The
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number of degrees of freedom is the number n of observations less 
the number of 'parameters' required to define the model or the 
hypothesis, so that the more complex the explanation the fewer the 
number of degrees of freedom. The test of any hypothesis H within 
the model M then depends on the extent to which Dg is bigger than 
and the critical value of the test quantity depends on the 
numbers of degrees of freedom ^  and dj*. The appropriate test is 
the well-known F-test used in standard analysis of variance: 
reject the hypothesis H within the model M at significance level P 
if
> Fp
where Fp is the appropriate upper P percentage point of the F 
distribution with and d  ^degrees of freedom. This test is
carried out successively on the various hypotheses starting at 
level 0, proceeding to level 1 only if the hypothesis at level 0 is 
rejected, moving up to level 2 only if the two hypotheses at level 
1 are both rejected, and so on. This process is stopped at the 
first level at which there is failure to reject a hypothesis, with 
all non-rejectable hypotheses at that level being regarded as 
possible explanations of the observed variability.
Animal gypgrimpntal model
Ninety five male Wistar rats were divided into two groups.
Group 1 received N-methyl-N'-nitro-N-nitrosoguanidine at a 
concentration of 50 fug/ml in their drinking water ad libitum for 16 
weeks and thereafter normal tap water. Group II served as a 
control receiving unadulterated tap water. The carcinogen
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was prepared freshly twice weekly and stored in a light proof 
container, the rats drinking bottles also being protected from 
light. The health of the rats was monitored by daily inspection 
and weekly weighing. Any animal showing significant deviation 
from normal health was humanely killed.
The animals were sacrificed at the following intervals shown 
in table 14.
The rats were injected intraperitoneally with 0.75 mg/kg 
vincristine sulphate and sacrificed at hourly intervals from time 
0, 1 hour, 2 hours, 3 hours and 4 hours. In addition to this two 
rats in each group were injected intraperitoneally with 500 Uci 
thymidine and sacrificed at one hour post injection.
A post mortem examination was performed. Hie stomach was 
removed with a cuff of duodenum and oesophagus, opened along the 
greater curvature and pinned on a small cork board. The board was 
then inverted and placed in Carnoy's solution for 24 hours and then 
transferred to Cellosolve (C). The fixed material was then 
sectioned and processed to paraffin blocks. Four urn sections were 
cut for haematoxylin and eosin staining and for autoradiography 
where appropriate.
Histological Examination
The haematoxylin and eosin sections were examined and the 
presence of ulceration, metaplasia and carcinoma noted.
Metaphase arrest technique
The metaphase arrest technique depends on correct 
application. Wright and Appleton, 1980, have highlighted certain
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Time
weeks
Control Group Carcinogen exposed
0 5 5
20 10 14
40 10 14
60 10 10
80 4 5
TABU2 14: Sacrifice intervals and number of animals 
for experimental carcinogenesis study.
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points and these are discussed below, in relation to the proposed 
experiment.
(1) Choice of metaphase arrest agent
(2) Dosage to be used
(3) Which cells to count
(4) Timing of readings
(5) Interpretation of results
(1) Which agent to use
Vincristine has been shown to be effective in the rat small 
bowel and this agent is regarded as the most suitable for gut 
epithelium when compared with vinblastine and colcemid (Tannock, 
1965).
(2) Dosage to be used
Tannock's experiments (1965) identified the optimum dose for 
Vincristine for rat gut in the range 0.25 mgAg to 1 mgAg. The 
dose selected in this experiment was 0.75 mgAg.
(3) Which cells to count
The number of metaphases should be counted and related to the 
total cell population. Bowel crypts act as closed systems from 
which arrested metaphases are unable to escape during the 
experiment. A technique of microdissection of whole colonic 
crypts is now widely accepted and this allows for the calculation 
of a crypt cell production. The advantage of this method is that 
it avoids the difficulty of correcting for the diameter of arrested 
metaphase and interphase nuclei in tissue sections (vide infra). 
The technique of whole crypt dissection has been widely applied in
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colonic crypts but not for gastric crypts. An initial experiment 
was performed to examine the application of the technique in the 
stomach. Unfortunately the gastric crypts appeared too friable 
and fragmented into clumps of cells. It was therefore decided to 
use tissue sections. The number of cells in each crypt and the 
number of arrested metaphases in the cryp± were counted. In 
counting tissue sections an important geometric factor has been 
identified by Tannock, 1965. Mitotic nuclei in the intestinal 
crypts are invariably situated nearer the axis of the crypts out of 
line with interphase nuclei. Using a simple cylindrical crypt 
sectioned along its axis, a mitotic nucleus of diameter d and at 
radius a will be counted in approximately d/2 a of the possible 
axial sections while an interphase nucleus of the same size will be 
counted in only d/b of these sections where b is the crypt lumen 
radius (see figure 14) . Thus the metaphase index will be 
overestimated by a factor of b/a. To determine the factor b/a, 50 
cross-sections of crypts were examined; the radius (b) and 
position of the metaphases (a) were measured using a graticule and 
expressed as the ratio a/b (see figure 15). The mean value was 
found to be 0.53 and this value for a/b was used as the Tannock 
correction factor for the gastric crypts.
(4) Timing of reading
Two errors may occur when taking readings (Wright and 
Appleton, 1980). Firstly, only two readings may be taken, one at 
time zero and the second after a given period. if the regression 
line is calculated using only these two points then any initial 
delay in the arrest of metaphases is not
Tannock Factor
Metaphase 
cell nucleus
Interphase 
cell nuclei
Figure 14. Diagrammatic explanation of Tannock Factor. Large 
circle represents cross section of intestinal crypt. 
Metaphase nuclei lie nearer the axis of the crypt 
compared with interphase nuclei. If an axial 
section of the crypt is taken a mitotic nucleus of 
diameter d and at radius a will be 
counted in only d/b of these sections where 
& is the crypt lumen radius
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RADIAL POSITIONS OF MITOSIS IN CRYPT CROSS SECTIONS 
IN RELATION TO CRYPT RADIUS.
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0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 10
Radial position of Mitosis (a) / Radius of Crypt (b)
Figure 15. Radial position of mitosis (a) in crypt cross 
sections in relation to crypt radius (b) in 50 
rat antral crypts. Mean value is 0.53.
taken into consideration and the rate of entry into mitosis will be 
underestimated. Secondly, readings may be taken over the non­
linear portion of the curve ie. when metaphases have begun to 
degenerate. Wright and Appleton, 1980, regarded 0 - 4  hours as a 
relatively standard period in metaphase arrest experiments in 
mammalian tissue. Tannock demonstrated linearity of metaphase 
arrest with vincristine over a four hour period. A four hour 
period was selected for the present experiment; metaphase 
degeneration was not seen over this time scale using vincristine at 
a dose of 0.75 mgAg.
(5) Interpretation of results
In the antrum ten crypts from each animal were assessed.
The number of arrested metaphases and the number of cells in each
crypt column were counted. Multiplication by a factor of two
gives the number of cells in each crypt section and allows the
metaphase index to be expressed as a percentage:
number of arrested metaphases x 1M  = mitotic index, 
number of cells per crypt section 1
This was then corrected using the Tannock factor.
The accumulation of metaphases over the four hour 
experimental period was calculated. The slope of the line was 
fitted using the least squares method assuming a rectangular age 
distribution. Hie slope of the line is the rate of entry into 
mitosis The rate of entry into mitosis is otherise known as
the cell production rate. Hie results can be expressed in the 
form of Crypt Cell Production Rate/Hour ie number of cells produced
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per crypt per hour.
Thymidine Labelling Technique.
The sections were processed for autoradiography and 
counterstained as described in Human Cell Kinetic Stud/. Serial 
sections were examined and the number of labelled cells and non­
labelled cells in the generative zone of the antral crypts were 
counted. A minimum number of 1,000 cells per animal were counted. 
The generative zone was defined as the section of the crypt from 
the uppermost labelled to the lowermost labelled cell. The 
Labelling Index was calculated as the number of labelled cells 
divided by the number of unlabelled cells and expressed as a 
percentage. The mean value of the LI of the two animals in each 
group studied is given in the results section. In view of the 
small numbers of animals no statistical comparison was attempted.
In addition to the estimation of the Labelling Index the site 
of the generative zone in the crypts was noted in each case. The 
site of the generative zone was classed as being in the lower, 
middle or upper third of the crypts.
Cell mediated immunity
The specimens were snap frozen in liquid nitrogen. Serial 
sections were cut 4 urn in thickness. The sections were then 
stained using a panel of monoclonal antibodies outlined in table 15 
using an alkaline phosphatase technique outlined below.
Alkaline Phosphatase Technique
Cryostat sections
1. Fix in acetone ten minutes
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Antibodies Cluster, of
differentiation
Specificity
Leu 1 
Leu 2
Leu 3
Leu 4 
Leu 7
Leu lib
IL 2RX 
HLA-Dr
CD 5 t lymphocytes, less
5% of B- lymphocytes
CD 8 Suppressor/cytotoxic T
cell subset and natural 
killer cells
CD 4 Helper/inducer T cell
subset; some peripheral 
blood monocytes, sane 
macrophages and 
Langerhans cells
CD 3 Mature thymocytes,
peripheral T lymphocytes.
? CD3/CD2/CD8 Subset of natural killer
cells; neuro endocrine 
tissue prostate.
CD 16 Low affinity F^, receptor
on natural killer cells, 
neutrophils and some 
macrophages.
CD 25 Interleukin 2 receptor
B lymphocytes, monocytes/ 
macrophages, Langerhans 
cells, interdigitaly 
reticular cells and 
activated T lymphocytes.
Table 15: Antibodies used to investigate cell mediated immune 
response in gastric material. Cluster of 
differentiation and specificity of antibodies shown.
2. Incubate with primary antibody (Dako) 1 hour roan temperature
3. Wash Tris buffered saline. Incubate with rat anti-mouse Ig
and alkaline phosphatase conjugate
5. Wash with Tris buffered saline
6. Visualise using substrate containing AS/ER phosphate in
veronal acetate buffer pH 9.2 (contains fast red violet as 
diazonium salt and levamisol to reduce endogenous alkaline 
phosphatase).
Analysis of data
A quantitative analysis of T cell subsets within the lamina 
propria was performed. Three techniques of counting were 
attempted; (1) counts per high power field (2) counts per mucosal 
length and (3) point counting using a graticule. Analysis of 
variance was used to determine the observer variation using the 
statistical package GLIM outlined in the Thymidine Labelling 
section.
Fetal Stomachs
The crown-rump and foot length of the fetuses were measured 
and the gestational ages estimated from this according to the 
method of Streeter, 1927. The fetuses were dissected within 24 
hours of death and the stomachs identified and removed with 
attached oesophagus and small intestine and fixed for 48 hours in 
10% formalin. In fetuses less than 16 weeks the entire stonach
was embedded in paraffin as a single sample. In fetuses older
than 16 weeks tissue blocks were taken from the pylorus, antrum and 
body of the stomach and from the lower oesophagus and duodenum.
154
Serial 4 urn sections were cut. The sections were stained 
with haematoxylin and eosin, PAS-diastase, PB/KOH/PAS, AB/PAS and 
HID/AB as outlined in the Mucin Histochemical Section. 
Immunoper oxidase stains were also performed using the antibodies 
raised against CEA and Intrinsic Factor as described previously. 
Analysis.
The fetal material was examined histologically to determine 
if any areas of metaplasia were present within the fetal stomach. 
The expression of mucin by the fetal stomach was determined by 
examination of the sections stained histochemically at the various 
gestational ages. The presence of intrinsic factor and CEA was 
determined at the various gestational ages by the presence of 
positive staining with the anti intrinsic factor and anti CEA 
antibodies.
CHAPTER 3
HOMAN GASTRECTOMY STUDY
m x m a
The work of this chapter is based on a histological and 
clinico-pathological assessment of the prospective series of 
gastrectomy specimens. The study is divided into four main areas; 
clinico-pathological, classification of tumours, intestinal 
metaplasia and dysplasia.
The literature review has highlighted the marked differences 
that are present between Europe and the USA compared with Japan 
regarding the prognosis and treatment for gastric carcinoma. A 
study of the clinical and pathological data over a three year 
period might be expected to illustrate some of the factors which 
cause these differences. This was the rationale behind the 
clinico-pathological section in this chapter.
The histological classification of gastric carcinomas is 
complex and several classification systems exist. The Lauren 
system (1965) is the most long established and well recognised. 
Although the reproducibility of the various classification systems 
has been addressed (Paginini and Rugge, 1982) a comparison between 
the systems has not been performed. Such a comparison would 
reveal any overlap between classification systems which could help 
rationalise this difficult area.
The heterogenous histological nature of gastric carcinoma has 
been emphasised in the literature review, and the variety of 
histological patterns that can appear within an individual tumour 
discussed. Ihe crucial importance of the Lauren system (1976) is 
that it divides gastric carcinomas into two types intestinal and
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diffuse with a possible difference in origin and biological 
behaviour between the types. If instead of using a subjective 
impression to apply the Lauren classification an objective scoring 
system were used this would allow for the co-existence of 
intestinal and diffuse features within a single tumour to be 
analysed.
The relationship of intestinal metaplasia to gastric 
carcinoma has been extensively discussed in Chapter 1. The 
collection of material from a prospective series of gastrectomy 
specimens allows for the classical studies of Morson (1955) to be 
repeated. The majority of studies of intestinal metaplasia have 
used a subjective assessment of the degree of metaplastic change 
and have frequently not taken into account other important 
variables such as age. The development of a simple quantitative 
assessment of intestinal metaplasia allows for the subjective 
element to be eliminated. Multivariate analysis can determine the 
effect of a variety of factors on the presence of intestinal 
metaplasia and this is the method chosen in the present study.
Although the association between Type lib intestinal 
metaplasia and sub-types of gastric carcinoma described by Jass 
(1980) has been tested by other authors (Filipe et al., 1985; 
Ectors and Dixon, 1986) in endoscopic biopsy material the original 
work by Jass has not been repeated in gastrectomy material. In 
this present study the observations of Jass (1980) are performed in 
a larger number of cases and in addition a multivariate analysis is 
performed to determine the relationship of other variables to the
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presence of Type lib metaplasia.
The review of the literature concerning gastric dysplasia has 
demonstrated that although dysplastic change can be recognised the 
natural history and clinical significance is uncertain. The 
importance of dysplasia as a precancerous lesion has been 
emphasised by leading authorities (Morson et al., 1985). It 
seemed appropriate therefore to attempt to describe and document 
dysplastic change in the gastrectomy material and to relate this to 
the studies discussed in Chapter 1.
AIMS
Clinico-Pathological Stucjy 
Clinical
The aim of the clinical section of this study was to 
determine the age, sex, presenting syptoms and pattern of referral 
of the patients who underwent gastrectomy for malignant disease. 
The method of diagnosis prior to surgery and the survival of 
patients following surgery was also investigated in those patients 
with a two year follow-up available.
Pathological
Ihe aim of the pathological section was to determine the T 
stage and N stage of the gastric tumours, and in conjunction with 
clinical data on the presence of metastases and the nature of the 
surgical resection, stage the tumours and assess the effect of 
surgical resection.
Classification Gastric Tumours
There were three aims in this section.
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(1) To classify the gastric tumours using the Lauren, Mulligan, 
Ming, Jass and WHO systems.
(2) To compare the latter three classification systems with the 
Lauren system.
(3) To evaluate the Lauren system using an objective scoring 
system described in Chapter 2 to determine relative 
heterogeneity or homogeneity of histological features within 
each individual tumour.
Intestinal metaplasia
The aims of this section were.
Quantitative data
1. Using the counting technique described in Chapter 2 to 
quantify the amount of the gastric mucosa replaced by 
intestinal metaplasia.
2. To determine if the observed amount of intestinal metaplasia
was significantly greater in stomachs resected for malignant 
disease than benign disease or between the intestinal type 
and diffuse type tumours (Lauren).
3. To determine if the observed proportions of the intestinal
metaplasia sub-types were significantly different between 
benign and malignant stomachs or between the intestinal type 
and diffuse type (Lauren).
Relationship to diagnostic group
4. To determine if the presence of intestinal metaplasia was
significantly associated with malignant compared with benign 
specimens or with intestinal type rather than diffuse type 
tumours (Lauren).
5. To determine if the presence of Type lib intestinal
metaplasia was associated with malignant compared with benign 
specimens or with intestinal type compared with benign type 
tumours (Lauren).
6. To determine if Type lib intestinal metaplasia was
significantly associated with the intestinal type of tumours 
as defined by Jass.
7. To perform a multivariate analysis to assess the relationship
of the presence of intestinal metaplasia within the gastric
mucosa of a gastrectomy specimen to diagnosis, age, 
ulceration and inflammation.
8. To perform a multivariate analysis to determine the
relationship of the presence of Type lib intestinal 
metaplasia within the gastric mucosa of a gastrectomy 
specimen to diagnosis, age, ulceration and inflammation.
9. To determine the relationship between the presence of
Helicobacter pylori and the observed amount of intestinal 
metaplasia within the resected specimens and the level of 
inflammation within the specimens.
D ysplasia
The aim of this section was to identify and describe the 
mucosal abnormalities adjacent to tumours or ulcers. The 
frequency of mucosal abnormalities in the benign, intestinal and 
diffuse groups (Lauren) were determined and also in relation to the 
degree of differentiation of the tumours.
l6l
BESETS
Ninety four gastrectoiny specimens were collected, 72 resected 
for malignant disease and 22 for benign disease. The results are 
presented in four sections. Firstly the clinico-pathological data 
of the 72 patients who underwent gastric resection for malignant 
disease. Secondly the classification of the gastric tumours. 
Thirdly the intestinal metaplasia data and finally, the dysplasia 
data. The clinico-pathological data of the 72 patients who 
underwent gastric resection for malignant disease is presented 
below.
fT,TNTfD-PATHOTPHTCAT, FEATORBS
Clinical data
Age and sex
The peak incidence was in the 60 - 79 age group with a 
male:female ratio of 3:2. The mean age and male:female ratio at 
all ages were 66.6 years and 1.6:1 respectively. The age and sex 
distribution of the patients with the gastrectomy specimens 
classified according to the Lauren system are shown in table 16. 
Pattern of referral
There were three distinct referral patterns by the general 
practitioner; for investigation and treatment of symptoms, for 
further investigation when the general practitioner had begun 
investigation with a barium meal and this had suggested endoscopy, 
these first two categories were referred to either medical or 
surgical out-patients, and the third category in which patients had 
symptoms requiring emergency admission to hospital - dysphagia or
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Mean Age (yrs) Sex Distribution
Benign 54.1 16 M 6 F
Intestinal 67.2 26 M 11 F
Diffuse 66.1 16 M 15 F
Table 16: Mean age and sex distribution of benicp and 
malignant gastrectomy specimens classified 
by Lauren criteria.
haematemesis (see table 17).
One patient was diagnosed as having gastric carcinoma at the 
time of laparotomy for an aortic bifurcation graft. The additional 
patient was referred directly to an endoscopy clinic for routine 
endoscopy following a cadaver renal transplant for chronic renal 
failure. All transplant recipients have routine endoscopies post­
transplant because of the high incidence of peptic ulceration. 
Symptoms.
The presenting symptomatology is displayed (see figure 16). 
The duration of symptoms was judged from the time prior to the 
initial general practitioner consultation. The mean duration of 
symptoms was 3.7 months and ranged from less than 1 month to two 
years, only three patients had symptoms for more than one year. 
Medication
At the time of referral by the general practitioner 37 
patients (51%) were on no specific therapy for their upper 
gastrointestinal tract symptoms, 15 (20%) were on antacids or 
alginates, and 20 (29%) were on H2 receptor blocking agents. 
Investigation and diagnosis prior to surgery
The in-patient investigations and the method and numbers in 
which a tissue diagnosis was reached prior to resection, are 
outlined in table 18.
Pathological data 
Microscopic assessment of stage
The depth of penetration of the tumour was easy to assess and 
is shown in table 19.
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XBdications-for. referral No of cases
Investigations and treatment of symptoms 56
Abnormal findings on barium meal 9
Symptoms requiring acute admission 5
Table 17: Indications for referral of patients with gastric
carcinoma to hospital by general practitioner.
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PRESENTING SYMPTOMS
SYMPTOM
Haematemesis
Weight loss
Pain
Dysphagia
Dyspepsia
Vomiting
Anorexia
15 20100 5
Number of patients
Figure 16. Main presenting symptoms of 72 patients undergoing 
gastrectomy for malignant disease
No of Patients 
59
2
2
Investigations Diagnosis prior to surgical resection
Endoscopy
Endoscopy
Nil
Incidental 
finding at 
laparotomy
Palpable epi­
gastric mass
Barium meal 
filling defect/ 
outlet 
obstruction
Biopsy proven carcinoma (7 on repeat
biopsy)
Negative biopsy, clinical suspicion
Nil. Emergency resection for 
haematemesis
Confirmed by frozen section
1 confirmed by frozen section
2 confirmed by frozen section
Table 18: Investigation and method of histological diagnosis
of gastric carcinoma prior to gastrectomy in 72 
consecutive patients.
T-Stage No of Cases % of Total
Tx 3 4.2
T2 3 4.2
T3 47 65.2
T4 19 26.4
Table 19: T stage (depth of penetration) of 72 
consecutive gastrectomy specimens.
The nodal status was in contrast extremely difficult to 
determine. As stated previously the nodal status was gathered 
from the histopathology report routinely issued. In eight cases 
no mention was made of nodes, in nine cases an unspecified number 
of nodes were deemed to be either positive or negative. A further 
complicating factor was that there was no attempt to identify the 
site of origin of the nodes described by the pathologist and in 
only 14 cases were nodes sent separately by the surgeon and 
identified as node from coeliac axis etc.
With this deficiency in nodal status it was impossible to
grade the cases into and N2 accurately, the only distinction 
possible was between node positive and node negative patients. 
The other factor which may have increased the inaccuracy between
the simple distinction between node positive and negative was the
number of nodes detected. The number of nodes ranged from none to 
18 but with a mean of 4.
Assessment of metastatic spread (M) was based on the findings 
at laparotomy. Ten patients had evidence of metastatic spread to 
liver or other organs. With the deficiencies in the N stage the 
tumours could not be staged accurately.
Site .of tumour
This was assessed from the macroscopic resection specimen and 
classified into antrum (48), body (21), or cardia (3).
Surgical resection
In view of the inadequacy of the nodal staging it was not 
possible to ascribe surgical treatment into the curative or non­
curative groups. Twelve cases involved a total gastrectomy, two 
of these with splenectomy and hemipancreatectcmy. The remainder 
involved sub-total gastrectomy and in four cases splenectomy. In 
only 14 cases were nodes separately identified and these were 
either from coeliac axis, sub diaphragmatic or porta hepatis. In 
no cases were splenic, justapyloric or retropancreatic nodes 
identified.
Resection margins
In ten cases the resection margin was involved with tumour. 
In 12 cases in which the tumour was situated in the body the 
resection margins were less than 5 cm.
Survival
Follow-up data was available on 50 patients followed for two 
years. A cumulative survival curve is shown (see figure 17). 
The operative mortality was defined as deaths within the first 
month following surgery and was 10% (n = 5). The two year 
cumulative survival for all cases surgically treated was 27%. 
CLASSIFICATION OF GASTRIC OTCPRS
The classification of the 72 tumours is shown in Table 20. 
The composition of the sub-groups of four classification systems, 
Mulligan, Jass, Ming and WHO with respect to the intestinal, 
diffuse and unclassified types of the Lauren system are given. 
Evaluation of Lauren System
The scoring system for intestinal and diffuse features 
outlined in the materials and methods section was used to assess 
the distribution of the histological features in the tumours. The
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Survival curve: Surgically treated gastric carcinoma
50 Patients.
100
75-
Percentage
survival
50-
25-
12 15 18 21 24 27 30 333 90 6
Months post-operatively
Figure 17. Percentage survival of 50 patients with surgically 
resected gastric carcinoma over a 33 month period 
calculated using Clinical Life Table Analysis.
Classification Rp Qf cases Comparison with Lanr^n System
LAURM
Intestinal 37
Diffuse 31 —
Unclassified 4 -
MULLIGAS
Intestinal cell 49 33 intestinal, 15 diffuse,
1 unclassified
Mucinous 16 16 diffuse
Pylorocardiac 4 4 intestinal
Unclassified 3 3 unclassified
PTOG
Expanding 37 22 intestinal, 14 diffuse,
1 unclassified
Infiltrative 35 15 intestinal, 17 diffuse
3 unclassified
JASS
Intestinal 23 16 intestinal, 7 diffuse
Gastric 49 21 intestinal, 24 diffuse,
4 unclassified
WHO
Tubular 37 24 intestinal, 13 diffuse
Papillary 8 8 intestinal
Mucinous 7 5 intestinal, 2 diffuse
Signet ring 14 14 diffuse
Adenosquamous 2 2 unclassified
Undifferentiated 4 2 unclassified, 2 diffuse
Table 20: Classification of 72 malignant consecutive gastrectomy
specimens into Lauren, Mulligan, Ming, Jass and WHO 
system. The subtypes of the latter four systems are 
compared with the intestinal, diffuse and unclassified 
of the Lauren system.
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results are displayed graphically (figure 18).
Using this scoring system 18 tumours (26.4%) showed all the 
histological features of both intestinal and diffuse, 39.8% 
displayed sane aspects of both and 33.8% showed only intestinal or 
diffuse features exclusively. Although the numbers were not 
sufficient for statistical analysis there appeared to be a positive 
correlation between the number of sections examined in each tumour 
and the finding of intestinal and diffuse features in the same 
tumour. A greater proportion of the diffuse tumours showed 
homogeneity of the histological pattern compared with the 
intestinal group.
INXESTINAL METAPLASIA 
Quant ita t iv e analysis
The coefficient of variance for the ten repeated counts 
ranged from 0-9% with a mean of 3.02% (see appendix). At this 
level of variance, statistical comparison utilising the data was 
regarded as valid.
The percentage distribution of the gastric crypts, and the 
three sub-types of metaplasia in the intestinal, diffuse and benign 
groups (Lauren classification) are displayed graphically (figure 
19). The four unclassified tumours are excluded from the 
analysis. There was a wide range of values. The intestinal and 
diffuse group had a statistically significantly greater amount of 
Type I metaplasia (p <0.05) than the benign group. There was no 
significant difference in amount of Type I metaplasia between the 
intestinal and diffuse groups. There was no significant
LAUREN CLASSIFICATION: SCORING SYSTEM
Number of 
tumours
•4 3 2 1 0 1 2 3 4
Diffuse < ------------------------------  — ---------^ Intestinal
features SCORE features
Figure 18. Results of the application of the scoring system, 
for intestinal and diffuse features based on the' 
four main histological criteria of the Lauren 
system, to the 72 gastrectomy specimens. A score 
of +4 indicates that all four intestinal type 
features and no diffuse type features were present 
within a tumour. A score of -4 indicates that all 
four diffuse features and no intestinal features 
were present. Scores between -3 to +3 indicate 
that both intestinal and diffuse features were 
present in the same tumour to varying degrees.
GASTRECTOMY SPECIMENS: COMPOSITION OF EPITHELIUM
100 H
%
Mucosa
Gastric
6 -
2 -
Type I Type lla
Types of Epithelium
|  Intestin;
□  Diffuse
□  Benign
+ 1 SD
T
Type lib
Figure 19. Percentage of mucosa from 90 gastrectomy specimens 
composed of gastric epithelium, Type I, Type lla. 
Type lib intestinal metaplasia in the three groups, 
intestinal type, diffuse type tumour (Lauren) and 
benign. Note the expanded scale for Type lla and 
Type lib. Four unclassified tumours are excluded 
from the analysis.
difference in the amount of Type lla or Type lib intestinal 
metaplasia between the intestinal, diffuse or benign groups.
The percentage distribution of the sub-types of intestinal 
metaplasia is shown in figure 20. There was no significant
difference in the proportion of each sub-type between the
intestinal,diffuse and benign groups. Figures 19 and 20 clearly 
show the small percentage of the mucosa that shows the specific 
features of type lib.
Relationship to Diagnostic Group 
Lauren Classification
The results are expressed numerically in table 21 for the 
presence or absence of the sub-types of metaplasia in the 
intestinal and diffuse type tumours (Lauren classification) and 
benign stomachs.
The presence of metaplasia of any type was significantly 
associated with the intestinal and diffuse tumours when compared
with benign specimens (X^  p <0.05). No significant difference m
the frequency of occurrence of intestinal metaplasia of any type 
could be demonstrated between the intestinal and diffuse groups. 
The presence of type lib was not significantly associated with the 
intestinal type when compared with diffuse type and benign 
groups. Combining the intestinal and diffuse tumours into a 
single malignant group resulted in a significant association with 
the presence of type lib when compared with benign (X =5.2 
p <0.05).
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PERCENTAGE DISTRIBUTION OF METAPLASIA SUBTYPES
□  Type
□  Type  
H Type
+ 1 SD
8 0 -
of total 
Metaplasia 6 0 -
BenignDiffuse typeIntestinal type
Diagnostic group (Lauren classification)
Figure 20. Distribution of intestinal metaplasia sub-types 
I, lla and lib as a percentage of the total 
metaplasia in 90 gastrectomy specimens 
divided into intestinal and diffuse types 
(Lauren) and benign. Four unclassified 
tumours excluded from the analysis.
03 
_
Q
Subtvpes of Metaplasia
Lauren Classification Type I Type lla Type lib
+ + - + -
Intestinal 30 7 9 26 16 21
Diffuse 25 6 4 27 10 21
Benign 10 12 1 21 2 20
+ = subtype present - = subtype absent
Table 21: Presence and absence of subtypes of intestinal
metaplasia in benicpi gastrectomy specimens and 
intestinal and diffuse type of tumours according 
to Lauren System.
Jass Classification
The tumours were classified into the intestinal and gastric 
type as defined by Jass and the relationship to the presence of 
type lib analysed using Chi square analysis (see Table 22). Only 
cases in which extensive metaplasia was present were used in the 
analysis, as this was the selected group in which Jass demonstrated 
a significant association between type lib and the intestinal type 
of tumour (Jass 1980). A significant association (x^  19.5 
p <0.01) was demonstrated between the presence of type lib and the 
intestinal type of tumour as defined by Jass.
Relationship between the presence of intestinal metaplasia and the 
variables diagnostic group, age, ulceration and inflammation.
Chi square analysis has demonstrated a significant 
association between the presence of metaplasia (of any type) in 
stomachs removed for carcinoma compared with those resected for 
benign disease. The benign and malignant groups differ not only 
in their diagnosis but also in mean age of patient, percentage of 
cases with ulceration and mean gastritis score (see table 23).
Ihe GLIM analysis demonstrated a significant association 
between age, ulceration and gastritis score to the presence of 
intestinal metaplasia. The estimates of probability for these 
variables are displayed graphically and compared with diagnostic 
groups (intestinal or diffuse tumour as defined by Lauren or 
benign). Estimates of probability for combination of factors ie 
50 year old with an ulcerated lesion, 55 year old with an ulcerated 
lesion and gastritis score = 3, 70 year old with grade 3 gastritis,
Typo ggpe lib  absent
Intestinal 19 *
Gastric 8 26
* p < 0.01 x2 19.5
Table 22: Relationship of Type lib metaplasia in 57 gastrectomy
specimens with extensive intestinal metaplasia to the 
"intestinal" and "gastric" types of tumour as defined 
by Jass.
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Benign
Mean age 66.6 54.1
% cases with ulceration 55 31
Mean gastritis score 3.63 3.09
Table 23: Comparison between benign and malignant 
gastrectomy specimens for the variables, 
age, ulceration and gastritis score.
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are also shown in figure 21.
Relationship between the presence of Tvne lib metaplasia and the 
variables diagnostic, group, age* ulceration and infiamnai-inn
The GLIM analysis demonstrated a signficant association 
between age, ulceration, diagnostic group (Intestinal type, Gastric 
type tumour as defined by Jass, or benign) and gastritis to the 
presence of type lib metaplasia. Estimates of probability for 
these variables are displayed graphically in figure 22. Estimates 
of probability for a combination of factors ie. 75 year old 
gastritis score = 3, 70 year old ulcerated lesion (benign or 
malignant) 60 year old ulcerated lesion (benign or malignant) 
gastritis score = 3.
Relationship between Helicobacter Pyloric intestinal metaplasia, 
diagnostic group and gastritis
Histology
Hie organisms lay close or in the mucus layer predominantly 
at the luminal surface of the gastric crypts. No organisms were 
seen in foci of metaplasia of any type nor in areas of malignant 
change.
Multivariate analysis
The GLIM analysis demonstrated no significant association 
between the presence of Helicobacter pylori and the presence of 
intestinal metaplasia. The relationship between the presence of 
Helicobacter pylori and diagnostic group according to the Lauren 
classification is shown in table 24. The presence of Helicobacter 
pylori was analysed with respect to two other factors. Firstly the
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Figure 21.
Probability
Benign
Diffuse
Intestinal
Ulceration
O
>
00
u>o
-p*o
00o
50 years 
ulcerated lesion
55 years 
ulceration 
grade 3 gastritis
70 years grade 3 
gastritis
Probability that intestinal metaplasia of any type 
will be present in gastrectomy specimens in relation 
to diagnostic groups (intestinal or diffuse tumours 
(Lauren) or benign) ulceration, gastritis score and 
age of patient, and combinations of these variables.
Probability
Benign
>  ’Gastric’TO
>  Intestinal
CD
r*mco
Ulceration
o
o
s
~oo
00o
75 years grade 3 
gastritis
70 years 
ulcerated lesion
60 years 
ulceration
grade 3 gastritis
Figure 22. Probability that Type lib intestinal metaplasia will 
be present in gastrectomy specimens in relation to 
diagnostic group (intestinal, gastric tumour (Jass 
Classification) or benign), lilceration, gastritis 
score and age of patient, and combinations of these 
variables.
Diagnosis H. pylori present H. pylori absent
Intestinal type 7 30
Diffuse type 2 29
Benign 10 * 12
* p < 0.01
Table 24: Relationship between presence and absence of
Helicobacter pylori in the mucosa of 90 
gastrectomy specimens and diagnostic group; 
benign, intestinal or diffuse type tumour 
(Lauren classification). H. pylori significantly 
associated (p <0.01) with beniop compared with 
other groups (Chi square analysis) •
amount of the gastric mucosa replaced by intestinal metaplasia in 
the gastrectomy specimens and secondly the gastritis score of the 
gastrectomy specimens. No significant association was found 
between the presence of Helicobacter pylori and these two 
variables. The results are displayed in table 25 and table 26. 
DYSPLASIA
Histological features
Three histological patterns were identified in the mucosa 
adjacent to carcinoma/ulcer.
(1) Regenerative hyperplasia
The constituent cells had basophilic cytoplasm, 
hyperchromatic nuclei with frequent motises and because of 
the associated inflammation intramural or intraglandular 
inflammatory cells. In mild to moderate inflammation there 
is an increase in cell numbers consistent with the term 
hyperplasia. However with epithelial loss in ulceration the 
glandular size is reduced and the epithelium forms 
rudimentary glands. The consistent feature of the 
epithelium in regenerative hyperplasia was the regular size 
and shape of the cells and their nuclei. In mild forms the 
cells showed maturation towards the luminal surface but with 
severe ulceration there was little or no maturation with 
reduction or absence of mucus secretion.
2. Atypical hyperplasia
This pattern of mucosal abnormality occurred predominantly in 
type lib metaplasia. The incomplete metaplastic crypts
B*. p y lo ri present h. pyi^i ahRAm-
Amount of metaplasia 
(mean value %)
Intestinal tumour 13.8 19.7
Diffuse tumour 3.4 3.9
Benign 3.9 1.5
All groups 10.5 12.5
Table 25: Relationship of Helicobacter pylori to amount of
gastric mucosa replaced by intestinal metaplasia as 
a percentage of the mucosa examined in 90 gastrectomy 
specimens classified into intestinal and diffuse 
tumours (Lauren) and benign.
Diagnosis I«_ p y lo ri present H, pylori absent
mean gastritis score
Intestinal type 3.4 3.9
Diffuse type 2 3.7
Benign 3.5 3
Table 26: Relationship between Helicobacter pylori and mean gastritis 
score in 90 gastrectomy specimens classified into benign, 
intestinal or diffuse type tumours (Lauren).
showed marked architectural abnormalities. The crypts 
extended from the muscular is to the luminal surface. The 
lower third contained a preponderance of goblet cells and 
Paneth cells were absent, the lower third joined the middle 
third at sharp angle and above this level there was marked 
papillary infolding pseudostratification of nuclei and 
columnar cells containing apical mucus and absent brush 
border. The constituent nuclei did not show any marked 
atypia in the majority of the glands. These histological 
features are equivalent to those classified by Jass as grade 
0 dysplasia.
(3) Dysplasia
The two types of dysplasia described by Jass were identified. 
The description of the two types of dysplasia given by Jass 
are complete in all details and cannot be significantly added 
to (Jass 1983).
Frequency of Atypical Hyperplasia, Regenerative^Hyperplasia and
Dysplasia in  Gastrectomy .Cfrecimens
The frequency of dysplasia, atypical hyperplasia and 
regenerative hyperplasia in the gastrectomy specimens is shown in 
table 27.
The relationship of the types of dysplasia to the 
differentiation of the tumours is shown in table 28.
DJSCPSSEOfl 
Clinico-Pathol ogical
This series of patients who underwent gastric resections for
MUCOSAL ABNORMALITY 
Regenerative hyperplasia 
Atypical hyperplasia 
Dysplasia Type I 
Type II
BMQPSnC OPqP
Benign Intestinal Diffuse 
n = 37n = 22
12
1
2
3
20
18
16
14
n = 31
14
2
6
9
Table 27: Frequency of mucosal abnormalities present in
90 gastrectomy specimens resected for benign 
conditions (22 cases). Intestinal (37 cases) 
and diffuse tumours (31 cases). Mucosal 
abnormalities classified according to Jass (1983).
jfagpsal  W ell d iffe re n tia te d  Poorly differentiated
abnormality
Atypical
hyperplasia 10 8
Dysplasia Type 1 7  9
Type II 4 10
28: Frequency of dysplasia subtypes and atypical
hyperplasia in well and poorly differentiated 
intestinal type tumour (Lauren classification).
carcinoma is not an attempt to provide an epidemiological survey of 
gastric carcinoma in the West of Scotland but provides a small 
sample to enable certain clinico-pathological features to be 
examined. The series only includes cases of gastric carcinoma 
that underwent resection - no estimate of inoperable cases has been 
made. The data generated has been used to illustrate certain 
points but no statistical comparisons have been made.
The age distribution of the patients is similar to previous 
studies (Weed et al., 1981). The male to female ratio is lower 
than in other studies at 1.6:1 compared with 1.8-1.85:1 (Weed et 
al., 1981).
The symptomatology of the patients is comparable to previous 
series. Hie interesting feature is the relatively short duration 
of symptoms (>80% less than six months) admitted to by the 
patients. Although almost half the patients were on therapy for 
upper gastrointestinal symptoms at the time of referral only three 
patients could be identified who had received therapy for longer 
than one year. One patient had been treated empirically without 
any investigation, one patient had a barium meal reported as 
showing no abnormality which in retrospect showed clearly a filling 
defect, and the remaining patient had a gastric ulcer biopsied and 
reported as malignant but this fact was not noted by the hospital 
clinician. The implications behind these findings are that 
firstly, patients tend not to seek medical advice until they have 
significant symptoms and by that time the disease is at an advanced 
stage. Secondly, that in the majority of patients the general
practitioner although he may prescribe therapy to alleviate the 
symptoms tends to refer these patients for investigation.
The two years survival rate of 27% in this series is not 
strictly comparable to other published data as the other studies 
publish five year rates. The five year survival rates in the 
Western literature, range from 7.4-20% (Weed et al., 1981). It is 
likely that in a further three years this series will be at the 
lower part of the range.
One of the aims of the dlinico-pathological study was to 
observe the staging of the tumours by the pathologists. This has 
clearly demonstrated that the nodal status is poorly assessed by 
the pathologists.
Initially one of the other aims of the study was to determine 
the effect of palliative or "curative" surgery. However as the 
study progressed it became obvious that due to the inadequacy of 
pathological staging and the surgical philosophy that this was not 
possible. From the operative data it was impossible to determine 
in the majority of cases whether the surgeon considered a curative 
or palliative procedure had been performed. This is not just a 
failing of the West of Scotland as most of the European and 
American series have inadequate clinical and pathological staging.
Ihe reasons for the deficiencies in surgical and pathological 
management of gastric carcinoma are probably multifactorial. The 
three main factors influencing the surgical and pathological 
management are the medical staff (both surgeons and pathologists), 
the nature of the disease process and the patients themselves.
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Within the Western Infirmary/Gartnavel complex there are ten 
Consultant Surgeons none of whom has a particular interest in 
gastric carcinoma. With the number of operable cases of gastric 
carcinoma presenting each year each of the Surgeons will on average 
perform only three gastrectomies per year for malignant disease. 
A total of five Consultant Histopathologists are routinely involved 
in the reporting of surgical specimens and so by a similar 
extrapolation will each examine on average six gastrectomy 
specimens per year. Etoring the period of the present study there 
were no clinical trials being undertaken in the treatment of 
gastric carcinoma in the Western/Gartnavel complex. These factors 
in conjunction with the advanced stage of disease at presentation 
and the elderly age of the majority of patients may partially 
explain the apparently nihilistic approach of treatment represented 
in this study compared with that reported in Japan.
CLASSIFICATION OP TPMOORS
The number of cases of gastric carcinoma in this study bear 
no comparison with the large series reported from Japan but are 
similar in magnitude (and in some cases greater) than many Western 
series (Morson 1955, Jass 1979, Paginini and Rugge, 1983).
A retrospective analysis of material on file would have 
rapidly yielded a large number of cases, the sampling of the tumour 
and the gastric mucosa undertaken for routine histological 
diagnosis would not have been sufficient for the purposes of the 
study.
The proportions in the WHO and Lauren classifications are
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comparable with previous published series (Paginini and Rugge,
1983). The results of the Mulligan classification in this study 
display a preponderance of intestinal cell tumours and a deficit of 
pylorocardiac tumours compared with the series reported by Mulligan 
(Mulligan and Rember, 1972). The explanation for this is the 
difficulty in distinguishing the pylorocardiac type from the 
intestinal cell; this defect in the Mulligan system has been 
highlighted (Day and Morson, 1978). Another problem with the 
Mulligan system is co-existence of pylorocardiac-like areas within 
tumours of predominantly intestinal cell differentiation. 
Paginini and Rugge (1983) described this mixture of types in almost 
half of the pylorocardiac cell tumours, in this series 16 of the 49 
tumours classified as intestinal cell had some areas with 
pylorocardiac features.
Two published series of the Ming classification appear in the 
literature; the original series by Ming, 1977, and the study 
described by Paginini and Rugge, 1983. The two series divide the 
tumours into expanding and infiltrative type in the proportion 2:1 
and 2:3 respectively. These contradictory results are further 
questioned by the approximately equal numbers of both types in the 
present study.
Comparison of classification systems.
Although the reproducibility of the classification systems 
has been examined (Paginini and Rugge, 1983), a comparison has not 
been studied. The Lauren system is the most extensively used and 
widely accepted system and this has been used as the standard and
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an examination of the sub-groups of tumours in other systems which 
fall into the three categories intestinal, diffuse or unclassified, 
is shown in the results section.
The Mulligan system compared with the Lauren system equates 
mucinous tumours with diffuse tumours, pylorocardiac tumours are 
variants of intestinal type and the intestinal cell an admixture of 
intestinal type and diffuse type.
The Ming classification appears to contain a mixture of both 
intestinal and diffuse type in the expanding and infiltrative 
groups. As the Ming classification primarily examines the mode of 
growth it might be expected that Lauren diffuse type would comprise 
the majority of the infiltrative and the intestinal type the 
majority of the expanding group. The mode of growth represents 
only one of the histological parameters used in the Lauren 
classification. The results of this study suggest that when used 
alone, the mode of growth, without consideration of the structure 
of the tumour does not divide the tumours into the same sub-groups 
as the Lauren system.
The results of the comparison of the classification systems 
are difficult to interpret. The Mulligan and the WHO system 
recognise two main sub-groups which correspond to the intestinal 
and diffuse type of Lauren. This applies to the Jass system to a 
limited extent. The plethora of sub-types within the 
classification systems is a reflection of the heterogenous nature 
of the histological appearance of gastric carcinoma. To seme 
extent each classification system appears to use the histological
features identified by Lauren but to apply them in different ways.
The rationale behind employing a classification system is to 
divide tumours into groups which have some biological significance. 
This significance may take the form of a prognostic difference or 
some difference in histogenesis or both of these factors. The 
overall survival in this present study was so low at two years and 
the numbers of patients were too small to allow a valid statistical 
comparison to be made between tumours in the various classification 
sub-groups. The possible difference in histogenesis is 
investigated in the subsequent chapters on Mucin and 
Immunohistochemistry.
Critical Appraisal of the Lauren Classification
The results of this section of the study depend on the 
accurate classification of the tumours into intestinal and diffuse 
types. For this reason the tumours were classified using two 
observers, the author and a Consultant Pathologist (ILB) with 
considerable experience in gastro-intestinal pathology.
The two sub-types, intestinal and diffuse, have differing 
morphologies as outlined by Lauren, but the crucial importance of 
this system is the proposed difference in the aetiology and 
pathogenesis of the two groups. The main difficulty in accepting 
this concept of a separate histogenesis is the finding in a large 
proportion of cases that both types of pattern are present in the 
same tumour. This phenomenon had led authors to use the 
predominant histological feature for classification (Paginini and 
Rugge, 1983). If this technique of classification using the Lauren 
system is employed then the tumours are sub-divided on the basis of
an overall subjective impression rather than an objective 
assessment of the four histological features outlined by Lauren in 
his original description.
Ihe method employed in the present study was to score each 
individual histological feature present in a tumour with a positive 
mark for intestinal and a negative mark for diffuse features. The 
aim of this scoring system was to determine the frequency with 
which the histological features of both intestinal and diffuse 
tumours co-existed in the 72 tumours in the study. A bimodal 
distribution might be expected if the tumours showed exclusively 
intestinal or diffuse features. The results of the present study 
do not show this expected distribution but demonstrate that two- 
thirds of the tumours show features of both types of tumour. 
Although in most tumours the features of one type of tumour 
predominate the value of the scoring system has been to illustrate 
the frequent co-existence of intestinal and diffuse features within 
the one tumour.
The basis of the Lauren classification is the identification 
of two tumour types with different histological features and by 
implication a different histogenesis. The concept of a separate 
histogenesis for intestinal and diffuse types of tumour is 
difficult to accept as the present study shows that such a high 
proportion of tumours contain histological features of both types. 
The term "histogenesis” in tumour pathology implies a putative 
"cell of origin" of a given neoplasm. The origin of the 
intestinal type of tumour has been regarded as intestinal 
metaplasia and diffuse type from gastric epithelium. However
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intestinal metaplasia is derived from the transformation of gastric 
epithelium. Both types of tumour are therefore derived from the 
same cell population and this may explain the frequent co-existence 
of histological features in the same tumour. The ability of 
neoplasms to change their pattern of differentiation during their 
lifespan has been well demonstrated (Gould et al., 1981) and this 
multidirectional differentiation may also explain the appearance of 
small areas of diffuse type features in a predominantly intestinal 
type tumour for instance.
Hie results of the present study in themselves cannot be used 
to confirm or refute any concept of histogenesis of gastric 
carcinoma. The study does illustrate the difficulties that might 
be encountered in using any immunocytochemical marker to 
investigate the histogenesis of gastric carcinoma. As such a 
substantial histological overlap has been demonstrated this might 
also be reflected in a considerable overlap in the expression of a 
particular antigen by the tumours.
Intestinal Hpf-aplasia 
Quantitative analysis
The counting technique employed in the study although tedious 
and time consuming was simple to perform and analysis of variance 
has demonstrated that it was reproducible by one observer. The 
counting technique provides more objective data than the scoring 
systems employed by other authors (Morson 1955; Stemmerman and 
Hayashi 1968; Jass 1980). The limitation of any form of 
objective or subjective scoring system is that only a sample of the
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gastric mucosa is studied. The standard sections taken in the 
present study ensured that the same geographical areas in each 
stomach were examined thus providing a representative sample of the 
gastric mucosa from each specimen. The quantitative values 
obtained in the present study provide only an estimate of the 
amount of gastric mucosa replaced by the various sub-types of 
intestinal metaplasia. No attempt as made to determine the 
geographical distribution of the intestinal metaplasia within the 
individual specimens as this macroscopic distribution has been well 
described by other authors Morson 1955; Stemmerman and Hayashi 
1968; Sugimura et al., 1982.
The percentage of the gastric mucosa replaced by Type I 
intestinal metaplasia in the intestinal, diffuse and benign groups 
quoted in the results section are mean values for each group. 
Although the mean value of both the - intestinal and diffuse groups 
are significantly higher than that of the benign group, a wide 
range of values in all groups was observed. The intestinal and 
diffuse groups differ significantly from the benign group with 
respect to age. The amount of intestinal metaplasia present in 
gastrectomy specimens has consistently been shown to increase with 
age (Morson 1955; Stemmerman and Hayashi 1968; Lauren 1965). The 
significantly greater amount of Type I metaplasia in the specimens 
resected for malignant disease cannot be directly ascribed to the 
presence of malignant disease without taking into account this age 
factor. The relationship between age and intestinal metaplasia is 
discussed further in the section on variables and intestinal
metaplasia.
The present study has not demonstrated any significant 
difference in the percentage of the gastric mucosa replaced by Type 
I intestinal metaplasia in the stomachs resected for intestinal 
compared with diffuse type tumours. This finding is at variance 
with those of other studies (Lauren 1965; Rubio et al., 1985) 
which have reported a larger amount of intestinal metaplasia in the 
intestinal group compared with the diffuse group. In the present 
study the mean age of the two groups was remarkably similar at 67.2 
and 66.1 years for the intestinal and diffuse groups respectively. 
Lauren (1965), although demonstrating that the incidence of 
intestinal metaplasia was greater in the intestinal group compared 
with diffuse at given age groups, did not make a similar age 
adjusted comparison for the amount of intestinal metaplasia. The 
figures quoted by Lauren 1965 of 66% of intestinal type and 24% of 
diffuse type showing "profuse" or "fairly profuse" intestinal 
metaplasia of the gastric mucosa refer to an intestinal group with 
a mean age of approximately ten years greater than that of the 
diffuse group. Rubio et al., 1985, in their quantitative study 
of intestinal metaplasia demonstrated a significantly higher amount 
of metaplasia in the intestinal group compared with diffuse. 
However the mean ages of the two groups in this study was 
significantly different.
The quantitative analysis clearly demonstrates that Type I 
intestinal metaplasia is the predominant variant of intestinal 
metaplasia in all the gastrectomy specimens examined. Although
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(as discussed in the next section) the frequency of occurrence of 
the Type lib variant is significantly greater in malignant than 
benign stomachs the mean amount of the gastric mucosa replaced by 
this variant is not significantly different between benign and 
malignant stomachs.
RelationshiP-.Qf-latestinal Metaplasia and Sub-tvpes to Lauren and 
Jass Classification
The quantitative analysis demonstrates that only a small 
percentage of the mucosa sampled (on average less than 1%) is 
replaced by type lib metaplasia. The implication of this finding 
is important in relation to screening for gastric carcinoma by 
endoscopic biopsy surveillance. Proponents of the theory that 
type lib intestinal metaplasia has malignant potential have 
undertaken a prospective study to assess the prognostic implication 
of the intestinal metaplasia sub-types using endoscopic biopsy 
surveillance (Filipe et al., 1985). In this study (Filipe et al., 
1985) three to four random biopsies with dimensions of 3 X 2 mm are 
taken. Such biopsies can only represent a tiny proportion of the 
total mucosal surface area, and given that type lib is present in 
such small amounts as shown by the quantitative analysis in the 
present study, a high false negative biopsy rate is likely to 
occur. This lack of sensitivity of endoscopic biopsy material has 
been demonstrated by one study (Silva and Filipe, 1986) which 
compared the frequency of type lib in stomachs from which 
endoscopic biopsies had been taken with the material from the 
subsequently resected specimen. This study found that type lib
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was identified twice as frequently in the gastrectcmy material 
compared with the endoscopic biopsies from the same specimens.
Analysis of the data in a non-parametric fashion (ie presence 
or absence of metaplasia and sub-types in relation to diagnostic 
groups) produced unexpected results in view of previous studies on 
intestinal metaplasia. Although the presence of intestinal 
metaplasia of any type was significantly associated with malignant 
stomachs compared with benign, there was no significant association 
with Lauren's intestinal type compared with the diffuse type. 
Similarly type lib intestinal metaplasia although significantly 
associated with malignancy was not significantly associated with 
intestinal type compared with the diffuse type of Lauren's 
classification. However when the tumours were reclassified into 
the "intestinal" and "gastric" types using Jass's criteria and only 
cases with extensive intestinal metaplasia examined then type lib 
did show a significant association with the "intestinal" type.
The failure to find a significant association between the 
presence of intestinal metaplasia of any type and Lauren's 
intestinal type of tumour would appear to be contradictory to 
Lauren's original observation (Lauren 1965) and various 
epidemiological studies which have shown an increased incidence of 
intestinal metaplasia in the intestinal type of tumour (Correa et 
al., 1970; Stemmerman et al., 1977; Munoz and Matko, 1972). 
Lauren's description (1965) of a higher incidence of intestinal 
metaplasia in intestinal compared to diffuse tumours although in 
age matched material was based on the mucosa adjacent to the tumour
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rather than on sampling the entire specimen as in the present 
study. The epidemiological surveys cited differ from the present 
study in several factors. Firstly there are differences in ages 
between the intestinal and diffuse groups whereas in the present 
study the groups are of a similar age. Secondly the patient 
population is selected from areas with a high incidence of gastric 
carcinoma. Finally the interpretation of the material appears to 
be different as a qualitative assessment of intestinal metaplasia 
is made, little or no intestinal metaplasia being regarded as 
absent (Stemmerman et al., 1977) whereas in the present study the 
presence of even a single crypt of intestinal metaplasia was 
regarded as a positive finding.
A second conflicting result in the present study was the 
significant association of type lib metaplasia with intestinal 
tumours of the Jass classification but not with this group in the 
Lauren classification.
Multivariate Analysis
In view of complicated and conflicting nature of the results 
a form of multivariate analysis was performed. The aim of this 
form of analysis was to determine the relationship between several 
important variables firstly, the presence of intestinal metaplasia 
of any type and secondly, the presence of the variant type lib.
Six variables were identified which were possibly of 
importance; diagnostic group, age, sex, gastritis score, presence 
or absence of ulceration, presence or absence of Helicobacter 
pylori.
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The variable "diagnostic group" was the category into which 
the gastrectomy specimen was classified. Intestinal, diffuse
(Lauren classification) or benign categories were used in the 
analysis regarding the presence of intestinal metaplasia. 
"Intestinal", gastric (Jass classification) or benign categories 
were used in the analysis of the type lib variant.
The frequency and extent of intestinal metaplasia have 
repeatedly been shown to increase with age (Morson 1955; Lauren 
1965; Filipe et al., 1985; Rubio et al., 1985; Rothery and Day, 
1985; Silva and Filipe, 1987), so this appears to be an important 
variable. Little attention has been directed to differences 
between males and females regarding intestinal metaplasia but 
because of the different sex ratios described between the 
intestinal and diffuse tumours (Lauren, 1965) this was included as 
a variable. The presence and severity of gastritis is 
inextricably linked to the development of intestinal metaplasia as 
observed by Magnus 1937 in his original paper and this was included 
as a variable. The severity of the gastritis was judged using a 
scoring system with standard photographs in order to gain some 
objective measurement. The presence of ulceration was also 
included as a variable because of recent histological studies which 
indicated that the development of intestinal metaplasia was related 
to disordered regeneration in the healing process of gastric 
erosions (Mukawa et al., 1987). The presence or absence of 
Helicobacter pylori in the gastrectomy material was included as a 
variable in view of the hypothesis that the development of 
intestinal metaplasia may be a response to longstanding infection 
with the organism (Ectors and Dixon, 1986) on the basis that foci
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of intestinal metaplasia are not colonised by the organism (Steer,
1984).
The multivariate analysis demontrates that four variables 
age, diagnostic group, ulceration and gastritis score are all 
significant factors in relation to the presence of intestinal 
metaplasia of any type. If the results are expressed in terms of 
probability (ie probability of 1 = 100% likelihood of event) then 
if only the variable diagnostic group is considered the intestinal 
type of tumour is most likely to have associated intestinal 
metaplasia compared with the benign or diffuse groups. If however 
the other variables are considered independently the probability 
that intestinal metaplasia will be present increases with age and 
increasing gastritis score and is closely linked to the presence of 
ulceration. The multivariate analysis allows for the combination 
of variables to be calculated and with this ability the probability 
of a 70 year old with grade 3 gastritis having intestinal 
metaplasia present is clearly greater than the probability of 
intestinal metaplasia being present with a diagnosis of intestinal 
type tumour.
The results of the multivariate analysis for type lib show 
that when the diagnostic group is considered in isolation the 
likelihood of type lib being present is much greater in the 
"intestinal" group compared with "gastric" or benign groups. 
However when the other variables are assessed the likelihood of 
type lib being present is greater in a 60 year old with grade 3 
gastritis and ulceration than in "intestinal" group.
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The results of the multivariate analysis suggest that the 
significant association often demonstrated in the literature 
between the presence of intestinal metaplasia and gastric cancer 
and the presence of type lib intestinal metaplasia with the 
intestinal type tumour can be explained by differences in age, 
ulceration and inflammation rather than by any causal link between 
intestinal metaplasia and gastric cancer. On the basis of the 
present study intestinal metaplasia and the type lib variant appear 
to be an epiphenomenon in relation to gastric carcinogenesis.
The alternative hypothesis that type lib metaplasia is 
related to the variables age, ulceration and inflammation rather 
than related to the intestinal type of tumour can be used to 
explain the fact that type lib variant was not significantly 
related to intestinal type of tumour by Lauren classification but 
was significantly associated with the intestinal type as defined by 
Jass, 1980. This curious finding may be explained by the use of 
metaplasia in the mucosa adjacent to the tumour as one of the main 
criteria used by Jass to classify tumours into the intestinal type. 
By redefining the classification in this way Jass has selected a 
group of patients who are older, have a higher percentage of 
ulcerated lesions and with a greater degree of gastritis (see table 
29). As all of these factors are related to the presence of type 
lib as shown by the multivariate analysis, Jass (1980) has selected 
an "intestinal" group which shows a significant association with 
type lib.
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"Intestinal Tumours" T^ anrpn aiVf
LAUREN JASS
Mean age 67.7 71.1
% cases ulcerated 30.5 76.1
Mean gastritis score 3.83 4.28
Table 29: Comparison of the mean age, % of cases ulcerated and
the mean gastritis score in the gastric mucosa betweeen 
the "intestinal tumours" as defined by Lauren (1965) 
and as defined by Jass (1980).
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Relationship of Helicobacter pylori to the presence of intestinal
Metaplasia
Although the multivariate analysis did not show any 
significant association between the presence of Helicobacter pylori 
and intestinal metaplasia some interesting features of the 
relationship did appear.
In the gastrectomy group the incidence of H. pylori (10 out 
of 22 stomachs) in the benign group was of the same magnitude as in 
other published series (Marshall 1984; Forrest 1984). The 
incidence of H. pylori in the malignant group was markedly lower 
for both types of tumour at 15%. The severity of gastritis in the 
malignant group was higher in the stomachs without H. pylori and 
there was no significant difference in the quantity of intestinal 
metaplasia between the groups with or without the organism.
The hypothesis that infection with Helicobacter pylori may 
cause gastritis leading to the formation of metaplasia as a 
protective response is not supported by the crude analysis of the 
percentage of the gastric mucosa replaced by metaplasia between 
"infected" and "non infected" gastrectomy specimens, as no 
difference has been shown. The natural history of Helicobacter 
pylori infection is unclear; the development of gastritis and 
intestinal metaplasia may in some individuals be sufficient to 
eradicate the organism whilst in others there may be a persistent 
infection. Therefore examining the area replaced by the 
metaplastic change may be too simple an analysis and other 
variables ie. pH may require to be evaluated.
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Dysplasia
Gastric dysplasia occurring in either gastric or metaplastic 
epithelium although identified as the potential pre-malignant 
lesion in gastric carcinoma (Morson et al., 1980) has not been 
extensively studied.
The results of any study on dysplasia must be interpreted 
carefully. The three points which must be considered are the 
source of the material studied, the relationship between dysplasia 
and carcinoma and the subjective variability in the interpretation 
of dysplastic change.
The study of gastric dysplasia in man can be performed on two 
sources of material; endoscopic biopsies or human gastrectomy 
specimens. Both sources have advantages and limitations. 
Endoscopic biopsy material relied on a relatively small amount of 
tissue which may be subjected to biopsy artefact. Invasion can be 
detected on biopsy material but the absence of invasion does not 
exclude this possibility in such material (Ming, 1984). The major 
criticism of many studies on endoscopic material is that repeated 
biopsies may not be sampling the same area. It is impossible to 
sample the same area on repeated biopsy over a time interval.
The use of gastrectomy material allows for the study of a 
large area of gastric mucosa and the relationship to the gastric 
neoplasm can be assessed.
The differences between the information gathered about the 
two types of material highlights the deficiencies. In endoscopic 
material changes in the gastric mucosa can be examined over a time
course but the same area cannot be assessed accurately. In 
gastrectomy material the area adjacent to the tumour can be 
examined extensively but the inference that mucosal abnormalities 
surrounding a neoplasm represent the source of malignant change is 
made. It is difficult to confirm or refute such an assumption.
The histological assessment of dysplasia is highly 
subjective. Observer variation is large: one study of dysplasia
of the colon showed agreement between observers as low as 34% 
(Brown et al., 1985). Variations in nuclear size and 
architectural abnormalities are the two main features which 
contribute to the subjective impression of dysplasia (Tosi et al., 
1987). These two components of dysplasia are well represented in 
Jass's classification. The important finding of this study is 
that the sub-types of dysplasia as described by Jass have been 
identified. This suggests that to a certain extent the Jass 
classification is reproducible.
Jass's histological sub-types of gastric dysplasia can be 
identified in the gastrectomy material. His elegant description 
of type I and type II dysplasia cannot be faulted or improved on. 
The association that he describes with particular types of tumour 
does not appear to be supported by this study. Neither does his 
hypothesis for the role of the sub-types of dysplasia in the 
histogenesis of tumours.
The result when expressed in terms of well and poorly 
differentiated tumours do not show any preponderance of type II 
dysplasia in the latter group as Jass describes (Jass 1983). The
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other features which are also at variance are the high proportion, 
approximately two-thirds of cases in which type 1 .and type II co­
exist and the presence of both types of dysplasia in the diffuse 
tumour group.
The last discrepancy may be explained by differences in the 
classification of the tumours. Jass appears to have included in 
the diffuse group of tumours only signet ring cell type and non- 
mucin producing tumours (Jass, 1983). This interpretation of 
Lauren's classification (Lauren, 1965) might tend to transfer some 
diffuse type of tumours in this series into the poorly 
differentiated intestinal type. This would result in dysplasia 
being almost exclusively restricted to the intestinal type. This 
point emphasises the difficulty in the use of the Lauren system 
which was illustrated in the previous section.
Jass has propounded a complicated hypothesis regarding the 
origin of the two types of dysplasia. The two cell types - goblet 
and columnar cell in type II dysplasia and the association with 
poorly diferentiated tumours provide the basis for his theory. 
Severe forms of type II dysplasia show only one cell type and no 
association with poorly differentiated tumours has been 
demonstrated with this study. A siirpler hypothesis is that all the 
forms of dysplasia result from a single cell type. Two-thirds of 
the intestinal tumours in which dysplasia was found in the adjacent 
mucosa showed atypical hyperplasia type I and type II dysplasia. 
This supports the concept of an unstable epithelium immediately 
adjacent to tumour. The unstable epithelium might originate from
a cell or population of undifferentiated cells which may transform 
into dysplasia of either type in some cases through an intermediate 
stage of type lib metaplasia.
CHAPTER 4
M0CIN HISTOCHEMISTBY
XNmXXJCTIQN
Four different mucins can be readily identified using the 
mucin histochemical techniques outlined in Chapter 2, namely 
neutral, 0-acetyl sialomucin, N-acetyl sialomucin and sulphomucin. 
The work of this chapter involved a study of the gastrectomy 
specimen material discussed in Chapter 3 processed for mucin 
histochemistry. The broad aim of this study was to analyse the 
changes in mucin histochemistry that occur in the various stages of 
the histogenetic sequence portrayed in figure 11.
The review of the literature has shown that there have been 
few systematic studies on the mucin histochemistry of inflamed 
gastric mucosa. Although a variety of changes have been described 
in inflamed gastric mucosa adjacent to tumours (Gad 1969, Jass and 
Filipe, 1979) it is not clear if these changes are related to 
neoplasia or inflammation alone. The inclusion of both benign and 
malignant specimens in the present study has allowed this question 
to be addressed.
The mucin histochemistry of intestinal metaplasia is 
complicated with a variety of classifications based on mucins 
contained within the cells. The Jass system (Jass, 1980} combines 
both morphology and mucin histochemistry and has been most 
extensively studied in the recent literature. Several aspects 
however of the Jass system require further study. Are the
descriptions of the mucin content of Type I, Ila and lib described 
by Jass 1980 accurate when a large number of crypts are examined? 
Is there any difference in the mucin content of the intestinal 
metaplasia sub-types between benign and malignant stomachs?
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Most authorities agree that gastric carcinomas contain a 
mixture of the four mucins mentioned above (Lev 1965; Filipe 1979; 
Montero and Segura, 1980). What is not clear is if the intestinal 
and diffuse types of the Lauren system show any significant 
differences in mucin content. The mucin content of the tumour 
sub-types of other classification systems have also not been 
studied systematically. Another aspect which has not been 
evaluated is the effect of the degree of differentiation of the 
tumours on mucin secretion. These questions have been addressed 
in this present study.
The mucin histochemical hallmark of Type lib intestinal 
metaplasia is the presence of sulphomucin in the columnar mucus 
cells. If as Jass suggests (Jass, 1980) type lib represents a 
possible premalignant variant then the sulphomucin present in the 
metaplastic crypts might be reflected in sulphomucin secretion by 
the intestinal type of tumours. By combining the mucin analysis 
of the intestinal metaplasia and carcinomas this hypothesis has 
been investigated.
Gastric Mucosa
The aim of this study was to determine the frequency of 
occurrence of the types of mucin in the gastric mucosa of the 
benign and malignant gastrectomy specimens, 
intestinal Metaplasia
The aim of this investigation was to determine a mucin 
profile of the sub-types of intestinal metaplasia. One hundred 
crypts of each sub-type from benign, intestinal and diffuse types
of tumour were examined to see if any differences were apparent in 
the mucin profile of the intestinal metaplasia sub-types between 
these groups.
Carr-innma
The aim of this section was to analyse the mucin content of 
the gastric carcinomas to determine if the tumours when classified 
into the Lauren, Mulligan and WHO systems or into well or poorly 
differentiated categories displayed any particular features.
Photomicrograph 1. Antral mucosa with Type I intestinal
metaplasia (Jass classification). AB/PAS x 
60.
BBSM S
Gastric Ifacosa
Neutral mucins predominated in the gastric mucosa in both 
benign and malignant gastrectomy specimens. Mucosa with 
significant inflammatory change and in particular areas of 
regenerative hyperplasia showed evidence of N-acetyl and 
sulphomucin in the columnar cells. O-acetyl mucins were not 
detected in the gastric epithelium. The number of cases in which 
Neutral mucins, N-acetyl and sulphomucins were present is shown in 
table 30.
Intestinal Metaplasia
The mucin profile of 100 crypts of the three sub-types I, Ha 
and lib for the benign gastrectomy specimens and the intestinal and 
diffuse types of tumour of the Lauren Classification are shown in 
table 31. As an illustrative example the mucin profile of the 
metaplasia sub-types in the intestinal type of tumour are displayed 
graphically (figure 23). - _
No significant differences were present (Chi Square analysis) 
in neutral, O-acetyl, N-acetyl and sulphomucin content of Type I,
I la and Type lib metaplasia respectively in the stomachs resected 
for benign disease, intestinal type or diffuse type of tumour.
Sicin content of the gastric carcinomas
The mucin content of the gastric tumours of all types and the 
sub-divisions according to the Lauren, Mulligan and WHO 
classifications are shown graphically. The mucin profile of well 
differentiated as compared to poorly differentiated is also shown
Mucin Benign Malignant
number _{% of total) number (% of total)
Neutral 22 (100) 72 (100)
N-acetyl 12 (54.5) 41 (56.9)
Sulphomucin 13 (59) 34 (47.2)
Table 30. Frequency of mucin types in the gastric mucosa in 
94 gastrectomy specimens resected for benign and 
malignant disease.
Gastrectomy
specimen
diagnosis
Intestinal
Metaplasia
sub-type
Golunnar
Cell
Goblet
Cells
N N-A O-A
Mucins 
S N N-A O-A S
Intestinal I 11 98 23 18
Diffuse I 8 100 25 17
Benign I 10 100 21 15
Intestinal Ila 24 100 22 33 95 8 22 14
Diffuse Ila 30 100 18 31 87 11 10 16
Benign Ila 27 100 25 30 85 6 12 11
Intestinal lib 10 100 18 13 21 6 14 96
Diffuse lib 12 95 14 14 19 8 10 88
Benign lib 14 100 21 17 26 7 17 98
Table 31. Presence of mucins in goblet and columnar cells in 
100 crypts of Type I, IIA and lib metaplasia from 
benign, intestinal and diffuse (Lauren classification) 
gastrectomy specimens
Key: N = Neutral mucin 
N-A = N-acetyl 
0-A = 0-acetyl 
S = Sulphomucin
Figure 23.
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Mucin profile of 100 crypts of Type I, Ila and lib 
metaplasia in stomachs containing intestinal type 
tumours. The lumber of crypts with columnar cells 
('type I) and columnar and goblet cells (Type Ila and 
Type lib) which express neutral/ N-acetyl/ 0-acetyl 
and sulphomucin are shown.
(figures 24 and 25).
The expression of each individual mucin by the tumours in the 
classification systems was compared using the Chi Square test. 
The Signet Ring cell in the WHO classification had a significantly 
higher frequency of N-acetyl secretion than the other tumours in 
the WHO systen (x^  = 6.712 p <0.05). The number of pyloro-cardiac 
tumours in the Mulligan System was too small to make a statistical 
comparison. No significant differences were demonstrated between 
the intestinal and diffuse type of the Lauren System or between 
well and poorly differentiated tumours.
Relationship of type lib metaplasia to sulphomucin content of 
gastric carcinomas
The presence of the sulphomucin containing variant of 
intestinal metaplasia - type lib, to the presence of sulphomucin in 
the gastric carcinomas is shown in Table 32.
DISQPSSIQfl
The results of this study demonstrate that in approximately 
half of the gastrectomy specimens from benign and malignant cases 
the columnar cells of the gastric mucosa express N-acetyl 
sialomucin and sulphomucin.
The mucin profile of intestinal metaplasia conforms with 
previous published work in that N-acetyl sialomucins predominate.
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Figure 24 A. Percentage of gastric tumours expressing neutral, 
N acetyl, 0-acetyl and sulphcnucin.
B. Percentage of gastric tumours classified into 
intestinal and diffuse types (Lauren) expressing 
neutral, N-acetyl, 0-acetyl and sulphomucin.
C. Percentage of gastric tumours classified into 
intestinal cell, pylorocardiac and mucous types 
(Mulligan) expressing neutral, N-acetyl, 0-acetyl and 
sulphomucin.
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Figure 25 A Percentage of tumours classified according to WHO 
expressing neutral, N-acetyl, 0-acetyl and 
sulphomucin.
B Percentage of well and poorly differentiated tumours 
expressing neutral, N-acetyl, 0-acetyl and 
sulphomucin.
Tumour mucin
content Type lib present Type lib absent
Sulphomucin present 17 29
Sulphomucin absent 9 17
x2 = 2.709 No significant difference
Table 32. Relationship of sulphanucin content of gastric 
tumours to the presence of type lib intestinal 
metaplasia
The results however show a significant proportion of 0-acetyl and 
sulphomucin. When analysed with respect to Jass's sub-types 
several interesting features emerge (Jass, 1980) . Firstly that 
type I metaplasia shows an appreciable content of sulpho and 0- 
acetyl sialomucin and secondly that in type lib variant although N- 
acetyl sialomucin and sulphomucin predominate in the columnar and 
goblet cells respectively 0-acetyl sialomucin is still present in 
approximately 10% of crypts. In 1980 Jass's original description 
of the sub-types of metaplasia describes the sub-types as secreting 
mostly acid mucins in the goblet cells of type Ila and type lib 
respectively, with an absence of 0-acetyl sialomucin. The 
findings of this study suggest that the distribution of mucins 
between the three sub-types is not so clear cut with a significant 
overlap, in the presence of sulpho and 0-acetyl sialomucin.
When mucin profile of the sub-types of intestinal metaplasia 
are compared between benign stomachs and malignant stomachs and 
between intestinal and diffuse type tumours, only slight 
differences are seen between the groups, which are not 
statistically significant.
The presence of sulphomucin within intestinal metaplasia has 
been promoted by some authorities as a possible indicator of pre­
malignancy (Jass and Filipe, 1979; Matsukara et al., 1980). 
Endoscopic biopsy studies have emphasised the relatively high 
sulphomucin content of type I metaplasia (Rothery and Day, 1985; 
Filipe et al., 1985). The results of this study confirm the 
presence of sulphomucin in type I metaplasia and demonstrate
Photomicrograph 2. Type lib intestinal metaplasia (Jass
classification). HTD/AR x 400.
Photomicrograph 3. Type lib intestinal metaplasia (Jass
classification). HID/AB x 600.
numerically that sulphomucin is present in approximately 18% crypts 
in this variant. Sulphomucin positivity per se in endoscopic 
biopsy material is unlikely to be of any benefit in the prediction 
or identification of malignancy. The application of mucin 
histochemistry requires to be interpreted in conjunction with the 
morphology of the crypts as emphasised by Jass, 1980, and 
subsequent studies (Rothery and Day, 1985).
This study confirms that gastric carcinomas contain a mixture 
of neutral, 0-acetyl and N-acetyl sialomucin and sulphomucin. The 
results are also in keeping with Cook's 1982, of a high neutral 
mucin content of gastric adenocarcinoma. Fifteen per cent of the 
gastric carcinomas in this study show 0-acetyl sialomucin secretion 
which is comparable to the original description of 10% Culling et 
al., 1975, in a smaller series.
This study has failed to find any significant difference in 
mucin expression between the intestinal and diffuse types in the 
Lauren classification. Lauren and Sorvar, 1969, described 
originally a higher incidence of neutral mucin content in diffuse 
compared with intestinal type carcinoma. This finding has been 
extrapolated by Paginini and Rugge, 1983, into the hypothesis that 
the mucin type in cancers arising from normal gastric mucosa is 
likely to be different from that observed in cancers developing 
from metaplastic mucosa. These authors have postulated that the 
diffuse type of tumour having origin from the gastric mucosa may be 
identified as the minority of tumours that secrete neutral mucins 
only. These authors also postulated that the intestinal type of
Photomicrograph 4. Low power view of intestinal type tumour
(large arrow) invading stomach secretory 
mainly neutral mucins and intestinal 
metaplasia (small arrow) containing N-acetyl, 
0-acetyl and sulphcmucins. AB/PAS x 10.
tumour secretes a mixture of sialo and sulphomucins typical of 
colonic cancer secretion. This hypothesis based on morphology and 
mucin secretion would appear theoretically to be a logical 
extension of Lauren's original concept (Lauren 1965). The authors 
however do not specify the number of tumours showing neutral mucin 
secretion alone. In the present study only two such tumours could 
be identified in the 81% tumours that were positive for neutral 
mucin. In addition to this when the tumours were classified into 
intestinal and diffuse types on morphological grounds, a smaller 
percentage of the diffuse type of tumours were neutral mucin 
positive. The second major criticism of this hypothesis is the 
use of the term "colonic cancer secretion". Colonic tumours show 
a predominance of sialomucins against sulphomucins in contrast to 
that seen in normal colonic mucosa, however this is only seen in 
two-thirds of cases (Montero and Segura, 1980). The other feature 
of colonic tumours is the presence of 0-acetylated sialomucins in 
two-thirds of the cases. (Filipe, 1979). Paginini and Rugge, 
1983, described a sialomucin to sulphomucin ratio of approximately 
75 to 52% in intestinal type tumours, a similar ratio for both 
intestinal and diffuse type of tumours can be obtained from the 
present study if 0-acetyl and N-acetyl positive tumours are counted 
together. Thus both intestinal and diffuse tumours show this so- 
called "colonic type" secretion but the type of sialomucin is 
different with 0-acetyl contributing only a small percentage.
The mucin histochemistry of the tumours classified according 
to the system of Mulligan and Rember (1972) show two interesting
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features; the pylorocardiac tumours all express neutral mucin and 
the PB/KOH/PAS stain fails to reveal any 0-acetyl sialomucin. The 
number of pylorocardiac tumours is however small and N-acetyl and 
sulphomucins are also present. Two other aspects of the mucin 
histochemistry of gastric carcinomas were studied in relation to 
classification; the descriptive WHO classification and the degree 
of differentiation of the tumours, either well or poorly 
differentiated. In the mucin expression according to the WHO 
classification there was a higher frequency of neutral mucin in the 
signet ring cell type compared with the other types. This may 
relate to the "true gastric type" of tumour expounded by Paginini 
and Rugge, 1983, but again there was a substantial expression of 
other types of mucin by this type of tumour.
The results of this study show a relative decrease of 
sialomucin and an increase in sulphomucin content in the poorly 
differentiated tumours. Gad 1969, and Paginini and Rugge 1983, 
describe the reverse, whereas Montero and Segura 1980, agree with 
the results of this present study. The present study involves a 
larger number of cases of gastric carcinoma than the previous 
reports. Hie increase in sulphomucin content is from 70 to 77% 
and the decrease in sialomucin is of the same order. The 
alteration in sialo and sulphomucin content was not statistically 
significant.
The characteristic histochemical feature of type lib 
metaplasia is the presence of sulphomucin. Hie results of this 
study show no clear relationship between the presence of
sulphomucin in the tumours with the presence of type lib metaplasia 
in the adjacent mucosa.
Several authors (Montero and Segura, 1980; Paginini and 
Rugge, 1983) have used isolated aspects of the pattern of mucin 
expression in normal gastric mucosa intestinal metaplasia and 
gastric tumours to constrict theories of the histogenesis of 
gastric carcinoma.
The present study has not demonstrated any significant 
differences in mucin histochemistry between the intestinal and 
diffuse type tumours of the Lauren classification to support a 
concept of a different histogenesis for these two types of tumours.
CHAPTER 5
DWDNDCXTOCHEMICAL STUDIES
nmomcricR
(frneral points
The review of the literature in Chapter 1 concentrated on 
three aspects of immunocytochemistry in relation to gastric 
pathology namely antibodies to specialised cell types, alterations 
in normal function identified using inmunocytochemical techniques 
and oncofetal antigens. The work of this chapter was performed on 
the human gastrectomy material discussed in Chapter 3 and involves 
the investigation of the three aspects of immunocytochemistry 
listed above in relation to the histogenetic sequence outlined in 
figure 11.
Antibodies to specialised cell types
A polyclonal antibody raised against intrinsic factor was 
selected for study. Ihe reason for this choice of antibody was an 
original observation made by Brown in 1982 that gastric tumours of 
the diffuse type (Lauren 1965) displayed immunoperoxidase staining 
with this antibody whereas intestinal type tumours did not. This 
preliminary observation was interpreted as possibly indicating the 
origin of the diffuse type of tumour from gastric epithelium. The 
intrinsic factor antibody was therefore included in the present 
study of a greater number of gastric tumours to determine if this 
pattern of immunoperoxidase staining was consistent in the gastric 
tumours and if any of the pre-neoplastic states displayed 
immunoperoxidase staining.
A second group of antibodies to specialised cell types in the 
gastric epithelium have also been studied namely the neuropeptides.
The literature review in Chapter 1 revealed that few studies 
existed concerning the neuro-endocrine cell population in 
inflammation and metaplasia of the gastric mucosa. The present 
study has concentrated on two particular aspects of the changes in 
the numbers of neuro-endocr ine cells and the changes in specific 
neuropeptides.
Alterations in normal function
The secretory immunity in normal, inflamed, metaplastic and 
neoplastic gastric mucosa is the aspect of normal function examined 
in the present study. The stages in the histogenesis of gastric 
carcinoma have been examined systematically and changes in the 
stomachs resected for malignant disease compared with those 
resected for benign disease. The importance of this comparison is 
the need to discriminate between changes in normal function that 
occur in response to inflammation alone rather than pre-neoplastic 
or neoplastic change. The inclusion of "control" material in the 
present study (ie. benign specimens) has often been lacking in 
other studies.
Acquisition of oncofetal antigens
The literature review has illustrated marked confusion 
concerning the immunocytochemical demonstration of CEA in gastric 
mucosal alterations. The reason for this confusion appears partly 
to be due to the presence of cross reactions with other 
glycoproteins in commercial CEA antisera. The present study has 
addressed this problem by comparing the immunoperoxidase staining 
pattern with and without the abolition of these cross reactions. 
As with the studies on secretory immunity outlined above the steps
in the hypothetical sequence of gastric carcinogenesis have been 
examined systematically using the anti-CEA antibody to determine 
the nature of the epithelial alterations associated with 
acquisition of this oncofetal antigen.
iam
1. To examine the expression of intrinsic factor, secretory 
component, IgA and carcino-embryonic antigen (with and 
without the abolition of cross reacting antigens in the 
anti sera) in normal and inflamed gastric mucosa, intestinal 
metaplasia sub-types, and dysplasia in human gastrectomy 
specimens resected for both benign and malignant disease.
2. To examine the expression of intrinsic factor, secretory
component, IgA and carcino-embryonic antigen in gastric
tumours sub-divided into the intestinal and diffuse types 
(Lauren) and well and poorly differentiated tumours.
3. To quantify the neuro-endocr ine cell population in normal
antral and body crypts and the numerical changes that occur
in gastritis and the intestinal metaplasia sub-types.
4. To identify the specific neuropeptides in the neuro-endocr ine 
cells in normal antral and body mucosa, inflamed antral 
mucosa and the intestinal metaplasia sub-types.
Sintrinsic factor, secretory component. IgA. cra
Eight tumours showed extensive necrosis with poor fixation 
and were not included in the analysis (4 unclassified, 3 diffuse 
type, 1 intestinal type). To quantify the staining pattern of SC, 
IgA and secretory component in the sub-types of metaplasia 1,323 
crypts which were axially sectioned to include the base and luminal 
surface were analysed.
Intrinsic factor 
Gastric mucosa
Immunoperoxidase staining was limited to the parietal cells 
situated below the level of the neck of the gastric crypts. The 
parietal cells were abundant in body type mucosa but an appreciable 
number were identified in the antral mucosa. The pattern of 
staining within the cells was characteristic: there was a strong
immunoreactivity in the luminal and supranuclear cytoplasm in a 
band-like configuration. Although the number of parietal cells 
tended to diminish with increasing severity of inflammation and 
atrophy, the staining pattern did not change. No difference in 
pattern was noted in the staining from benign or malignant 
stomachs.
Intestinal metaplasia and dysplasia
No immunoreactivity was noted in any of the sub-types of 
intestinal metaplasia, regenerative hyperplasia or dysplasia. 
Carcinoma
No immunoreactivity was noted in any of the cases examined.
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secretory component
tastric Mucosa
Normal antral and body mucx)sa showed no immunoreactivity for 
secretory component. Mild superficial gastritis resulted 
(gastritis score = 1) in slight immunoreactivity in the columnar 
cells at the neck of the antral crypts. More severe degrees of 
gastritis (gastritis score 3 -5) led to increasing numbers of 
cells within the gastric crypts in both antral and body mucosa 
staining for SC. Severe chronic atrophic gastritis (gastritis 
score = 5) particularly in areas adjacent to tumour and ulcer 
showed immuno-peroxidase staining in almost all of the cells within 
the gastric crypts above and below the neck region. The columnar 
cells alone were stained; the parietal and peptic cells showed no 
immunoreactivity. The staining was present predominantly on the 
apical surface of the cells.
Intestinal, metaplasia 
Type I
The columnar cells throughout the length of the metaplastic 
crypts were immunoreactive with secretory component.
Type Ha
This showed a variable pattern of expression with cell crypt 
demonstrating immunoreactivity at the neck but faint staining 
throughout the remainder of the crypts. In approximately half of 
the crypts SC was expressed by the columnar cells at the neck of 
the crypts only, in the remainer there was immunoreactivity in 
columnar cells at the neck and the base.
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Type lib
Secretory component was expressed predominantly by columnar 
cells at the base of the crypts , in a few crypts there was faint 
staining in cells at the neck.
Regenerative hyperplasia
The constituent cells in areas of regenerative hyperplasia 
displayed intense and widespread staining for secretory conponent. 
Atypical hyperplasia
As with type lib the immuno-peroxidase staining for secretory 
component was limited predominantly to cells at the base of the 
crypt.
Dysplasia
Type I and II dysplasia displayed staining for secretory 
component in the columnar cells distributed throughout the gland, 
from base to luminal surface.
IgA
The pattern of IgA expression mirrored that of secretory 
component in normal, inflamed and type 1 and type 11a metaplasia 
and dysplasia. In type lib metaplasia often staining for IgA 
staining was absent and when present tended to be extremely faint 
and restricted to the base of the crypts. The number of crypts 
showing IgA and secretory component staining is shown in table 33. 
IgA and secretory component in gastric carcinomas
IgA and SC expression within the tumours was highly variable 
in respect of cellular distribution, types of cells, distribution 
and the number of cells within the tumour. The most reproducible 
feature was the co-existence of scanty IgA and secretory component
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Type of Metaplasia Type 1 Type 11a Type lib
Number of crypts 1195 51
Percentage of crypts 
expressing antigen
88
SC 100 100 85.3
IgA 100 100 40.6
CEA 17.3 27.4 69.3
Table 33. Staining pattern of intestinal metaplasia sub-types with 
antibodies to secretory component, IgA and carcino- 
embyronic antigen.
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Photomicrograph 5. Cross section of antral epithelium with
positive staining for secretory component. 
PAP method x 350.
expression within the same tumours. The cellular distribution was 
different to that seen in the gastric mucosa and intestinal 
metaplasia; immunoreactivity was distributed on the apical surface 
of cells within tumour acini and in addition to this on the 
basolateral surface and apparently within the cytoplasm. The 
expression of SC and IgA was not limited to acinar cells but was 
found in signet ring cells and within other malignant cells not 
within acini. The staining tended to be localised to discrete 
areas within the tumour. Some areas within the tumour showed 
strong immunoreactivity whilst areas which did not appear 
histologically different displaying a marked lack of staining. 
The number of tumours stained is shown in table 34. 
Carcino-embryonic antigen 
Normal mucosa
Antral and body type mucosa with no evidence of inflammation 
displayed no immunoreactivity for CEA. In areas with significant 
gastritis (ie. gastritis score = 3-5) both antral and body mucosa 
displayed positive CEA staining in the columnar mucus cells mainly 
at the base of the crypts. Absorption of the CEA antibody with 
normal stomach did not abolish this staining. Immuno-peroxidase 
staining for CEA was found both in the gastric mucosa of the benign 
and the malignant stomachs.
Intestinal metaplasia
Foci of metaplasia of all three types showed CEA 
immunoreactivity but not in a consistent pattern. Ihe presence or 
absence of CEA immunoreactivity is shown in table 33. The columnar 
cells displayed immunoreactivity in the apical cytoplasm, cells in
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sc
IgA
CEA
Positive
58
54
53
Negative
6
10
11
•Cable 34. Frequency of positive and negative staining in 
64 gastric tumours with antibodies to secretory 
component, IgA and carcino-esnbryonic antigen.
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Photomicrograph 7. Parietal cells positive for intrinsic factor.
PAP method x 350.
Photomicrograph 8. I intestinal metaplasia. Epithelial
cells (large arrow) and plasma cells (small 
arrow) positive for IgA.
all areas of the crypts in each type showing staining. The 
determining factor in producing CEA inmunoreactivity appeared to be 
the level of inflammation in the surrounding lamina propria. 
Absorption of the CEA antibody did not alter this pattern of 
staining.
Carcinoma.
Cellular distribution: Two distinct patterns were noted;
large intra cytoplasmic granules staining positively for CEA, and a 
linear band-like inmunoreactivity along the apical surface of the 
cells. Both patterns often co-existed within the same tumour. 
Regenerative hyperplasia
The constituent cells of regenerative hyperplasia displayed 
staining for CEA in all foci examined. Absorption of the anti CEA 
antibody with normal stomach did not alter this staining pattern. 
Atypical hyperplasia and dysplasia
The immuno-peroxidase staining for CEA was present in 
columnar cells distributed throughout the crypts in areas of 
atypical hyperplasia, Type I and Type II dysplasia. Absorption of 
the anti-CEA antibody with normal stomach did not change this 
staining pattern.
The intracytoplasmic staining was seen in signet ring cells 
and large anaplastic cells, the apical surface staining in cells 
forming malignant acini.
The SC, IgA and CEA expression of the tumours in relation to 
the Lauren classification and the degree of differentiation are 
shown in tables 35 and 36.
Photomicrograph 9. Well differentiated gastric carcinoma with
positive staining for CEA. PAP method x 
300.
Photomicrograph 10. Poorly differentiated gastric carcinoma with
positive staining for CEA. PAP method x 
280.
Type of Ttmnur
SBtitosfc In te s tin a l Diffuse
n = 36 n = 28
eositiw positive
SC 35 23
IgA 33 21
CEA 31 22
Table 35. Frequency of positive staining. 36 intestinal 
and 28 diffuse tumours (Lauren) with antibodies 
to secretory component, IgA and carcino- 
enobryonic antigen.
flntibOfr Degree of dlfferenhiatinn
Well Poor
n * 39 n_= 25
SC 38 20
IgA 37 17
CEA 37 16
Table 36. Frequency of positive staining in 39 well
differentiated and 25 poorly differentiated 
gastric tumours with antibodies to secretory 
component, IgA and carcino-embryonic antigen.
Mpnro-endocrine cells
The results of the neuro-endocr ine cell content as identified 
by immunoperoxidase staining are shown in table 37.
oTflcrcssicw
Rpithelial and ftrafetal Antigens
The results presented above are based on a single observer. 
The nature of the sub-types of metaplasia, degree of inflairenation 
and types of tumour are all evident when examining the histological 
material. This makes the objective interpretation of the 
immunoperoxidase material difficult as the observer is aware of 
which particular type of tissue he is studying. The panel of 
antibodies were selected for two reasons. Firstly, they are all 
available either commercially or through the auspices of S.A.P.U. 
The presentation and publication of data using antibodies not 
available to other centres although of biological interest prevents 
the validation of such data and limits the use of the antibodies in 
diagnostic histopathology. Secondly, the panel of antibodies 
provide information on the expression of antigen of functional and 
histogenetic interest in gastric carcinogenesis.
On the basis of the preliminary study of the IF antibody 
(Brown 1982) with its differential pattern of staining appeared to 
show great promise. The failure in this study to reproduce these 
results and in fact to demonstrate any staining whatsoever in the 
gastric carcinomas illustrates the limitations and inadvertent 
results that can be achieved using immunocytochenical techniques. 
The initial immunocytochemical studies were performed using non­
purified antibody which had not been adequately characterised.
Tissue
Normal Antrum
Antrum gastritis 
grade 3
Antrum gastritis 
grade 5
Efct.Qf crypts
85
625
715
Intestinal metaplasia
Type I 235
Type Ila 60
Type lib 85
positive cells 
Per unit
17.2
20
22.1
16.7
18.9
17.5
Neuropeptides
present
Gastrin
Somatostatin
Gastrin
Somatostatin
Gastrin
Somatostatin
Glucagon
OCR
CGRP
GIP
Somatostatin
Glucagon
Gastrin
Bombesin
GIP
OCR
Table 37. Number of chromogranin positive cells per morphological unit 
and presence of specific peptide containing cells in normal 
and inflamed antral crypts and sub-types of intestinal 
metaplasia.
The positive staining described appears to have resulted from 
inadequate removal of endogenous peroxidase. In this study 
endogenous peroxidase activity was abolished using incubation with 
hydrogen peroxide. Examination of controls ie. normal rabbit 
serum instead of test IF serum without removal of peroxidase 
revealed strong positive staining with DAB in approximately 70% of 
the carcinomas.
The absence of secretory component and IgA staining by normal 
antral and body mucosa has been well documented (Isaacson, 1982), 
often, however, this has been taken to imply that gastric mucosa 
never expresses these antigens (Nagura et al., 1983). Isaacson 
1982, in his elegant study demonstrated that in stomachs resected 
for malignant disease the expression of secretory component 
appeared to be related to the presence of gastritis. The results 
of this study confirm those of Isaacson (1982) and in addition 
demonstrate that a similar phenomenon occurs in benign stomachs.
The staining pattern in intestinal metaplasia has also 
previously been described (Isaacson, 1982) but these authors did 
not differentiate the sub-types of metaplasia.
This study illustrates that the variants of intestinal 
metaplasia all retain the ability to express SC and IgA. The 
cellular localisation is similar to that of small bowel, ie the 
columnar cells. Type lib metaplasia did show different pattern of 
SC expression. The restriction of SC expression to the base of 
such crypts is perhaps a reflection of the columnar cells at the 
higher levels of the crypts synthesising mucus as suggested by 
(Jass et al., 1984). The ability of such cells to produce mucus
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is paralleled by the loss of the brush border and this may be an 
equally valid reason for the loss of SC expression. The 
immunocy tochemical studies miqht be interpreted as suggesting that 
the surface columnar cells are less differentiated but this is not 
true of the crypts as a whole, as the base retains this ability.
The absence of IgA expression in these crypts suggests that 
although the cells in the crypt bases express SC the functional 
ability to transport IgA is lost. The loss of IgA translocation 
will reduce the bactericidal potential of the mucosal secretion and 
it has been suggested that this may allow bacteria to convert 
nitrates to carcinogenic nitrosamines and deconjugate bile acids 
(Jass et al., 1984). Whilst this can neither be confirmed nor 
refuted, the small proportion of type lib crypts in the stomach 
with intestinal metaplasia as demonstrated in Chapter 3, would seem 
unlikely to influence significantly the general bactericidal 
activity.
Commercial CEA antibodies cross-react with NCA, BGP biliary 
glycoprotein and NCA2 (Nap et al., 1983). Absorption of anti CEA 
(Dakopatts) with normal human stomach abolishes NCA2 
immunoreactivity on immnunoperoxidase staining in the normal 
stomach (Nap et al., 1983). Nagura et al., 1983, examined only 
normal antral and fundic mucosa and the anti CEA serum was absorbed 
with ABO blood group antigens and human spleen. This group of 
workers detected no CEA immunoreactivity in normal stomach but did 
not examine inflamed mucosa. Borch et al., (1987) studied inflamed 
antral and body mucosa using anti CEA serum non-reactive with NCA 
and BGPj and absorbed with human AB erthrocytes showed a linear CEA
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staining in the glycocalyx of the surface and foveolar columnar 
cells. The absorption of the Dako anti CEA antibody in this study 
with spleen f ABO blood groups and normal human stomach resulted in 
an absence of staining in normal antral and body mucosa but 
positive staining in gastritis and intestinal metaplasia indicating 
that the CEA immunoreactivity is related to the presence of "true"
CEA rather than NCA2 . CEA has been described in intestinal 
metaplasia (Nagura et al., 1983; Nielsen and Teglbjaerg, 1984) but 
the systematic staining of the sub types has not been widely
examined. Neilsen and Teglbjaerg, 1984, describe CEA imnmnoreactivity 
in "colonic" type metaplasia positive for O-acetyl mucin and the 
absence of CEA immunoreactivity in "small intestinal" type 
netaplasia with absence of O-acetyl mucin. Jass et al., 1984, 
describes CEA staining in both type I and type lib metaplasia.
results of this study confirm Jass's (Jass et al., 1984) findings 
insofar as both sub-types show CEA positivity. Type lib showed a 
higher percentage of crypts staining and the staining pattern was 
distributed throughout the cytoplasm rather than just confined to 
the luminal surface. The significance of these findings is 
difficult to determine, certainly the expression of CEA cannot be 
regarded as a marker for neoplasia as it is present on inflamed 
gastric epithelium.
The immunocytochemical studies do not appear to have shown 
any distinct pattern. The histogenetic sequence described by 
Correa et al., 1982, of chronic atrophic gastritis, intestinal 
metaplasia leading to intestinal type of tumour would fit the 
expression of SC, IgA and CEA by these mucosal abnormalities. The
confounding feature, however, is the expression of SC, IgA, CEA by 
both types of tumour. Isaacson (1982) pointed out that as the 
mucous neck cells of the gastric crypt synthesise SC (and in this 
study CEA): the finding of CEA, SC in both types of tumour neither
supports nor contradicts the hypothesis that intestinal type 
carcinomas arise from intestinal metaplasia while the diffuse 
tumours arise from the mucous neck.
The staining pattern of the gastric car cinemas proved to be 
variable within areas of the same tumour and between tumours. 
There appeared to be no relationship between the classification 
into intestinal or diffuse type of the Lauren classification (1965) 
and the presence of SC, IgA or CEA staining. There did appear to 
be a trend towards diminishing SC, IgA and CEA staining and the 
poorer degree of differentiation of the tumour.
Several studies have attempted to use the staining pattern of 
gastric mucosal alterations to support or refute the concept of two 
types of gastric carcinoma with differing histogenesis (Hirsch- 
Marie et al., 1976; Nielsen and Teglbjaerg, 1982; Reid et al., 
1982,; Nardelli et al., 1983; Nardelli et al., 1984). Such 
studies have, for instance, equated the presence of a particular 
antigen detected by immunocytochemical techniques on intestinal 
metaplasia and the presence of the same antigen in gastric tumours 
of intestinal type as being evidence that the tumour is derived 
from intestinal metaplasia
To draw such inferences from immunocytochemical studies is 
unjustified without first considering the following factors 
regarding gastric carcinogenesis. Firstly that intestinal
metaplasia itself is derived originally from gastric epithelium. 
Secondly that (as shown in Chapter 3) a large proportion of gastric 
tumours on light microscopy show histological features of both the 
intestinal and diffuse types as described by Lauren (1965) . 
Thirdly that multidirectional differentiation can occur in 
epithelial tumours and the change in differentiation is associated 
with alterations in phenotypic expression (Gould et al., 1981). 
Multidirectional differentiation has been well described in gastric 
tumours with metastatic deposits of tumour showing different 
histological patterns from the primary tumour in a third of cases 
(Stalsberg, 1972).
Following consideration of the above-mentioned factors it is 
perhaps not surprising that the results of the present 
immunocytochemical studies show no clear pattern in the 
distribution of epithelial and oncofetal antigens in the gastric 
mucosal abnormalities and neoplasia studied. It is clear from the 
present study that the change from normal healthy gastric mucosa to 
inflamed gastric mucosa is accompanied by alterations in phenotypic 
expression of the epithelial cells as identified by 
immunocytochemical techniques. The changes in phenotypic 
expression that occur in the transition from normal to inflamed 
mucosa are also seen in varying degrees in the metaplastic, 
dysplastic and neoplastic epithelium. Hie present study has not 
identified any specific "immunocytochemical marker" peculiar to any 
putative premalignant precursor.
Neuroendocrine Cells
Chromogranin is present in all the identifiable endocrine
cell types in the human gut, thus the number of chromogranin 
positive cells gives an indication of the endocrine cell population 
as a whole (O'Connor et al., 1983; Lloyd and Wilson, 1983; Facer 
et al., 1985). The advantage of chromogranin in the present study 
has been to attempt to quantify the changes that occur with 
gastritis and metaplasia. The expression of the data in terms of 
number of cells per morphological unit has been shown to be more 
suitable than cells/unit area as oedema and atrophy can modify the 
dimensions of the tissue substantially (Marsh, 1980; Buchan et 
al., 1984).
The chromogranin cell quantification demonstrates a stepwise 
increase in the number of neuro-endocrine cells with increasing 
severity of inflammation. Similar elevations in neuro-endocrine 
cells have been detected in the small intestine in active coeliac 
disease compared to normal controls (Pietroletti et al., 1986). 
In grade 5 gastritis equivalent to active chronic gastritis not 
only is there a marked elevation in neuro-endocrine cell numbers 
but there is also the appearance of peptides not seen in the normal 
antral mucosa. Glucagon positive cells were found in large 
numbers and the sporadic appearance of other peptides GIP, CCK, and 
CGRP. Large numbers of glucagon positive cells were found in 
antral crypts adjacent to lymphoid follicles often with foci of 
intestinal metaplasia in the nearby epithelium. The significance 
and role of the glucagon - immunoreactive cells in this situation 
is unclear although this finding has been noted in another study 
(Ito et al., 1984). Glucagon immunoreactive cells can be detected 
in small numbers at nine weeks gestation in the fetal stomach
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Photomicrograph 11. Inflamed antral mucosa with lymphoid
aggregate with Chromogranin positive cells in 
antral glands. PAP method x 100.
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Photomicrograph 12. Type lib intestinal metaplasia with
somatostatin positive cells. PAP method x 
350.
although they are not detected in the normal adult stcmach but are 
located predominantly in the ileum (Bloom, 1978; Facer et al., 
1989). Glucagon has been shown to have a trophic action on 
intestinal epithelium (Bloom 1981) and the hypothesis that glucagon 
cells in the situation described in the present study may promote 
metaplasia via a paracrine route can be advanced.
In the fetal stomach gut activity is preceded by a fully 
differentiated neuro-endocrine component (Facer, 1989). This 
embryological form of development is perhaps being seen in the 
inflamed stcmach. The appearance of different neuro-endocrine 
cells in areas of severe gastritis adjacent to foci of intestinal 
metaplasia may herald the development of intestinal metaplasia in 
these crypts. Thus the changes in the neuro-endocrine component 
are preceding the epithelial changes in a similar fashion to the 
fetal gut.
In intestinal metaplasia there is an overall decrease in the 
number of neuro-endocrine cells compared with antral gastritis. 
The decrease in numbers is accompanied by a change in the type of 
neuroendocrine cells with somatostatin replacing gastrin as the 
most frequent peptide and glucagon immunoreactive cells are less 
frequent compared with antral gastritis. In addition sporadic 
immunoreactive cells for the peptides CCK, OGRP and GIP appear. 
The function of these neuro-endocrine cells cannot be assessed by 
the present histological study. Somatostatin and GIP have both 
been shown to be potent inhibitors of gastric acid secretion 
(Pederson and brown, 1972; Bloom et al., 1974; Barros et al., 
1975). The inhibition of gastric acid secretion by somatostatin
is partly mediated via inhibition of gastrin release (Bloom et al., 
1974). It is interesting to speculate that the release of 
peptides by areas of intestinal metaplasia may modify the acid 
environment of the stomach.
No appreciable difference has been shown in the number of 
chromogranin positive cells per unit length in the various sub- 
types of intestinal metaplasia. No difference was apparent in the 
specific peptides contained in the neuro-endocrine cells in the 
various sub-types. These findings are in concordance with a 
previous study which examined sulphated versus non-sulphated 
intestinal crypts (Mingazinni et al.f 1984). One previous study 
has identified quantitative and qualitative differences in the 
neuro-endocrine cell population in different sub-types of 
intestinal metaplasia (Tsutsumi et al., 1983). However in this 
study a combination of silver methods and irrmunohistochemistry was 
used and the counting technique was ill defined. The results of 
the present study suggest that despite the differences in 
epithelial cells and mucin histochemistry which exist between the 
various sub-types the neuro-endocrine cell population is similar in 
number and nature of peptides contained within the cells.
CHAPTER 6
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general Considerations
The technique of in vitro thymidine labelling is ideally 
suited for the analysis of cell kinetics in endoscopic gastric 
biopsy material. The technique of counting cross sections of 
gastric crypts as discussed in Chapter 1 described by Hansen et 
al.f 1975, allows the Labelling Index to be determined. The 
Labelling Index is a measure of the proliferative rate of a given 
tissue. Although the Labelling Index is not as sophisticated as 
stathmokinetic analysis, it is more suitable within the ethical 
constraints imposed when dealing with human material. Another 
advantage of the thymidine technique is that the biopsy material 
can be re-orientated and important information determined regarding 
the site of the proliferative zone within gastric and intestinal 
metaplastic crypts. As the counting of thymidine labelled cells 
was performed by one observer a statistical analysis was performed 
to determine the reproducibility of the counting technique.
Area of Stufly
The effect of alkaline reflux gastritis on gastric cell 
kinetics in a group of patients who had undergone gastric surgery 
for benign disease is the main area of study in this chapter. The 
importance of such patients has been discussed in Chapter 1. 
There is considerable but disputed evidence that such patients 
represent an iatrogenic risk group for the development of gastric 
carcinoma. In addition the histological features of alkaline 
reflux gastritis have only recently been reported (Dixon et al.,
1986).
Hie main difficulty in interpreting the results of the cell 
kinetic studies in the post-surgical patients is the identification 
of a suitable control group with which to compare and controlling 
other variables which might affect the labelling index. For this 
reason preliminary studies were required on biopsy material from 
patients medically treated for peptic ulcer disease to assess the 
effects of gastritis, Helicobacter pylori and type of epithelium on 
the Labelling Index and the site of the proliferative zone.
In addition to the endoscopic biopsy material tissue was also 
obtained from a proportion of the gastrectomy specimens discussed 
in Chapter 3. Tissue was taken from tumour, the gastric mucosa 
immediately adjacent to the tumour or ulcer and from a site distant 
from any mucosal lesion in the specimen.
The study of the material from the gastrectomy specimens was 
designed to address several questions. Firstly the labelling 
indices and the site of the proliferative zone in the intestinal 
metaplasia sub-types was examined. Although tritiated thymidine 
studies have been reported on intestinal metaplasia as discussed in 
the literature review, these have not taken into account the recent 
description of the variants of intestinal metaplasia.
The study of gastric mucosa adjacent to tumour or ulcer and 
at a distance from the lesion is the second aspect of the 
gastrectomy material examined. The intention behind this was to 
determine if abnormalities of cell kinetics in the gastric mucosa 
existed in stomachs resected for malignant disease compared with
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benign disease.
The third aspect of the gastrectomy material studies is the 
thymidine labelling of the tumours themselves. The distribution 
of labelled cells within tumours is of biological interest as it 
indicates the areas of proliferation. The Labelling Index of 
tumours particularly comparing intestinal and diffuse tumours 
warrants study because of the differences between these tumour sub- 
types discussed in Chapter 1. The effect of the degree of 
differentiation of the tumours on the cell kinetics is the final 
aspect studied.
AE5S
1. To determine if the counting of thymidine labelled cells was 
reproducible by one observer.
2. To determine the Labelling Index in antral and body mucosa in 
a series of endoscopic biopsy specimens in patients 
undergoing medical treatment for peptic ulcer disease.
3. To analyse the effect of gastritis, Helicobacter pylori and 
diagnosis on the Labelling Index.
4. To determine the site of the proliferative zone within antral 
crypts in patients treated medically for peptic ulcer disease 
and the effect of gastritis on this parameter.
5. To determine the Labelling Index and site of proliferative 
zone in endoscopic biopsy material in a series of patients 
surgically treated for peptic ulcer disease.
6. To compare the Labelling Index and site of proliferative zone 
between a matched group of medically and surgically treated
patients with peptic ulcer disease and assess the 
relationship to the the Reflux Score.
7. To establish the Labelling Index and site of proliferative 
zone in Type I, Ha and lib intestinal metaplasia.
8. To establish and compare the Labelling Index of the gastric 
mucosa adjacent to and distant from intestinal and diffuse 
type tumours and benign lesions.
9. To assess the distribution of labelled cells within gastric 
tumours and compare the Labelling Index of intestinal and 
diffuse type and the effect of the degree of differentiation 
of the tumours on the Labelling Index.
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The statistical analysis on the observer error in the 
counting techniques demonstrated that the hypothesis that there was 
no difference between counts from different areas of mucosa or 
tumour or when the counts were repeated on the same area could not 
be rejected. The deviances and degrees of freedom associated with 
the model and each hypothesis are shown in figure 26.
The statistical analysis confirms that the counting 
techniques used to generate the Labelling Index are reproducible if 
the count is performed on the same area or another area within the 
same sample. This finding allows for statistical comparisons to 
be made between cases.
MEDICAL TBEMHENT GSROPP 
LahPllihg Tnrfry
The labelling index in the antral mucosa was significantly 
higher (p < 0.01) than the body mucosa (see figure 27). There was 
no significant difference in the LI in both types of mucosa in the 
three main diagnostic groups of gastric ulcer, duodenal ulcer and 
normal (see table 38).
Relationship between Gastritis Score and Labelling Index
The Labelling Index showed a stepwise progression with the 
increase in the gastritis score in the antral mucosa. There were 
insufficient numbers of cases with high gastritis scores in the 
body mucosa to make a valid comparison (see figure 28).
Relationship between Labelling Index and Helicobacter pylori
The organism, Helicobacter pylori was detected in the antral
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Lattice of hypotheses within maximal model M : xij = p + ai + /3j + error
(12) M :xij = ( i  + a \  +/3j + eij (error)
02=03 
No difference between 
replication of counts 
D m =3.30 ( f i )  
(19)
01 = 0 2 = 03
*  Level of rejection of hypothesis 
O  = Number of independent parameters 
Dm for given hypothesis 
( ) = Degrees of freedom
\ 0 2 ~ 0 3
4 01 “  -----2
No difference 
between areas
D m = 3.36 
(19)
0  difference between 
'observers'.either area 
or replication 
Dm =3.39 
(90)
<*1 = . . . . =  o r10 
No difference between 
cases
®  % £ - 47
D m = 35.59 
(29)
'Random' hypothesis. Count does 
not depend on case or observer
a 1 = ..... “ 10 > 01 =02 = 0 3
Figure 26. Lattice of hypothesis for observer error of thymidine 
Labelling Index from different areas of mucosa or when 
counts were repeated on the same area. Ihe hypothesis 
(H2) that there was no difference between observers 
when the same area was counted twice or different areas 
within the same specimen could not be rejected (D^  = 
3.39, DF = 90) indicating that counts could be 
replicated in both these circumstances.
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Figure 27. Labelling Indices of antral and body mucosal biopsies 
from patients in Medical Treatment Group. Labelling 
Indices of antral mucosa are significantly higher 
(p <0.01) than body mucosa. Bar indicates mean ± 1 
Standard Deviation.
Non Ulcer Duodenal Ulcer Gastric Ulcer
Body mucosa (mean) 10.7 12.1 12.7
(range) (5-22) (6-19) (5-18)
Antral mucosa (mean) 17.3 21.3 21
(range) (8-28) (13-31) (17-27)
(No significant difference between groups)
Table 38. Mean value and range of Labelling Indices in the 
Medical Treatment Group for antral and body 
mucosa. Medical Treatment Group divided by 
diagnosis into Non-Ulcer Dyspepsia, Duodenal 
Ulcer and Gastric Ulcer.
Mean labelling indices and gastric score: Antral mucosa
Labelling 
index
%
30*1
2 0 -
1 0 -
54321
Gastritis score
Figure 28. Mean Labelling Indices of antral mucosal biopsies from 
Medical Treatment Group at different gastritis scores. 
Bar indicates one Standard Deviation.
biopsies of 27 patients (56%). The presence of the organism was 
associated with a significantly higher gastritis score and 
consequently a higher labelling index (p <0.05) but only in antral 
mucosa (see table 39).
Crypt column length and position of proliferative zone
The crypt column lengths obtained by counting the number of 
cells from luminal surface to base of the crypts decreased slightly 
with increasing grades of gastritis (see table 40). The position 
of the proliferative zone relative to the luminal surface and base 
did not change. The position of the labelled cells within the 
crypt at different grades of gastritis is shown in figure 29. 
SORGICAL TREATMENT GROOP 
Labelling Indices
The labelling index from the three sites, 1, 3 and 5 cm from 
the stoma showed no significant difference (table 41). None of 
the biopsies from the Surgical Treatment Group showed any evidence 
of Helicobacter pylori.
COMPARISON BETWEEN SQRGICAL AND MEDICAL TREATMENT GROOP
The labelling indices were consistently high in the Surgical 
Treatment Group. Antral biopsies with the same degree of gastritis 
and no evidence of Helicobacter pylori were selected from fifteen 
patients in the Medical Treatment Group who were age matched with 
the Surgical Treatment Group. The Labelling Index reflux scores 
and crypt column length of the two groups were compared. The 
labelling Index was significantly higher in the post-surgical group 
compared with the Medical Treatment Group (p <0.001) (see table 
42).
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Photomicrograph 13. Inflamed gastric mucosal biopsy from body.
Arrow indicates thymidine labelling on 
epithelial cells. Note absence of labelling 
on parietal cells. Autoradiograph/ 
haematoxylin and eosin counterstain x 450.
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Photomicrograph 14. Biopsy of antral mucosa from patient with
alkaline reflux gastritis. Note the large 
numbers of labelled cells in the cross 
sections of the crypts. Autoradiograph/ 
haematoxylin and eosin counter stain x 450.
fl*. p y lo ri present H. pylori absent 
Mean gastritis score 4.1* 2
Mean labelling index 23.3* 16.4
* p <0.05
Table 39. Relationship between the presence or absence of 
Helicobacter pylori in the antral biopsies of 
the Medically Treated Group and mean gastritis 
score and mean Labelling Index.
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Axial sections: Position of labelled cells in crypts
Grades o f gastritis 
Above surface- o
Grade 1
1-5
Cell position 
in crypt
6-10
11-15
16-20
21-25
26-30
31-35
0 10 20 30 40 0 10 20 30 40 0 10 20 30 40
% of labelled cells
Figure 29. Position of labelled cells in axially sectioned antral 
crypts from Medical Treatment Group at three grades of 
gastritis 1/ 3 and 5. One hundred crypts analysed for 
each level of gastritis. Bar represents percentage of 
total number of labelled cells present with entire 
crypt at each defined cell position.
Column Length. Medical Treatment Grniip
Mean. Column-Length Grade of Gastritis
(range)
38.2 1
(33-43)
36.9 3
(28-40)
34.8 5
(21-40)
Table 40. Mean value and range in crypt column length in 
the antral crypts of the Medical Treatment Group 
at three grades of gastritis 1, 3 and 5.
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Distance
(cm) 1 3 5
Mean Labelling Index 32 30.9 31.4
p NS
Table 41. Mean labelling indices of biopsies taken at 1, 3 and 
5 an from stana in the Surgical Treatment Group.
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Medical Treatment Surgical Treatment
Group Group
BL= 15
Age (mean) 54.1 51.2
(range) (26-87) (32-74)
Gastritis score (mean) 3 3
(range) (1-5) (1-5)
Labelling index (mean) 20.6 31.4 *
(range) (12-28) (23-37)
Reflux score (mean) 7.4 11.2 +
(range) ( 6-11) ( 8-15)
* p <0.001 + p <0.01
TUble 42. Mean value and range of age, gastritis score, labelling 
index and reflux score of age matched patients in 
Medical Treatment Group conpared with Surgical 
Treatment Group.
The reflux scores of the age matched Surgical and Medical 
Treatment groups showed a significant difference p <0.01 (table 
42) . The reflux score was positively correlated with the 
labelling index (see figure 30) (R = 0.618 p <0.001).
Histological examination of the axially sectioned crypts 
revealed a striking difference between the surgical treatment and 
medical treatment group. In conjunction with the foveolar 
hyperplasia characteristic of reflux gastritis there was an 
increase in the length of the proliferative zone and its position 
within the crypt. The column length in cells increased 
significantly compared with the control group (p < 0.001). The 
proliferative zone extended from the neck of the crypts on to the 
surface resulting in the distinct feature of cells on the luminal 
surface displaying labelling with thymidine (table 43, figure 31). 
XMTEgnNfth MEEftPtASIA
Gastric mucosa containing metaplastic crypts were studied 
from both the endoscopic biopsy and the gastrectomy material. In 
the endoscopic biopsy group 18 patients (37.5%) had some degree of 
intestinal metaplasia present in the endoscopic biopsy material. 
Eighty-three per cent of the intestinal metaplasia was type I, 17% 
type Ila. No foci of type lib were identified. The small amount 
of tissue contained in the biopsy material made analysis of the 
labelling index of the metaplastic crypts technically difficult.
The larger amount of material from the gastrectomy group 
allowed for all three types of metaplasia to be identified in the
Correlation between Reflux Score & Labelling Index
Labelling 
index
401
35-
30-
o Surgical 
•  Medical
R = 0.61
25-
20 -
15-
1 0 -
4 5 6 7 8 9 10 11 12 13 14 15 16
Reflux Score
Figure 30. Correlation between reflux score and Labelling Index 
for Medical and Surgical Treatment Groups.
Crypt column length (mean) 
(cells) (range)
Number of crypts examined
Surgical Treatment 
Group
44.06 *
(38-51) 
25
* p < 0.001
M edical treatm ent 
Group
36.7
(25-45)
33
Table 43. Comparison between the Crypt Column Length in antral 
mucosa between the Medical Treatment and Surgical 
Treatment Groups.
Surgical treatment Medical treatment
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Figure 31. Percentage distribution of labelled cells at defined 
cell positions within antral crypts: comparison
between Medical Treatment and Surgical Treatment 
Groups.
samples from B and C areas. The focal nature and low proportion 
of type lib metaplasia resulted in a low yield of type lib crypts 
available for complete examination.
The labelling index for all three types of crypts showed a 
wide range; no statistically significant difference was 
demonstrated between the three groups (figure 32). The labelled 
cell zone was located at the base of the crypts in the type I and 
type lib crypts. In the type Ila crypts the labelled zone 
occupied an intermediate position at the neck of the crypts, 
similar to the position seen in the gastric crypts.
GASTRECTOMY MATERIAL
Thirty-seven gastrectomy specimens were examined. In four 
specimens due to technical error the specimens were unavailable for 
analysis. Thirty-three specimens, 26 for malignant and 7 for 
benign disease were available for study.
Mucosa, adja cent t o tum our/ulcer  area p
Histological examination showed a wide range of features from 
mild superficial gastritis to severe gastritis and ulceration with 
almost complete loss of gastric crypts, the luminal surface being 
lined by a layer of regenerative epithelium. In four cases there 
were no discernible gastric crypts on which to perform counting.
The tumours were classified into diffuse and intestinal type 
and the degree of gastritis scored from 1-5 according to the 
scoring system previous described. The results are shown in 
tabulated form (table 44).
A matched comparison between mucosa of the same type (ie
Labelling indices of subtypes of metaplasia
Labelling
index
%
Figure 32.
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Photomicrograph 15. Axial section of Type I intestinal
metaplasia crypt. Note paneth cells at 
base of crypt (small arrow) and thymidine 
labelled cells at base of crypt (large 
arrow). Autor adiogr aphy/baematoxy 1 in and
eosin counter stain x 80.
Mature of
fSafftrectafly Area B - Adjacent to nmmir Area C - Distant
No of Gastritis Labelling Gastritis Labelling 
cases Ssqis. Index. Score Index
laeanL .(mean) Iroean) (mean)
Benign 7 4.7 24.8 3.9 18
Intestinal 13 4.8 24.3 3.2 18.3
Diffuse 9 5 22.1 3.5 17.4
Table 44. Gastritis score and Labelling Index of gastric mucosa 
adjacent to (area B) and distant from (area C) tumour 
or ulcer in the three groups benign, intestinal and 
diffuse type tumours.
antral or body) and grade of gastritis was not possible because of 
the small numbers in the study. There was, however, no significant 
difference between the Labelling Index of the gastric mucosa 
adjacent to intestinal type tumour, diffuse tumour and benign 
ulcers using the unmatched data. The regenerative epithelium in 
both benign and malignant cases showed labelling on the luminal 
surface.
Mucosa at a distance from tumour area C
There was no significant difference between the labelling 
index of the mucosa at a distance from tumour/ulcer when malignant 
stomachs were compared with benign, nor was there any difference 
between the two tumour types. The gastritis scores in the 
distant mucosa were lower than in the mucosa immediately adjacent 
to the tumour (table 44).
Tterour Material 
Histological appearance?
The distribution and frequency of labelled cells varied 
greatly between tumours and within different areas of the tumour. 
Acini, either well developed in intestinal type tumours or the 
rudimentary glandular structure in diffuse tumours showed labelling 
in cells forming the acini. The number of labelled cells in the 
acini was greatest if these structures were adjacent to or in some 
cases within blood vessels or lymphatic channels. The acini which 
formed the periphery of the tumour did not appear to have more 
labelled cells than similar structures within the centre of the 
tumour. Another feature which was associated with a high number of
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Photomicrograph 16. Infiltrating gastric tumour cells labelled
with thymidine adjacent to vein. 
Autoradiograph/haematoxylin eosin 
counterstain x 350.
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Ihotanicrograph 17. Partially necrotic gastric tumour with
cells labelled with thymidine (arrows). 
Autoradiograph/haematoxylin and eosin 
counter stain x 350.
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Photomicrograph 18. Moderately well differentiated gastric
carcinoma with thymidine labelled cells in 
tumour acini (arrows). Autoradiograph 
haematoxylin and eosin counterstain x 400.
labelled cells was the presence of polymorphonuclear leucocytes 
within the acini.
Sheets of tumour cells which were characteristic of diffuse 
type carcinoma showed no particular pattern on initial examination. 
However closer scrutiny demonstrated that the classic signet ring 
cells did not appear to label with thymidine. The cells which 
labelled in this type of tumour were those with large nuclei and 
absence of intracellular mucin. Tumours which provoked a 
desmoplastic host response (predominantly diffuse type) resulted in 
the host stromal cells labelling with thymidine.
Labelling index
The Labelling Index of the tumours varied considerably with a 
tenfold difference between the lowest and highest values.
There was no significant difference between the LI of the 
intestinal and diffuse tumours classified according to the Lauren 
system. There was no significant difference in LI between well and 
poorly differentiated tumours (see figures 33 and 34).
DlgOTSSCT
Medical Treatment Group
These results confirm that antral and body mucosa have 
differing cell kinetics as has been demonstrated by other workers 
(Hansen et al.f 1975; Hansen et al., 1977). In view of the 
histological differences between these two types of gastric mucosa 
this finding is not entirely unexpected. The importance of this 
finding is to ensure that a histological assessment of the types of 
mucosa examined is taken into consideration in any study comparing
Labelling indices of gastric tumours 
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Figure 33. Labelling Indices of intestinal and diffuse type 
tumours (Lauren Classification).
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Figure 34. Labelling Indices of gastric tumours divided into well 
and poorly differentiated groups.
groups of patients. In the Surgical Treatment Group the two 
patients who had undergone a Billroth II resection by definition 
did not have antral mucosa and the biopsies were of body type 
epithelium. The biopsies were included in the comparison with the 
Medical Treatment Group in order to achieve sufficient numbers for 
statistical analysis. As body type has a lower labelling index 
than antral this factor would have tended to reduce the mean 
labelling index of the Surgical Treatment Group.
The positive correlation between the gastritis score and 
labelling index has also been noted by earlier workers (Hansen et 
al., 1977). The aetiology of the inflammatory change has been ill 
defined until the recent identification of campylobacter-like 
organisms in gastric biopsy specimens (Marshall and Warren, 1984). 
Hie presence of the organism has been strongly associated in some 
studies with both gastritis and peptic ulceration (Marshall and 
Warren, 1984; Jones et al., 1984). Although the organism does 
appear to be strongly associated with gastritis the relationship 
with peptic ulceration has been disputed by sane authors (Rollason 
et al., 1984? Forrest et al., 1984).
Fifty six per cent of the biopsies contained Helicobacter 
pylori which is similar to the findings in other endoscopic surveys 
(Marshall and Warren, 1984; Rollason et al., 1984; Forrest et 
al., 1984). The significantly higher LI in patients with the 
organism is a reflection of the similar elevation in gastritis 
score in this group. No other reports have appeared in the 
literature regarding the relationship of Helicobacter pylori to
cell kinetics.
The decrease in Crypt Column Length that accompanies 
increasing severity of gastritis is simply a numerical expression 
of the gastric atrophy that results from gastritis. Despite 
severe inflammation, however, the relative position of the 
proliferative zone does not alter. This is in marked contrast to 
the situation in the post-surgical stomach.
Surgical Treatment Group
The Labelling Index of the mucosal biopsies from this group 
were notably higher than the Medical Treatment Group. The LI of 
the biopsies from all distances from the stoma were elevated 
suggesting that this feature was widespread throughout the stomach. 
The absence of Helicobacter pylori in all the biopsy material from 
the post-surgical patients has been noted in similar groups of 
patients in another study (OfConnor et al., 1986). The absence of 
the organism has been ascribed to the post-surgical alteration in 
the gastric milieu due to altered pH and bile acid content. 
Comparison hptw^n Medical and Surgical Treatment Groups
Age matched patients medically treated for peptic ulcer 
disease and dyspepsia represent the best available control group 
for comparison with the post-surgical group. Both groups of 
patients share the same original disease process in peptic 
ulceration.
Hie results of the Medical Treatment Group study demonstrates 
a significant difference in LI between antral and body mucosa, 
differing grades of gastritis and the presence of Helicobacter
pylori. For this reason the comparison between Medical and 
Surgical Treatment Groups used cases which were matched for these 
variables. The finding of a highly significant elevation in LI in 
the post-surgical patients with matched medically treated patients 
is of considerable interest as it suggests that reflux in sane 
manner increases the LI. Unfortunately no assessment was made of 
the degree of enterogastric reflux or of bile and alkali 
concentrations within the surgically treated group. All of these 
patients had, however, endoscopic evidence of bile reflux and were 
subsequently treated for this condition.
Although the Medical and Surgical Group were matched for 
gastritis score the surgical patients had a significantly higher 
reflux score. This apparent discrepancy can be explained by 
examining the scoring systems. The gastritis score is based 
primarily on the quantity and content of the inflammatory 
infiltrate? the reflux score is dependent on more subtle 
epithelial changes ie. foveolar hyperplasia. The results of this 
study suggest that the abnormal histological features identified by 
Dixon et al., 1986, in reflux gastritis are associated with a 
significant elevation in the Labelling Index. NOt only is there a 
numerical increase in the LI but the proliferative zone shifts 
position to involve the luminal surface in the post-surgical group.
The relationship of this abnormal kinetic picture in the 
post-operative stomach to carcinogenesis remains speculative. 
Assuming that the S phase is constant the LI is proportional to the 
rate of cell proliferation then the elevated LI in the post-
surgical group is indicative of a higher rate of cell turnover. 
This increase in cell proliferation coupled with an expansion in 
the proliferative zone has been noted in pre-neoplastic lesions in 
the colon (Bleiberg et al., 1970). The shift of the proliferative 
zone on to the luminal surface appears to be a feature unique to 
the post-surgically treated stomach as it was not seen even in 
mucosa in medically treated patients.
Intestinal Metaplasia
The presence of intestinal metaplasia in over one third of 
cases from the endoscopy group is comparable to the range of 20-37% 
found in larger series in benign stomachs (Rothery and Day, 1985? 
Filipe et al., 1985).
Thymidine autoradiographic studies of intestinal metaplasia 
have been reported by several authors (Willems and Lehy, 1975? 
Hattori and Fujita, 1979) but with conflicting results. The sub- 
types of intestinal metaplasia as described by Jass (1980) have 
not been studied. Winawer and Lipkin (1969) described 
incorporation of thymidine into cells at or near the luminal 
surface in both gastric and intestinal metaplastic glands in two 
patients with gastric carcinoma. Hattori and Fujita (1979), 
failed to confirm this finding and demonstrated only a shift of the 
generative zone from the neck of the gastric crypts to the base of 
the intestinal crypts.
The findings of this study partially confirm those of Hattori 
and Fujita (1979), as the labelled zone was located at the base of 
the crypts in type I and lib sub-types. A possible explanation
for the discrepancy between the two previous authors might have 
been that they were examining different sub-types of metaplasia. 
The nature of the material studied by Hattori and Fujita (1979), 
and Winawer and Lipkin (1969) was different: Lipkin (1969) ,
examined biopsies taken from the stomach immediately adjacent to an 
adenocarcinoma and from a patient who had undergone surgery for 
gastric carcinoma and also had pernicious anaemia. Hattori and 
Fujita (1979) examined mucosal biopsies taken from non-diseased 
portions of the mucosa away from any tumour. Given our subsequent 
knowledge on the distribution of intestinal metaplasia it would be 
reasonable to suppose that some type lib metaplasia was included in 
Winawer and Lipkin*s (1969) study, however, as no mucin 
histochemistry was performed it is impossible to comment 
definitively on this fact. Winawer and Lipkin's (1969) second 
patient had several factors which may have led to abnormal gastric 
mucosal kinetics; previous surgery leading to bile reflux, 
pernicious anaemia. Hattori and Fujita (1979) study by taking 
biopsies away from the carcinoma is likely to have missed any foci 
of type lib by this sampling technique.
The present study involves a larger number of patients and 
examination of different sub-types of intestinal metaplasia 
identified by mucin histochemistry, 
gastrectom Material
Mucosa adjacent to tumour and mucosa at a distance (<5 cm)
Hie mucosa immediately adjacent to tumour is of considerable 
interest as it is closest to the region from which the tumour has
arisen. Cell kinetic changes similar to those found in tumour 
development might be seen in this area as dysplastic features are 
commonly found in the mucosa adjacent to tumours. The thymidine 
Labelling Index is difficult to interpret in the mucosa immediately 
adjacent to tumours as abnormalities may arise due to the secondary 
effects of the tumour rather than in association with the evolution 
of the tumour. The secondary effects of the tumour most apparent 
are ulceration, necrosis and inflammation and for this reason 
gastric ulcers have been included as controls.
The high labelling index adjacent to tumours was also 
demonstrated adjacent to benign ulcers in the present study. This 
elevation in the labelling index may be explained by the severe 
gastritis associated with the presence of a tumour rather than a 
specific relationship to malignant process.
Tumour, material
The interpretation of the thymidine labelling index in 
carcinomas is more complex than in gastric crypts. A relatively 
constant S phase duration has been demonstrated in gastric 
epithelium thus the labelling index is indicative of a cell growth 
fraction; no such relationship has been demonstrated for the S 
phase in malignant gastric epithelium. In vivo stathmokinetic 
studies have been performed but ethical and considerable technical 
problems severely limit the usefulness of this technique (Wright et 
al., 1977).
The high counting and sampling error pointed out by other 
authors (Buyse and Bleiberg, 1987) prompted statistical evaluation
of this problem, which indicated that statistical analysis was 
valid.
Hie great variability of the LI between different carcinomas 
has been highlighted by other authors (Smallwood et al., 1983). 
There is no clear explanation for this phenomenon. As the S phase 
duration is not known and its constancy unproven in gastric 
carcinoma, the biological relevance of an LI in isolation is 
doubtful. NO attempt has been made in this study to compare the 
LI of the gastric carcinomas with gastric or metaplastic mucosae. 
The LI of the malignant material is an expression of the number of 
labelled cells in the total population whereas the LI in mucosa is 
a measurement of the number of labelled cells in the gastric 
crypts. These are not the same measurement. Previous studies 
have tried to compare the two but this is not tenable. The 
present study has not demonstrated any statistically significant 
differences between the LI of intestinal type and diffuse type 
tumours or between well and poorly differentiated tumours. 
Assuming that the S phase duration is constant this can be 
interpreted as showing that there is no biological difference 
between intestinal and diffuse tumours or well and poorly 
differentiated tumours in terms of cell kinetics. However as the 
S phase duration has not been estimated in the present study 
tumours with a similar LI may have widely differing S phase 
duration and cell cycle times. For this reason firm conclusions 
regarding cell kinetic parameters cannot be drawn from the results 
of this study.
The peripheral edge of a tumour is often assumed to be the 
site of growth and invasion. The labelled cells appear to be 
distributed throughout the tumour and the mode of growth of the 
tumour would appear to be by cell division amongst cells in all 
areas of the tumour. This distribution of labelled cells occurred 
in both intestinal and diffuse types of tumour. Lauren's (1965) 
description of differing modes of growth (infiltrative for diffuse 
type, expanding for intestinal type) for his two main types of 
tumour do not appear to be reflected in the distribution of 
thymidine labelled cells.
Lymphatic and blood vessel invasion by tumour cells has been 
shown to be associated with a poor prognosis (Monafo et al., 1962). 
The high number of labelled cells in tumour acini, in or around 
these vessels, noted in this study may have at least two possible 
implications. Firstly that such cells have an inherently high 
proliferative activity and so tend to be more invasive. Secondly, 
that some blood or lymphatic factor induces proliferation in these 
sites.
CHAPTER 7
General Oitline
The literature review has discussed the various gastric 
tumour models that exist in the rat. The experiment described in 
this chapter has utilised MNNG as the carcinogenic agent in a low 
dose as this has been shown to induce both intestinal metaplasia 
and gastric carcinoma in the rat (Tatematsu et al., 1983). The 
metaphase arrest (or stathmokinetic) technique previously described 
allows for more dynamic measurements of the cell cycle than 
tritiated thymidine labelling. In the bowel the number of cells 
produced by the crypts can be estimated and expressed as Crypt Cell 
Production Rate per hour.
M££>
The aim of the animal experiment was to use an established 
model for the induction of intestinal metaplasia and gastric 
neoplasia to study the cell kinetic changes that occur in these 
states. Hie metaphase arrest technique was used to establish the 
Crypt Cell Production Rate and tritiated thymidine to determine 
alterations in the Labelling Index and site of the proliferative 
zone.
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Histological Abnormalities
Hie histological abnormalities in the carcinogen exposed and 
control animals at each sacrifice interval are shown in table 45. 
No foci of intestinal metaplasia and no tumours were identified at 
any stage in either group.
flPt-aphasg A rrest Data
The metaphase arrest data is displayed graphically in figure 
35 in the form of metaphases accumulated over the four hour study 
period post vincristine injection. The values shown are the 
corrected values using the Tannock Factor of 0.53 established in 
the Material and Methods section in Chapter 2. The rates of entry 
into mitosis calculated from the slope of the regression line is 
equal to the Crypt Cell Production rate per hour and these values 
are shown in table 46. There was no significant difference in the 
Crypt Cell Production rate per hour between the carcinogen exposed 
and the control animals at any of the sacrifice intervals.
Thymidine L i n in g  nata
Hie thymidine labelling index data is shown in table 46. No 
statistical comparison was made in the LI between the control and 
experimental groups in view of the small numbers of animals studied 
with the thymidine technique. Hiere did not appear, however, to 
be any marked difference between the groups with regard to LI on 
simple scrutiny of the figures.
The site of the proliferative zone within the crypts did not 
differ between the groups or throughout the duration of the
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Figure 35.
c a r c i n o g e n  e x po sed CONTROL
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Metaphase accumulation data for control and carcinogen 
exposed groups at sacrifice intervals from 0 - 8 0  
weeks. Slope of graphs fitted using least squares 
method. No significant difference in slope 
identified between carcinogen and control groups at 
any of the sacrifice intervals.
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T&ble 45. Histological abnormalities in rat stomachs at sacrifice 
intervals. Numbers indicate number of animals 
affected: Controls shown in parentheses.
G a s tritis  U lcera tio n  Neoplasia Metaplasia
2 (1) (1) 
3 (1)
1 1 (2)
Sacrifice Interval Carcinogen Exposed Control
CCPR LI CCPR LI
0 2.2 20.9 2.3 16.2
20 2.3 22.6 1.4 19.3
40 2.0 - 1.9 -
60 2.4 14.9 2.1 17.1
80 2.4 13 2.5 16.6
Table 46. Crypt Cell Production Rate per hour (CCER) and 
Labelling Index (LI) for Control and Carcinogen 
Exposed Animals at Sacrifice Intervals.
experiment. The labelled cells were distributed in the lower 
third of the antral crypts in all cases examined. At the 40 week 
sacrifice interval no thymidine was visualised in any of the 
sections from the four animals after autoradiographic development. 
PI SCTSSICM
The administration of MNNG ad libitum in the drinking water 
of male Wistar rats at a concentration of 50 ug for 16 weeks has 
not resulted in the production of intestinal metaplasia or 
neoplasia in the present study.
A review of the literature and the experimental design of the 
present study showed no difference between the present experiment 
and studies which have reported a 60-90% incidence of intestinal 
metaplasia and adenocarcinoma in rats treated for 16 weeks with 50 
ug MNNG (Matsukura et al., 1978; Tatematsu et al., 1983). The 
gastric carcinomas and foci of IM produced in the rats are 
microscopic (Matsukura et al., 197 8) and a possible explanation for 
the absence of tumours in this study was that inadequate amounts of 
the rat stomachs were examined; to refute this the entire antrum 
in the experimental animals were cut into blocks and the material 
ribboned. This procedure, though laborious, discounts the 
criticism of inadequate sampling resulting in an absence of tumour 
yield.
The substance MNNG used as the carcinogen may not have been 
"active" or administered correctly is a second possible reason for 
the failure of the experiment. The material was stored at -40°C 
according to the manufacturers instructions (Sigma), and was
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Photomicrograph 19. Longitudinal section of rat gastric mucosa 
two hours post vincristine injection. 
Note arrested metaphases within crypts 
(arrows). Haematoxylin and eosin x 60.
obtained from the same source as the Japanese workers (Matsukura et 
al., 1978). The carcinogen was diluted in a similar manner and 
administered ad libitum. Administration by gavage would have 
ensured a fixed dose received by each animal but this experimental 
procedure was not employed by the previous workers. Unfortunately 
no in vitro method is available to test the carcinogenetic activity 
of the chemical.
The male Wistar strain employed in the present experiment 
were the experimental animals employed in all the previous 
published work.
The metaphase arrest data demonstrates that with the Tannock 
Correction Factor the Crypt Cell Production Rate varies from 1.4 - 
2.6 per hour. There did apear to be a trend towards and 
increasing CCPR in the carcinogen exposed group at 20 weeks which 
although not statistically significant did suggest that an 
alteration in cell kinetics was starting to occur at this stage of 
the experiment. This trend however did not appear to be sustained 
at subsequent sacrifice intervals. The higher CCPR at 20 weeks in 
the carcinogen exposed group may indicate that the carcinogen did 
initiate sane abnormality in cellular proliferation but that this 
was not sustained perhaps due to the lack of some undefined co­
factor.
The addition of autoradiographic techniques in the present 
study was designed primarily to determine the position and changes 
in position of the generative zone with intestinal metaplasia and 
neoplasia in view of the abnormalities described in Chapter 6 in
Photomicrograph 20. Longitudinal section of rat gastric mucosa
with epithelial cells labelled with 
thymidine (arrows) . Autoradiograph/ 
haeroatoxylin and eosin counter stain x 60.
the human stomach. The absence of any neoplasia or metaplasia 
within the rat stomachs meant that this aim was not achieved. The 
Labelling Index was calculated and displayed a wide range from 13 - 
22.6. As only two rats in each group were injected with 
thymidine no statistical comparison between the Labelling Index in 
the two groups was possible.
CHAPTER 8
TmninrnrTrcAL stpdies
Hie review of the literature in Chapter 1 demonstrated that 
the majority of studies of gastric mucosa in relation to iirmunology 
have concentrated on the humoral component. The role of cell 
mediated immunity in the gastrointestinal tract has only recently 
been established and knowledge is still incomplete. The cell 
mediated responses in the small bowel in diseases such as Crohn's 
and coeliac states have received most attention.
The present study was designed to determine the nature of the 
T cell infiltrate in gastritis and in response to gastric tumours. 
Gastritis plays a fundamental role in the development of intestinal 
metaplasia and the elucidation of the T cell infiltrate is an 
important component of the inflammatory process. The differing 
pattern of the immune response to the intestinal and diffuse type 
tumours embodied in the Lauren classification system is of interest 
and may be related to differences in prognosis.
The material for the present study was derived from the 
gastrectomy specimens discussed in Chapter 3. The 
immunocytochemical techniques using lymphoid markers are difficult 
to perform and also difficult to interpret. Quantification of the 
T cell subsets has been performed in small bowel. As the results 
of the present stucfy were dependent on one observer the critical 
stage was to validate the counting techniques.
MESS
1. To assess three techniques of quantifying the T cell subsets
in the gastrectomy material by one observer.
2. To determine the pattern of T cell subsets and Class II MHC
antigens in normal, (HLA Dr) inflamed and metaplastic gastric 
mucosa.
3. To assess the effect of Helicobacter pylori on T cell subsets
and Class II MHC antigens (HLA Dr).
4. To determine the pattern of T cell subsets and Class II MHC
antigens (HLA Dr) in gastric carcinomas of intestinal and 
diffuse type.
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RESQLT5
Investigation of Observer Error in the Counting of Lvnpboid Markers
The three techniques of counting outlined in the Materials 
and Methods section, Chapter 2, were assessed.
(1) Number of labelled cells/unlabelled cells per high power 
field.
(2) Point counting using graticule.
(3) Number of labelled cells/unlabelled cells for a given mucosal 
length which was selected as four gastric crypts.
Three sets of counts for each counting technique were 
obtained using the Leu 1 antibody in five cases by the 
investigator. The first set of counts was on area 1, the second 
and third counts were on the same area 2. This provided 
information on the reproducibility of the counts between two 
different areas of the same case and also on the ability of the 
investigator to reproduce stable counts in the same area. Hie 
data was analysed using log ratios and the GLIM (Generalized Linear 
Interactive Model) statistical package as described in Chapter 2.
The deviance and degree of freedom d^ for the data on the 
three counting techniques are shown in table 47. The deviance Dg 
and degrees of freedom dg for the hypothesis Hq there is no 
difference between cases or observer ie the counts are completely 
randan and are also shown in table 47. Using the F test the Hq 
hypothesis cannot be rejected at the p <0.10 level for all of the 
counting techniques under study. This indicates that counts 
cannot be reproduced by one observer in the same area or within 
different areas from the same case.
The statistical analysis demonstrates that counting
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(^ n iirrM rv j T lp rh n irp ip
High Power Fields 
Point counting 
Mucosal unit length
Table 47. Results of GLIM analysis for counting techniques of 
lymphoid markers. Model M represents the data 
obtained by replicate counts by one observer on the 
same area and different areas in the same case. 
Hypothesis Hq represents the random hypothesis that 
count results are completely random. D = deviance, 
d = degrees of freedom. Using the F test the Hq 
hypothesis could not be rejected for any of the 
counting techniques.
Model M Dfl = 8.97 dj* = 18
Hypothesis Hq Dg = 14.42 dg = 29
Model M Dpj = 3.81 = 14
Hypothesis H q  D g  = 6.48 d g  = 23
Model M = 3.88 = 14
Hypothesis H q  D g  = 5.28 d g  = 23
techniques on the lymphoid markers were not reproducible. The 
results of the study are therefore presented in a subjective 
descriptive manner.
In the interpretation of the T cell subsets to simplify the 
results the following assumptions have been made; Leu 1 and Leu 4 
positivity indicates Pan T cell origin. Leu 3 positivity indicates 
T helper/inducer cells. Leu 2 positivity indicates T 
cytotoxic/suppressor cells, Leu 7 and lib positivity indicates 
natural killer cells (NK).
Gastric mucosa
In the mucosa which appeared histologically normal ie no 
excess of inflammatory infiltrate and normal glandular pattern, a 
consistent distribution of T cell subsets was seen. The 
lymphocytes in the lamina propria were predominantly of the T 
helper/inducer subset. A small number of intra-epithelial 
lymphocytes were seen mainly in the upper reaches of the glands and 
these were T cyt/suppressor cells. There was some faint HLA Dr 
staining within the lamina propria but the epithelium showed no HLA 
Dr positivity. Very occasional lamina propria and intra- 
epithelial cells (IEL) were NK positive. Ihese findings were 
present in both antral and body type mucosa. Staining of 
myenteric nerve bundles was seen with Leu 7.
With increasing degrees of gastritis antral and body type 
mucosa from both the benign and malignant stomachs showed 
increasing numbers of intra-epithelial T cytotoxic/suppressor cells 
and lamina propria T helper/inducer cells. A higher proportion of
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Photomicrograph 21. Inflamed antral mucosa with lymphoid
follicle with positive staining for Leu 1. 
Alkaline phosphatase technique x 300.
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Lymphoid follicle in antral mucosa with 
positive cells for Leu 1. Alkaline 
phosphatase technique x 340.
IEL showed an NK phenotype. Lymphoid follicles when present 
stained in the germinal centre and at the periphery strongly for T 
helper/inducer cells and T cytotoxic/suppressor cells. HLA-Dr was 
expressed strongly on the epithelium at the isthmus of the crypt 
particularly adjacent to lymphoid follicles. With increasing 
severity of inflammation and with a strong active component ie 
polymorphonuclear infiltrate, HLA-Dr was expressed widely on all 
areas of the epithelium throughout the crypt and on all cell types. 
Intestinal Metaplasia
Areas of gastric epithelium immediately adjacent to foci of 
intestinal metaplasia showed a consistent and characteristic 
feature; large numbers of intra-epithelial lymphocytes which 
showed expression of NK markers. Within areas of well developed 
intestinal metaplasia there was a marked reduction in the number of 
T helper/inducer lymphocytes within the lamina propria compared 
with the inflamed gastric mucosa. Unfortunately the alkaline 
phosphatase enzyme used (despite removal of endogenous alkaline 
phosphatase) in the immunocytochemical technique stained the 
surface villi of the intestinal metaplasia making interpretation 
difficult. It was, however, possible to determine IEL lymphocytes 
exhibiting NK markers within the intestinal metaplasia. Areas of 
both type 1, 11a and type lib metaplasia were studied; no 
difference was seen between the expression of the T cell subsets in 
the lamina propria or intra-epithelial lymphocytes.
Mucosa adjacent to tumour/ulcer
The area of mucosa adjacent to the benign gastric ulcers and
Photomicrograph 23. Intestinal type tumour with widespread
positive staining for HLA Dr. Alkaline 
phosphatase method x 360.
Photomicrograph 24. Infiltrating tumour with positive staining
for Leu 7 (small arrows) and non specific 
staining of nerve (large arrow) for Leu 7. 
Alkaline phosphatase technique x 360.
ulcerated tumours were compared to determine if any difference 
could be seen in T cell subsets. Both areas showed the 
distribution of T cell subsets described above for severe 
inflammation.
Effect. Qf-HeligQbac.ter. Pylori
In the series of gastrectomy specimens there were six 
stomachs in which the organisms had been demonstrated by cresyl 
violet staining, four benign and two malignant. Although the 
mucosa within the stomach tended to show severe inflammation with 
an active component there was no obvious difference in the pattern 
of distribution of the T cell subsets and HLA-Dr expression when 
compared to mucosa from other specimens with similar severity of 
inflammation which did not show the presence of the organism.
Tumour.
Both the intestinal (7 cases) and the diffuse tumours (5 
cases) classified by the Lauren criteria (1965) displayed both T 
helper/inducer and T cytotoxic/suppressor cells in the inflammatory 
infiltrate within the tumours and in the tissue surrounding the 
tumours. There was no appreciable difference in the number nor 
any obvious difference in the histological distribution of the T 
cell subsets in the inflammatory infiltrate between the two types 
of tumour. Faint staining with IL2 was seen in scattered 
lymphocytes in all the tumours.
In four of the seven cases of intestinal type of tumour 
lymphocytes with the T cyt/suppressor and NK phenotype were 
identified in between malignant cells forming glandular lumina.
Photomicrograph 25. Negative control for alkaline phosphatase
technique in area of intestinal metaplasia 
showing non-specific staining of
Photomicrograph 26. Intestinal type tumour positive for HLA Dr.
Alkaline phosphatase technique x 360.
The three remaining cases of intestinal type of tumour did not show 
this feature.
All the tumours examined showed immunoreactivity with the 
HLA-Dr antibody in lymphocytes in the inflammatory infiltrate. In 
four of the intestinal cases and all the diffuse cases the tumour 
cells showed positive staining with the HLA-Dr antibody. In the 
remaining three intestinal cases there was a complete absence of 
staining of tumour cels with the HLA-Dr antibody.
Diacusgicfl 
General Points
Immunocytochemical studies using antibodies to lymphocyte 
sub-populations allows the micro-anatomical distribution within the 
tissue and the preponderance of given sub-populations to be 
determined. Such histological studies however provide no 
information regarding the functional role of lymphocyte sub­
populations in the tissue under study. The optimum approach would 
be a combination of histological and functional studies of the T 
cell sub-populations. Functional studies in human tissue 
lymphocytes are extremely difficult to perform for logistical and 
technical reasons. The present study is limited to the 
examination of T cell subsets and their distribution within the 
gastric mucosa by immunocytochemical methods. In the absence of 
functional studies no firm conclusions can be drawn about the role 
played by the T cell subsets in the immune response.
The use of the alkaline phosphatase enzyme instead of 
peroxidase in the present study has circumvented the need for
Photomicrograph 27. Inflamed antral mucosa with lymphoid
follicle with widespread positive staining 
for HLA Dr on adjacent epithelium. 
Alkaline phosphatase method x 300.
removal of endogenous peroxidase from the gastric specimens. 
Positive staining with alkaline phosphatase of foci of intestinal 
metaplasia however occurred due to the presence of this enzyme 
within this type of epithelium (Matsukara et al.f 1980). The 
presence of this non-specific staining made interpretation of 
intra-epithelial lymphocyte staining in foci of intestinal 
metaplasia difficult to interpret although it did not affect the 
identification of T cell sub-sets in the surrounding lamina propria 
in foci of intestinal metaplasia.
Q u an tifica tio n
The value of counts per unit area or in relation to some 
stable reference feature has been proven to be more useful than a 
subjective visual impression in determining the differences in the 
relative numbers of lymphocyte sub-sets in inflammatory conditions 
in the skin (Beck et al., 1986). In the lamina propria of the 
bowel several studies have used counts per high power field to 
compare T cell sub-sets in different disease states (Selby et al., 
1981; Selby et al., 1983). Ihe present study was performed by 
one observer (due to the constraints of the context of an MD 
thesis). The counting of the immunocytochemical preparations 
proved to be technically difficult due to several factors. The 
use of frozen section material made the discrimination of cells 
harder to perform visually. There was an uneven distribution of 
lymphocytes within the lamina propria; lymphoid follicles or 
aggregates with large numbers of densely packed cells being 
particularly difficult to count. The presence of oedema and
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atrophy in the mucosal specimens caused considerable variation in 
the lamina propria in some cases. In view of the fact that counts 
were performed by one observer and the technical difficulties 
encountered a statistical analysis was performed to validate the 
reproducibility of counts using three different counting 
techniques. This analysis demonstrated that stable counts could 
not be reproduced by any of the techniques. The results of the 
study could therefore be expressed only as a subjective visual 
impression of the differences in the relative numbers of T cell 
subsets. Thus the results are constrained by the observations of 
Beck et al., 1986, vdio demonstrated this to be less useful than 
counting techniques.
Normal Mucosa and Intestinal Metaplasia 
T Cell Sub-sets
On the basis of a subjective visual impression the present 
study has demonstrated a predominance of T helper/inducer cells in 
the lamina propria in gastric mucosa which appears histologically 
normal. The increased numbers of lamina propria lymphocytes which 
are recognised by conventional light microscopy as "gastritis" are 
due to increasing numbers of T helper/inducer cells and a relative 
increase in the number of T cyt suppressor cells. In addition to 
these changes in the lamina propria increasing numbers of intra- 
epithelial lymphocytes expressing mainly T cyt/suppressor phenotype 
are seen. The findings of the present study for normal mucosa are 
similar to those reported for the normal small intestine (Selby et 
al., 1981; Selby et al., 1983). The changes in the lamina
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propria and intra-epithelial lymphocyte populations described in 
the present study are also similar to the changes indent if ied in 
patients with coeliac disease receiving a diet containing gluten.
An important finding in the present study is the 
identification of intra-epithelial lymphocytes expressing NK 
phenotype. These cells appeared most frequently in areas of 
gastric epithelium adjacent to foci of intestinal metaplasia. In 
the small intestine the NK phenotype on intra-epithelial 
lymphocytes has been identified by some workers (Shioda et al., 
1984) but not by others (Selby et al., 1983; Cerf-Bensussan et 
al., 1983) although ultrastructurally the intra-epithelial 
lymphocytes appear similar to circulating granular lymphocytes with 
NK activity (Cerf-Bensussan et al., 1983).
Intra-epithelial lymphocytes are in intimate contact with the 
antigenic load of the gut and constitute one of the largest 
lymphocyte populations in the body (Ferguson, 1977). The role of 
the intra-epithelial lymphocytes in local defence is still unclear. 
Intra-epithelial lymphocytes have been shown to have NK activity in 
vitro (Mowat et al., 1983) but not in vivo (Baca et al., 1987). 
This discrepancy between the in vitro and in vivo properties of 
intra-epithelial lymphocytes appears to be due to the inability of 
the cells to recirculate in vivo. Recent work has suggested that 
the intra-epithelial lymphycytes are already activated in vivo and 
may play an important role in protecting the epithelium (Baca et 
al., 1987).
The finding in the present study of NK phenotype in the
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intra-epithelial lymphocytes in the gastric crypts in view of the 
current knowledge regarding intra-epithelial lymphocyte function 
suggests that this forms part of the immune response of the gastric 
mucosa to an antigenic stimulus from the lumen. The presence of 
Helicobacter pylori on the luminal surface of the gastric crypts 
would appear to be a candidate for the source of this antigenic 
stimulus. However NK phenotype was identified in the intra- 
epithelial lymphocytes in cases in which Helicobacter pylori could 
not be demonstrated.
The identification of an increased frequency of intra- 
epithelial lymphocytes with NK activity in the gastric crypts 
adjacent to foci of IM in the present study is of interest. It is 
possible that the NK positive cells represent a response to a 
marked antigenic stimulus. The presence of adjacent foci of 
intestinal metaplasia suggests that the end stage of the gastric 
epithelia response may be the transformation to intestinal 
metaplasia.
Although mentioned in the introduction to the discussion it 
must again be stressed that in the absence of quantification and 
functional studies of the lymphocyte sub-populations the 
interpretation of the present study is based solely on the 
subjective impression of the micro-anatomical distribution of the T 
cell subsets.
BLA-Dr
Class 11 histocompatibility antigens (HLA-Dr) are genetically 
encoded molecules that restrict the immune response (Nixon et al.f
1982). In addition to the detection of HLA-Dr antigens on bone 
marrow derived cells such antigens have been detected on cells in 
the gut (Scott et al., 1980; Selby et al., 1981; Spencer et al., 
1986). Previous studies have identified that HLA-Dr positive
epithelial cells appear in the normal small intestine and colon 
(Scott et al., 1980; Spencer et al., 1985) and in the gastric 
mucosa affected by gastritis (Spencer et al., 1986). The 
epithelial cells expressing the HLA-Dr antigen appear in specific 
sites in the gut; on epithelial cells adjacent to lymphoid 
follicles in the stomach and the intestine (Scott et al., 1980; 
Spencer et al., 1986).
The present study has demonstrated (in a larger number of 
cases than previously reported) that epithelial cells expressing 
HLA-Dr antigen are absent from normal mucosa but with lymphocytic 
infiltrate within the lamina propria the gastric epithelial cells 
adjacent to the lymphoid follicles express HLA-Dr antigen. In 
severe gastritis with a heavy infiltrate of lymphocytes the crypt 
epithelium at all levels express HLA-Dr. Previous studies have 
postulated that the presence of HLA-Dr antigen in specific sites 
adjacent to lymphoid tissue suggests a relationship between the 
lymphoid tissue and the HLA-Dr positive epithelium (Spencer et al., 
1986). The hypothesis has been advanced that the lymphoid tissue 
may produce a substance, possibly interferon (Steeg et al.,
1982; Hirsch M R  et al., 1983) which may recruit epithelial cells 
into the immune process. The epithelial cells expressing HLA-Dr 
may be able to present antigens from the lumen underlying 
lymphocytes in the lymphoid follicle. Although the present study
has confirmed the previous observation that HLA-Dr expression is 
present in mild gastritis on the epithelium adjacent to lymphoid 
follicles (Spencer et al.f 1986) it has also demonstrated that in 
severe gastritis the HLA-Dr expression is present on all cell types 
in the gastric crypts from the luminal surface to the base and is 
not always associated with organised lymphoid structures. If the 
hypothesis of antigen presentation by the epithelial cells is 
correct then it suggests that in severe gastritis this is a 
widespread phenomenon.
Tumour
T Cell Sub-sets
The inflammatory response to gastric carcinoma has been 
identified as an important prognostic variable (Monafo et al., 
1962). The nature of the inflammatory response is also one of the 
criteria used by Lauren (1965) to distinguish between intestinal 
and diffuse type tumours. The difficulty in interpreting the 
results of any study on T cell sub-sets and tumour material is in 
determining what represents a response to necrosis within the 
tumour rather than a specific response to tumour itself. Within 
the limits of the present study in which objective numerical data 
on the T cell sub-sets was not available and the number of cases 
are small, there appeared subjectively to be no difference in the 
distribution of T cell sub-sets between the intestinal and diffuse 
type tumours of Lauren.
Lauren (1965) described the inflammatory response to the 
intestinal type of tumour as predominantly polymorphonuclear and
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that to diffuse as mononuclear. The polymorphonuclear response to 
the intestinal type is frequently associated with partial tumour 
necrosis (Mehrotra et al., 1978). The present study suggests that 
if T cell sub-sets are examined independently of the 
polymorphonuclear response then there is no subjective difference 
between the immune response in intestinal and diffuse types.
The identification of lymphocytes in the present study within 
tumour acini in an "intra-epithelial" position is of interest in 
view of the role of intra-epithelial lymphocytes discussed in the 
previous section. Are these "tumour intra-epithelial lymphocytes" 
responding to some antigenic stimulus within the glandular lumina, 
and if so then what is the nature of the stimulus? The answer to 
these questions requires further study.
HLA-Dr
The present study has identified a dichotomy in the staining 
with the anti HLA-Dr antibody on the tumour epithelial ie present 
in some cases, completely absent in others. A similar pattern of 
expression of HLA-Dr has been noted in colorectal carcinoma (Daar 
et al., 1982; Van de Ingh, 1987) and these studies have not 
identified any relationship between the degree of differentiation 
of the tumour or tumour stage and the presence of HLA-Dr. The 
expression of HLA-Dr in the present study on inflamed gastric 
epithelium suggests that the expression of HIA-Dr by the tumour 
cells is not a feature of overt malignant transformation only.
293
CHAPTER 9 
FbflHftL Sx^ ffiQI
Several aspects of the developing human fetal stccnach are of 
relevance to the histogenesis of gastric carcinoma. The concept 
of intestinal metaplasia as a congenital heterotopia although 
abandoned by Magnus (1937) has been rekindled by the description of 
intestinal type cells in fetal stomachs by Salinius (1962). Tfte 
second aspect of relevance to the adult is the expression of mucins 
and carcino-embryonic antigen by fetal gastric epithelia. To 
what extent the mucin histochemical and immunocytochemical changes 
in the adult stomach described in Chapter 4 and Chapter 5 represent 
a return to an embryonic pattern requires investigation. A 
further related feature is the appearance of specialised cells in 
the gastric mucosa during fetal development and the intrinsic 
factor antibody developed in Chapter 5 has been used to examine 
parietal cell development.
ASMS
1. To determine if intestinal type epithelium is present in the
fetal stomach in the various stages of gestation.
2. To examine the mucin expression of fetal gastric epithelial
throughout gestation.
3. To examine the expression of carcino-embryonic antigen by
fetal gastric epithelial throughout gestation.
4. To study the development and distribution of the parietal
cell using an intrinsic factor antibody in fetal gastric 
epithelium throughout gestation.
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RESOUS
The number of cases and gestational age of the fetal stomachs 
calculated using the crown rump length is shown in table 48. 
HigmmGY
The preservation of the fetal and neonatal gastric mucosa was 
excellent in most cases. However in four specimens the columnar 
mucus cells which constituted the cells of the gastric crypts were 
disrupted and lay free in the lumen of the stcmach.
Changes throughout development
In the earliest fetus (gestational age 8 weeks) examined the 
gastric mucosa was formed by a pseudostratified columnar epithelium 
containing numerous mitotic figures. The mucosal cells had a 
uniform appearance and none showed any distinct morphological 
features.
By 11 weeks rudimentary gastric crypts were easily identified 
with an average three to four larger eosinophilic cells lying at 
the base of the glands in all areas of the stomach examined. 
These cells closely resembled parietal cells on morphological 
grounds: they were roughly conical in outline with the broad base
protruding out from the wall of the gland. At the 11 week stage 
the epithelial changes were accompanied by the development of a 
well defined circular muscle layer.
In fetuses from 13-17 weeks the gastric crypts still appeared 
rudimentary but had increased in height. In both the antrum and 
body of the stomach groups of 4-5 cells with the morphological
Fetus Neonate
gestational., age Term +. days
(weeks)
8 11 13 14 15 17 18 20 21 24 25 26 28 +1 +3 +2 1
No of
cases 1 1 4 3 1 1 2 5 3  4 2 6 8  1 1 1
Table 48. Gestational age of fetuses and age of neonates.
Photomicrograph 28. Stomach of 11 week gestation fetus with
primitive gastric crypts. Haematoxylin 
and eosin x 100.
Photomicrograph 29. Fetal stomach at 11 weeks gestation showing
primitive crypts with eosinophilic cells at 
base. Haematoxylin and eosin x 420.
features of parietal cells at the base of the glands.
In fetuses of 18-2 weeks the mucosa had increased in 
thickness with the gastric glands in the body taking on the 
characteristic adult pattern of simple tubular glands. The 
surface was lined by tall mucous secreting columnar cells that 
extended down to the isthmus of the crypts. Below the level of 
the isthmus the tubular gastric glands were cut in cross section. 
The antral region at the 18-28 week stage was formed by glands of 
branched tubular type containing a large proportion of mucous 
columnar cells.
Neonatal Stomachs
In the five neonatal stomachs examined the body and antral 
mucosa had a similar appearance to adult gastric mucosa although 
the thickness was less. Morphologically distinct parietal and 
peptic cells were present in large numbers in the body mucosa. 
However in all the cases examined small numbers of parietal cells 
were identifiable histologically in the antral mucosa situated 
mainly at the base of the glands just above the muscular is mucosae. 
Observations regarding intestinal metaplasia in the fetal and 
neonatal stomach
All the fetal stomachs were carefully examined histologically 
for the presence of foci of intestinal metaplasia. In the early 
gestation period when the stomachs were embedded and cut as a 
single sample small intestinal crypts were seen on the sections but 
these crypts were clearly situated within the duodenum. An area 
of transition between the gastric epithelium and duodenal
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Photomicrograph 30. Fetal stomach at 14 weeks gestation.
Neutral mucin in epithelial cells AB/PAS x 
300.
Photomicrograph 31. Fetal duodenum at 18 weeks gestation.
Haematoxylin and eosin x 100.
epithelium was identified in a few cases. In this transitional 
zone occasional goblet cells and columnar absorptive cells were 
present in the gastric epithelium immediately adjacent to the 
duodenal mucosa. In two cases in the transitional zone between 
the gastric and oesophageal mucosa goblet like cells were 
identified.
MPCIN HIgroCHBgSHg
At eight week gestation in the earliest fetus examined mucin 
stains did not reveal the presence of any type of mucin. By 11 
weeks of gestation the columnar cells were seen to contain neutral 
mucins only with no evidence of sialo or sulphomucins within these 
cells. In the 13-17 week fetuses the columnar cells both at the 
base and surface of the glands contained neutral mucin. In 
fetuses of 18-28 weeks the body mucosa contained neutral mucins in 
the columnar cells on the surface and upper half of the glands, the 
columnar epithelial cells at the base did not display any positive 
staining for mucin. In the antral glands of fetuses from 18-28 
weeks columnar cells containing mucin were distributed throughout 
the entire length of the crypts.
Sialo and sulphomucins were identified in only two fetuses 
and were restricted to the oesophago-gastric junction as described 
in the histological section. N acetyl sialo-mucin and sulphomucin 
were present in both columnar and goblet cells in this area. 
TMMDTOCTKXHBgSTRY 
Intrinsic Factor
In the earliest fetus (8 weeks) no immunoreactive cells were 
identified with the intrinsic factor antibody. In the 11 week 
fetus the larger eosinophilic cells lying at the base of the glands
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Photcmicrograph 32. Oesophago-gastric junction at 18 weeks
gestation. Haenvatoxylin and eosin x 100.
Photomicrograph 33. High iron diamine/Alcian blue stain of
oesophago-gastric junction at 18 weeks 
gestation showing sulphomucin positive 
material in columnar cells x 360.
were strongly immunoreactive for intrinsic factor, the luminal and 
supranuclear cytoplasm showing intense staining in a bandlike 
configuration. In fetuses from 13-17 weeks the cells with 
morphological features of parietal cells in both the antrum and 
body were strongly immunoreactive for intrinsic factor.
In fetuses of 18-28 weeks in the body mucosa the glands lying 
below the level of the isthmus of the gland which were cut in cross 
sections contained numerous cells strongly immunoreactive for 
intrinsic factor. Occasional cells with eosinophilic cytoplasm 
and a centrally placed nucleus were identified at the isthmus of 
the glands, or above this level, between the mucous columnar cells 
and the surface mucosa. These cells were also strongly
immunoreactive for intrinsic factor.
In the antral crypts of fetuses 18-28 weeks parietal cells 
were present in the basal part of the glands in small numbers and 
these were immunoreactive for intrinsic factor.
Sections of duodenum and oesophagus from fetuses of all 
gestational ages studied showed no positive staining with the 
intrinsic factor antibody.
In the neonatal stomachs parietal cells could be clearly 
identified in the body mucosa on histological grounds and these 
were immunoreactive for intrinsic factor and were distributed below 
the isthmus of the gland. The parietal cells sporadically
identified in the neonatal antral mucosa by histology were also 
immunoreactive for intrinsic factor.
Photomicrograph 34. Fetal stomach at 11 weeks gestation with
parietal cells positive for intrinsic 
factor at the base of the crypts. PAP 
method x 360.
Photomicrograph 35. Fetal stomach at 11 weeks gestation with
parietal cells positive for intrinsic 
factor at the base of the crypts. PAP 
method x 420.
Photomicrograph 36. Fetal stomach at 24 weeks gestation with
parietal cells with positive staining for 
intrinsic factor in the lower part of the 
glands.
Photomicrograph 37. Fetal stomach at 8 weeks gestation.
Gastric epithelium formed by pseudo— 
stratified cells positive for CEA. PAP 
method x 400.
Photomicrograph 38. Fetal stomach at 18 weeks gestation with
cells throughout the gastric crypts 
positive for CEA. PAP method x 360.
eosinophilic cells at the base of the primitive pits at 11 weeks 
confirms the finding of Salenius (1962). The identification of 
these cells as parietal cells and the presence of these cells in 
the antral region are discussed later in relation to the intrinsic 
factor antibody.
Observations on the presence of intestinal epithelium
Earlier this century the presence of intestinal epithelium in 
the gastric mucosa was regarded as a congenital heterotopia 
(Taylor, 1927). The basis for this view appears to have been the 
histological findings of intestinal epithelium in stomachs resected 
for gastric carcinoma or ulcer in areas of the stomach with "no 
signs whatever of an inflammatory condition". This finding in 
Taylor's view resulted in the conclusion that their (aberrant 
glands) "only abnormality is one of position and their congenital 
and their nature is beyond doubt" (Taylor, 1927). The concept of 
the presence of intestinal epithelium in the gastric mucosa as an 
example of congenital heterotopia was challenged by Magnus (1937) 
who regarded the presence of intestinal islets in the gastric 
mucosa as a metaplasia as the result of faulty regeneration of the 
gastric mucosa as a consequence of gastritis. To emphasise the 
acquired rather than congenital nature of intestinal metaplasia 
Taylor (1927) examined 12 fetal stomachs of gestational age six to 
nine months and found no histological evidence of intestinal 
epithelium.
The congenital origin of intestinal heterotopia was 
disregarded following the work of Magnus (1937) until the recent
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description of intestinal type cells in fetal stomachs by Salenius 
(1962). This finding has led to the suggestion that intestinal 
metaplasia seen in the adult with atrophic gastritis could be 
associated with a return to this more primitive cell population 
(Deren, 1971). The apparent discrepancy between the work of
Magnus (1937) and Salenius (1962) regarding the presence of 
intestinal cells in the fetal stomachs can be explained by the 
different gestational ages examined by the two authors. Salenius 
(1962) describes intestinal type cells being numerous in fetuses up 
to the age of five months, whereas Magnus (1937) studied only 
fetuses of six months gestation onwards.
Although Salenius (1962) describes "intestinal type cells" 
being "encountered abundantly" up to 20 weeks gestation, two 
aspects of his work require to be considered. First his 
description is not of mature foci of intestinal epithelium within 
the fetal gastric mucosa but is of isolated goblet cells and 
absorptive type columnar cells. Secondly that the occurrence of 
such cells is restricted to two sites; the pyloro-duodenal 
junction and the cardio-oesophageal junction. The presence of 
intestinal type cells in the antrum is not recorded in the present 
study as the junction between stomach and duodenum was regarded as 
a transitional zone, neither truly stomach nor truly small 
intestinal type epithelium. The presence of goblet cells and 
columnar absorptive cells with gastric epithelium in this small 
area of transition was not regarded as a heterotopia but rather as 
gradual change from one type of mucosa to another.
The present study has also detected goblet cells at the 
cardio-oesophageal junction as described by Salenius (1962). It 
is difficult in the histological material to determine if these 
cells are oesophageal or gastric in origin. The mucin 
histochemistry of this area shows a pattern similar to that found 
in Type lib metaplasia (Jass, 1980). Goblet and columnar cells in 
the adult at the gastro-oesophageal junction may originate from the 
cardiac glands or from the development of columnar epithelium lined 
oesophagus (Barret's oesophagus) (Peuchmaur et al.f 1984). 
Columnar epithelium lined oesophagus is generally regarded as an 
acquired condition (Bremner et al., 1970) of adult life so the 
origin of the goblet cells in the present study is likely to be 
from the cardiac glands. The goblet cells in the present study 
were present only in two cases and unfortunately disappeared on 
serial sectioning. The site of such cells at the gastro- 
oesophageal junction and their likely origin in the cardiac glands 
cannot be construed as evidence that heterotopic intestinal 
epithelium is present in the gastric mucosa.
Mucin hi gfrnrhpmi crf-ry
Sialomucins have been identified in the total gastric 
epithelial cells using Alcian blue pH 2.5 stain in two previously 
reported studies (Stemmermanr 1967; Lev 1968). Small numbers of 
cases were examined in these studies and the exact stage of 
gestation during which the sialomucins were identified is not clear 
(Stemmerman, 1967; Lev 1968). The present study identified only 
neutral mucins in the columnar cells of the fetal gastric
epithelium at all stages of gestation. The reason for the 
discrepancy between the results of the present study in which 
neutral mucins only were identified and previous studies in which 
sialomucins (Lev, 1968; Stemmerman, 1967) were identified is not 
clear. The results of the present study do not support the 
hypothesis that the expression of sialomucin and sulphomucin in the 
diseased adult stomach represents a reversion to a fetal pattern as 
suggested by some authorities (Filipe, 1979).
Tmmmonytnrhprni atry
Intrinsic factor antibody
In the adult gastric mucosa, parietal cells are easily 
recognised by their typical histological appearance as described by 
Ito (1967); the cells are located on the periphery of the wall of 
the gastric gland - hence "parietal" - and this name is preferred 
to the alternative "oxyntic" (acid forming) cell. They are easily 
distinguished from the chief cells, mucous neck and surface mucous 
cells and neuro-endocrine cells by their characteristic position 
and histological appearance.
The first differentiated gastric cells appear at the base of 
the evolving gastric crypts at 11 weeks gestation. 
Ultrastructural studies (Nomura, 1966) and enzyme histochemical 
studies (succinic dehydrogenase) (Salenius, 1962) have suggested 
that these cells are parietal cells. The present study using a 
polyclonal antibody has localised intrinsic factor within these 
cells, presumptive evidence that these large eosinophilic cells at 
the base of the crypts have already differentiated into functional
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parietal cells by 11 weeks of gestation. The significance of the 
finding of intrinsic factor within parietal cells at such an early 
gestational age is not clear and requires further study. Recent 
work (Pacer et al., 1989) has demonstrated that the development of 
the fetal gastric epithelium may be preceded by the development of 
a fully differentiated endocrine cell component as endocrine cells 
are identifiable by 8 weeks gestation in the human fetal stomach. 
The relationship between the endocrine component and the 
development of the fetal stomach has still to be determined.
There is considerable variation of opinion as to the 
distribution of parietal cells within the developed stomach, a 
point which is of importance in the interpretation of gastric 
biopsies. Textbooks of histology such as Ham (1974) suggest that 
parietal cells may be seen in the region of the pyloric sphincter. 
Ito (1967) agrees with this but some clinical texts, for example, 
Morson and Dawson (1979), say there are no "acid secreting" cells 
in the region. The intrinsic factor-containing cells identified 
in the present study in the antral region of the fetal stomach are 
according to standard morphological criteria parietal cells. 
Schwartz & Weber (1971) demonstrated intrinsic factor to be present 
in homogenates of the antral region of the fetal stomach at 11 
weeks gestation. Salenius (1962) described the presence of 
parietal cells in the antrum in his study of the ontogeny of human 
gastric epithelial cells. Tominaga (1975) also noted parietal 
cells in the antral region of both adult and neonatal stomachs in 
98% of cases. The present study using the polyclonal antibody has
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detected parietal cells at all stages of gestation in the antral 
region. Although fewer in number than in the body of the stomach 
the present study suggests that in the fetal stomach the antrum and 
body do not show a sharp demarcation with regard to the
distribution of the parietal cells.
Carcino-embryonic antigen
The investigation of the concept that human embryonic tissues 
and adult tumours might share similar antigens led to the discovery 
of carcino-embryonic antigen discovered by Gold and Freeman, 1965, 
as present in fetal gut in the second and third trimester and was
also present in a variety of adult epithelial tumours of gut
origin. Since its initial discovery it is now clear that CEA may 
occur in benign disease of the adult gastro-intestinal tract 
(Huitric et al., 1976; Isaacson and Judd, 1977). The
significance of CEA is further complicated by the cross reactions 
with normal antigens that can occur with anti CEA sera (Nap et al., 
1983). Non specific cross reacting antigen (NCA) and non specific 
cross reacting antigen 2 (NCA2) have been shown to occur in normal 
stomachs (Nap et al., 1983).
Although CEA was first extracted from fetal gut (Gold and 
Freeman, 1965) little is known about the cellular localisation of 
CEA within the fetal stomach. The present study has demonstrated 
that, using immunoperoxidase techniques and the commercially 
available (DAKO) with CEA antibody, CEA can be demonstrated in the 
gastric epithelium of first and second trimester fetal stomachs. 
Unfortunately third trimester stomachs were not available for study
307
but CEA could not be demonstrated in the neonatal stomachs studied. 
After absorption of the DAKO antibody with normal adult stomach to 
remove the NCA2 activity (Nap et al., 1983) the immunoperoxidase 
staining pattern was unchanged, thus indicating that the 
immunoreactivity was due to CEA rather than "CEA like material".
Characteristic patterns of CEA localisation have been 
described in gastric metaplasia and normal and neoplastic colonic 
epithelia (Nagura et al., 1982; Neilsen et al., 1982; Ahnen et 
al., 1982). In intestinal metaplasia and normal colon the CEA was 
found on the apical surface of the cells and in the cytoplasm 
adjacent to the nucleus whereas in malignancy the CEA was 
distributed over the entire cell. The present study has 
demonstrated that CEA in fetal stomachs is located on the luminal 
surface and the basal cytoplasm adjacent to the nucleus in a 
similar manner as that described in intestinal metaplasia and 
normal adult colon. The CEA was present in cells at all levels of 
developing gastric crypts. The biological significance of the 
expression of the CEA glycoprotein in the fetal stomach is unclear. 
Studies on adult gastric epithelium presented in this thesis 
indicate that in the presence of gastritis the mucus neck cells of 
the gastric crypts express CEA. The expression of CEA may be a 
primary or secondary event in cell transformation both in the fetal 
and adult stomach.
308
CHAPTER 10
Sunnary and Conclusions
The aim of this thesis was to investigate aspects of the 
sequence outlined in figure 11 with particular reference to the 
role of intestinal metaplasia in the histogenesis of gastric 
carcinoma. To summarise and discuss the conclusions of the thesis 
it is appropriate to start at the origin of the sequence - the 
fetal stomach/ and end with the intestinal and diffuse type tumour.
The histological study of the forty fetal stomachs 
illustrated the development of the gastric epithelium from a 
primitive pseudostratified structure to the specialised glandular 
formation similar to that in the adult. No histological evidence 
was seen to support the concept of intestinal metaplasia as a 
congenital heterotopia. Intestinal type cells were seen but in 
two distinct sites - the oesophago-gastric and duodeno-gastric 
junction. Both these sites represent a transition from one type 
of epithelium to another and with an oblique section the presence 
of goblet or columnar cells in this region in the gastric mucosa 
was not considered to represent a true heterotopia.
The immunocytochemical studies on the fetal tissue 
demonstrated two important findings. First that as early as 11 
weeks gestation cells were immunoreactive with intrinsic factor 
antibody. Secondly that in the first and second trimester the 
fetal stomach is immunoreactive with CEA antibody. Hie first 
finding is of biological interest but further studies are required 
to assess the functional significance. The second finding 
illustrates that in the evolving stomach CEA is expressed by the 
epithelium as it is in the adult stomach in response to gastritis,
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metaplasia, dysplasia and neoplasia.
Several aspects of the change from a healthy to an inflamed 
gastric mucosa have been addressed in this thesis. This change is 
accompanied by alterations in phenotypic expression of the 
epithelial cells. Abnormal mucins have been detected and the 
epithelial cells express secretory component, IgA and carcino- 
embryonic antigen. In addition to these changes in the epithelial 
cells there is an increase in number of neuro-endocrine cells 
within the gastric crypts. An increased cell turnover has been 
demonstrated in the inflamed mucosa by the thymidine labelling 
studies. The immunological studies have illustrated increasing 
numbers of intra-epithelial lymphocytes with T cytotoxic/suppressor 
and NK phenotype in gastritis and widespread induction of Class II 
MHC antigens (HLA-Dr) on the inflamed epithelium.
To try to integrate all the individual items of information 
obtained on the alterations that occur in the gastric crypts and 
lamina propria with inflammation into a cohesive whole is extremely 
difficult. Ihe study of histological material although providing 
micro-anatomical detail does not provide information regarding the 
functional significance of these changes. The finding of large 
numbers of neuro-endocrine cells adjacent to lymphoid follicles 
suggests that there may be sane link between these components of 
the gastric mucosa and that in turn the neuro-endocrine cells may 
play a role in controlling via a paracrine route the increased cell 
turnover of the crypts identified in the present study.
Two specific elements amongst the many aetiological factors
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proposed for gastritis have been studied, namely alkaline reflux 
and Helicobacter pylori. Alkaline reflux gastritis is of 
particular surgical interest because of the possible role of 
surgery for benign peptic ulceration on the development of gastric 
cancer. The study of patients in this thesis who had undergone 
gastric surgery for peptic ulceration has confirmed the work by 
Dixon et al., 1986, in identifying the specific histological 
features characteristic of reflux gastritis. The kinetic studies 
in the present work have shown an elevation in labelling index in 
such patients correlated to the reflux score when compared with 
controls and changes in the distribution of the proliferative zone 
within the gastric crypts. In view of the reported increased 
incidence of gastric cancer in these patients these kinetic 
abnormalities may be direct relevance to the carcinogenetic 
process. The exact role played by vagal sectioning, bile 
constituents and alteration in pH in the genesis of the kinetic 
changes in the post-operative stomach require to be addressed. 
The most suitable vehicle for this would be an animal model.
The identification of Campylobacter-like organisms within the 
stomach by Warren and Marshall in 1984 coincided with the start of 
the collection of data for this thesis. The incidence of 
Helicobacter pylori in the gastrectomy study and in the biopsy 
material from the Medical Treatment Group is similar to that of 
previous studies. Ihe low incidence of the organism in the post­
operative stomach and the absence of the organism in foci of 
intestinal metaplasia reported by other authors, have been
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confirmed. The presence of the organism has been shown in the 
present study to be significantly associated with a higher 
gastritis score and this in turn results in a significantly higher 
labelling index when compared with mucosal biopsies in which the 
organism could not be demonstrated. The relationship of the 
organism to the genesis of intestinal metaplasia was examined by 
comparing the amount of intestinal metaplasia in the gastrectomy 
specimens with and without the organism. The comparison showed no 
significant difference in the amount of metaplasia between the 
groups. The natural history of Helicobacter pylori remains 
unclear and if gastritis with subsequent intestinal metaplasia 
formation results in eradication of the organism then a comparison 
of the amount of intestinal metaplasia in gastrectomy specimens 
might not be expected to show any difference as the stomach with 
extensive IM may have eradicated the organism. The study of T 
cell subsets revealed no difference in the pattern of T cell 
distribution in inflamed mucosa with or without the organism. The 
presence of intra-epithelial lymphocytes in inflamed mucosa 
suggests that these cells in this position are a response to an 
antigen within the gastric lumen. Helicobacter pylori may 
represent the antigenic stimulus in some cases but the migration of 
lymphocytes demonstrated in this thesis into the intra-epithelial 
position is not specific to stomachs with Helicobacter pylori 
present.
The role of intestinal metaplasia in the histogenesis of 
gastric carcinoma was the initial central area of investigation of
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this thesis. The present study has identified a significant 
association between the presence of intestinal metaplasia in 
stomachs resected for malignant disease compared with benign 
disease and a significantly increased amount of intestinal 
metaplasia in stomachs resected for malignant disease compared with 
benign disease, The benign and malignant
groups however are not comparable as there were differences in age 
and the secondary effects of the tumours ie. inflammation and 
ulceration were more marked than the benign lesions. For this 
reason a multivariate analysis was performed and this demonstrated 
that age, inflammation and ulceration provided at least an 
alternative (and at the extremes of age, inflammation and 
ulceration are a more likely) explanation for the presence of 
intestinal metaplasia than the presence of malignancy per se. A 
similar pattern was seen when Type lib intestinal metaplasia was 
assessed. The significant association of Type lib intestinal 
metaplasia demonstrated by Jass 1980 with the intestinal type of 
tumour was again demonstrated in this thesis. However the results 
of this thesis suggest the reason for the association is not a 
histogenetic link between Type lib and the intestinal type of 
tumour but due to effect of a higher age, gastritis score and 
frequency of ulceration in the intestinal tumour group.
The interpretation and identification of dysplasia is 
extremely difficult and observer dependent. The sub-types of 
dysplasia described by Jass 1983 were identified in the study but 
no association between any particular sub-type and specific types 
of tumour could be identified. Studies are required to clarify 
the natural history of gastric dysplasia and its clinical
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significance.
The classification of the gastric tumours into the major 
classification systems and a comparison with the Lauren system 
resulted in data which was difficult to interpret but did give some 
insight into the problems in dealing with tumours with such a 
heterogenous histological picture. In an attempt to examine the 
Lauren classification system in a more objective manner an 
artificial scoring system was created. This demonstrated the 
considerable histological overlap between the intestinal and 
diffuse types of tumour. This finding raises serious misgivings 
about the validity of the Lauren system in dividing the tumours 
into intestinal and diffuse types. Ihe question mark placed by 
the work of this thesis on the separate existence of tumours of 
intestinal and diffuse types is a further reason for doubting the 
role of intestinal metaplasia in the histogenesis of gastric 
carcinoma.
The mucin and immunocytochemical studies presented have 
identified a series of phenotypic changes that occur in inflamed 
gastric mucosa. Metaplasia, dysplasia and neoplasia have also 
been shown in this study to result in phenotypic changes which do 
not appear to be significantly different from those occurring in 
inflamed mucosa. The results of these studies have been 
interpreted as objectively as possible and no attempt has been made 
to prove or disprove any particular preconceived theory of 
histogenesis using the changes in phenotypic expression. When 
the results are interpreted from this viewpoint there does not
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appear to be any discernible sequence of changes in phenotypic 
expression which are specifically associated with malignancy or any 
tumour sub-group.
The most important facet of any study in the field of 
medicine is the benefit to patients. The clinico-pathological 
section of the thesis has illustrated that the majority of patients 
present with an advanced tumour and that the prognosis is extremely 
poor. Tlie clinical and pathological staging of the tumours is 
poorly performed. The encouraging results from Japan quoted in 
this thesis even in the treatment of advanced lesions may hopefully 
alter the therapeutic approach to these patients.
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appbtoix
Statistical Methods
Mucin Histochemical Techniques
Statistical Methods
1. Statistical tests
The two sample t test, Chi square analysis with Yates' 
correction, method of least squares and correlation coefficient 
analysis were performed using the methodology outlined in 
"Interpretation and Uses of Medical Statistics" by Bourke, G.J., 
Daly, L.E., McGilvry, J., Blackwell Scientific Publications, 
Oxford, 1985.
2. GkIM analysis
A. Estimates of probability for the presence of intestinal 
metaplasia of any type are given below for single variables 
and for combinations of variables.
For any particular hypothesis the probability of the presence 
of metaplasia in a patient with a particular set of variable 
values takes the form:
expit )  
exp(t) +1
where t depends on the hypothesis and the variable values. 
Ulceration
t = c + ur ui = non ulcerated = 0
U2 = ulcerated = -0.2301 
c = 1.186
344
Inflammation
A1 = grade 1 gastritis = 0
i2 = grade 2 gastritis = 0.1335
i3 = grade 3 gastritis = 1.281
H = grade 4 gastritis = 10.92
c = -0.6931
Age
t = c x age
c = -2.751 b = 0.06155
Diagnostic Group
t = c + gr g3 = benign = 0
g2 = intestinal type = 9.681
g3 = diffuse type = 8.929
c = -9.496
Inflammation and age (i + a) 
t = c + ir + b x  age
■*■0 = 0
i2 = 0.8485
i3 = 1.972
A4
= 11.85
A5 = 11.67
c = -6.363
b 0.0808
345
Ulceration and age
t = c + ur + a Uj = no ulceration = 0
U£ ® ulceration = h
b = 0.06178
c = -2.650
Ulceration and inflammation
t = c + ur + is = 0
i2 = 0.1643 
3 = 1.487
14 = 11.27
15 = 11.35
Uj = no ulceration = 0 
u2 = ulceration = 0. 
c = -1.312 
Ulceration, inflammation and age 
t = c + ur + is + bx age
*1 = 0
h = 0.9052
i3 = 2.358
= 12.36
*5 = 12.56
b = 0.09068
U1 = 0 = no
u2 = 1.172 =
c - -7.940
.2482
8811
346
t = c + i,
B. Estimates of probability for the presence of Type lib 
intestinal metaplasia for single variables and 
combinations of variables are given below.
Inflammation
ij = grade 1 gastritis = 0
i2 = grade 2 gastritis = -0.693
i2 = grade 3 gastritis = 0.5109
i^  = grade 4 gastritis = 2.120
i5 = grade 5 gastritis = 1.341
c = -1.609
Age
t = c + b x age c = -3.923 
b = 0.04853
Ulceration
t - c + u, = no ulceration = 0 
u2 = ulceration = 0.3875
Diagnostic group
t = c + gr g-L = benign = 0
g2 = diffuse type tumour = 0.575 
g2 = intestinal type tumour = 3.526 
c = -2.079
347
Inflammation and age
t = c + is + b age
11 “ 0
12 = -0.2527
13 = 0.7906
14 = 2.527
15 = 1.527
b = 0.04946 
c = -5.124
Ulceration and age
t = c + ur + b x  age
Uj = 0
u2 = -0.0403
i j  = 0
12 = 0.6944
13 = 0.502
14 = 2.109
15 = 1.325 
c = -1.583
348
Ulceration, inflainnation and age 
t = c ur + is b x age
= 0 
U2 = 0.0603
ii-0
12 = -0.2547
13 = 0.8009
14 = 2.545
15 = 1.551
b = 0.04978 
c =-5.185
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3. Validation of Counting Techniques
A. The repeated counts of the number of gastric crypts and
intestinal metaplatic crypts in 10 cases from the human 
gastrectomy study are shown in table 49.
B. The repeated counts between two different areas and on the
same area in 10 cases from the Thymidine Labelling Study are
shown in table 50.
C. The repeated counts between two different areas and on the
same area in 10 cases from the Immunological Study for the
three counting techniques, high power fields, point counting 
and mucosal unit length are shown in tables 51, 52 and 53.
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Casa First Count Second Count Coefficient
gastric I Ila H k gastric I U a H b of variat
1 1317 32 0 0 1341 32 0 0 1.27
2 164 821 0 0 175 837 0 0 3.2
3 707 221 8 23 725 208 11 24 4.3
4 342 17 0 9 353 19 0 8 0.43
5 1417 36 0 9 1417 36 0 9 0
6 1457 48 7 0 1506 53 6 1 3.8
7 1011 52 11 13 1001 56 8 14 2.5
8 1628 57 0 0 1639 63 0 0 4.6
9 2178 0 0 0 2206 0 0 0 0.9
10 1439 210 0 0 1480 26 0 0 9.2
Table 49. Repeated counts of the number of gastric crypts and
intestinal metaplastic crypt sub-types (I, Ila and lib) 
in 10 cases from the Hunan Gastrectomy Study. 
Coefficient of variation for ratio of gastric to 
metaplastic crypts between counts is shown.
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Area 1
L U
l 15 762
2 48 1011
3 51 758
4 173 1937
5 11 2263
6 47 1174
7 118 2181
8 253 1712
9 65 1304
10 3 1198
Atea_2
First, count SaconsLco.unt
Ll IX L 11
4 465 9 891
27 843 76 1733
91 1046 87 1209
159 1221 182 1226
17 866 23 798
23 897 27 809
60 1607 49 1584
167 1022 152 933
84 1212 79 1331
5 643 8 1554
Table 50. Repeated counts in 10 cases from Thymidine Labelling 
Study. TVo areas counted - area 1 and area 2, count 
repeated in area 2.
L = labelled cells; D = unlabelled cells.
Count. JL*..Area .1 Count 2. Area 1 Count 3, Area 2
Case L U T L U T L U T
1 51 162 213 24 185 209 17 120 137
2 17 89 106 35 90 125 53 65 118
3 22 97 119 41 97 138 29 84 113
4 37 113 150 60 78 138 18 113 131
5 11 51 52 21 54 75 37 57 94
6 61 76 137 53 85 139 23 72 95
7 33 143 176 15 129 144 48 135 183
8 12 80 92 70 36 106 18 77 95
9 9 124 133 34 99 133 48 102 150
10 23 163 186 41 158 191 30 163 193
Table 51. Repeated counts in 10 cases using High Power Fields 
z 5 for Leu 1 labelled cells. Three counts 
performed: two counts on same area and third count
on different area (area 2) •
L = labelled, U = unlabelled, T = total number of cells 
counted.
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Case
Count lx.
L 0
Area 1 
T
Count. It. Area 1
L O T
Count
L
3 r
u
Area.,
T
1 21 41 62 13 26 39 23 28 51
2 17 24 41 9 41 50 17 31 48
3 30 60 90 22 37 59 30 19 49
4 7 43 50 15 20 35 33 42 75
5 45 29 74 16 33 49 15 15 30
6 11 19 30 25 40 65 19 26 45
7 26 15 41 28 51 79 21 28 49
8 14 26 40 10 19 39 35 39 74
Table 52. Repeated counts in 10 cases using Point Counting 
Technique for Leu 1 labelled cells. Three counts 
performed: tiro counts on same area and third count
on different area (area 2) •
L = labelled, D = unlabelled, T = total lumber of 
cells counted.
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Count l r Area 1 .Count. 2 r Area 1 Count 3 r Area 2
Case L 0 T L u T L 0 T
1 27 65 92 37 41 78 33 81 114
2 33 81 114 47 80 127 41 69 110
3 40 73 113 15 72 87 26 42 68
4 19 49 68 29 65 94 43 67 110
5 45 60 105 34 51 85 27 72 99
6 16 73 89 37 66 103 39 83 122
7 13 87 90 44 90 134 25 56 81
8 43 93 136 18 84 102 49 41 90
9 17 50 67 24 26 50 36 59 95
10 42 63 85 18 41 59 23 38 61
Table 53. Repeated counts in 10 cases using Mucosal Unit Length
for Leu 1 labelled cells. Three counts performed:
two counts on same area and third count on different
area (area 2).
L = labelled, U = unlabelled, T = total number of cells 
counted.
y
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4. Correction Factor for counting ttymidine labelled cells in 
cross, sections (a f ter Hansen e t al.-r 1975)..,
When cross sections containing labelled cells are counted, 
the labelling index will be overestimated because cross sections 
through the progenitor region which do not have labelled cells will 
not be included in the estimation. This error can be reduced by 
the use of the equation:
(1 - p)n = 1 - £
L I
where p represents the corrected labelling index, n equals the mean 
number of cells in the cross sections and LI the actual estimated 
labelling index.
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Alcian Blue/PAS technique (pH 2.5)
Method
(1) Bring sections to water.
(2) Stain in freshly filtered 1% Alcian blue 8GX in 
3% acetic acid for 30 minutes.
(3) Wash in water.
(4) Oxidize for 5 minutes in 1% aqueous periodic acid.
(5) Wash in running water for 5 minutes and rinse in
distilled water.
(6) Treat with Schiff reagent for 15 minutes.
(7) Wash for 10 minutes in running water.
(8) Counterstain with haematoxylin.
(9) Dehydrate, clear and mount in synthetic resin. 
Piastase-gejLiQdlg- acid. Schiff (ref 133).
Method
(1) Bring sections to water.
(2) Digest with diastase (1:1000 malt diastase in distilled 
water)
for 30 minutes at 37°C.
(3) Wash in water for 5-10 minutes.
(4) Wash with 90% alcohol, then absolute alcohol for half a 
minute.
(5) Transfer to stoppered container of 1% celloidin in equal 
parts
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alcohol and ether for 2 minutes.
(6) Drain off the excess of celloidin and transfer to 80% alcohol 
for 5 minutes.
(7) Wash in running tap water for 2 minutes.
(8) Oxidize for 5 minutes in 1% aqueous periodic acid.
(9) Wash in running water for 5 minutes, and rinse in distilled 
water.
(10) Treat with Schiff reagent for 15 minutes.
(11) Wash for 10 minutes in running water.
(12) Counter stain with haematoxylin.
PB/KOH/PAS (REF 134)
Method
(1) Bring sections to water
(2) Oxidize in 1% periodic acid at room temperature for 1 hour.
(3) Wash in water for 10 minutes.
(4) Treat with 0.1% sodium borohydride in 1% disodium hydrogen 
phosphate for 30 minutes.
(5) Wash in water.
(6) Treat with 0.5% potassium hydroxide in 70% alcohol for 30 
mins.
(7) Wash in 70% alcohol.
(8) Wash in water.
(9) Stain by PAS technique.
(10) Dehydrate, clear and mount in synthetic resin.
PB/PAS Method
Used as a control to ensure that all PAS reactivity has been
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abolished by the periodic acid.
Method
(1) Bring sections to water
(2) Treat as above, omitting steps (6)-(8).
(3) Dehydrate, clear and mount in synthetic resin.
High Iron Diamine/Alcian Blue
Reagent - diamine solution.
N,N-dimethy 1 -m-phenylenediamine dihydrochloride 120 mg 
N,N-dimethyl-p-phenylenediamine hydrochloride 20 mg 
Diamines dissolved in 50 ml of distilled water and 1.4 ml of 40% 
ferric chloride. The pH of prepared solution should be between 
1.5-1.6. The solution is used immediately.
Method
(1) Bring sections to water.
(2) Stain in diamine solution in Coplin jar for 24 hours.
(3) Stain in freshly filtered 1% Alcian Blue 8GX in 3% acetic acid 
(pH 2.5) for 30 minutes.
(4) Wash in water.
(5) Dehydrate, clear and mount in synthetic resin.
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